allerg
factor
hous
dust
mite
environ
childhood
asthma
control
dung
bach
mai
vietnam
children
hospit
vietnam
background
indoor
pollut
allergen
includ
hous
dust
mite
influenc
asthma
control
level
object
determin
rate
allergi
hous
dust
allergen
impact
associ
indoor
pollut
asthma
control
level
method
studi
questionnair
total
ige
test
skin
test
allerg
hous
dust
collect
children
asthma
enrol
januari
march
diagnosi
assess
asthma
control
level
child
determin
accord
gina
criteria
result
children
posit
skin
test
least
one
indoor
respiratori
allergen
remain
children
neg
skin
test
posit
group
posit
allergen
posit
proport
dermatophagoid
pteronyssinu
dermatophagoid
farina
highest
follow
hous
dust
allergen
blomia
cockroach
hairi
dog
lowest
rate
account
cat
fur
rate
posit
allergen
test
children
year
age
higher
children
year
p
similarli
rate
posit
allergen
test
children
total
ige
iuml
higher
children
total
ige
p
children
posit
allergen
test
uncontrol
partli
control
asthma
higher
group
children
neg
allergen
test
p
similarli
children
posit
test
two
allergen
uncontrol
partli
control
asthma
higher
group
children
posit
test
one
allergen
p
indoor
pollut
tend
associ
increas
risk
uncontrol
partli
control
asthma
particularli
irregular
bed
hygien
per
month
p
charcoal
fume
p
smoke
p
dog
cat
ownership
p
respect
remain
element
live
citi
countrysid
famili
hous
area
slightli
averag
whether
play
stuf
anim
associ
increas
risk
uncontrol
partli
control
asthma
conclus
rate
children
asthma
high
posit
skin
prick
test
respiratori
allergen
hous
dust
mite
irregular
bed
hygien
less
per
month
charcoal
fume
smoke
pollut
dog
cat
ownership
found
associ
increas
risk
uncontrol
partli
control
asthma
characterist
bronchial
respons
korean
gener
popul
suh
yoon
lee
yang
kwon
jang
sun
woo
yoon
park
cho
kook
yi
chung
kim
kim
jung
woo
hong
seoul
nation
univers
hospit
seoul
south
korea
univers
ulsan
colleg
medicin
seoul
south
korea
hallym
univers
sacr
heart
hospit
anyang
south
korea
seoul
nation
univers
bundang
hospit
seongnam
south
korea
nation
health
insur
servic
ilsan
hospit
goyang
south
korea
gachon
univers
gil
medic
center
incheon
south
korea
chungbuk
nation
univers
cheongju
south
korea
colleg
medicin
cathol
univers
korea
daejeon
south
korea
presbyterian
medic
center
jeonju
south
korea
chonnam
nation
univers
hospit
gwangju
south
korea
gwangju
veteran
hospit
gwangju
south
korea
cathol
univers
daegu
school
medicin
daegu
south
korea
ulsan
univers
hospit
ulsan
south
korea
pusan
nation
univers
yangsan
hospit
yangsan
south
korea
anatomi
colleg
medicin
univers
busan
south
korea
gyeongsang
nation
univers
colleg
medicin
jinju
south
korea
backgroundaim
bronchial
hyperrespons
intermedi
phenotyp
asthma
bronchial
respons
exist
dichotom
express
rather
exist
spectrum
aim
evalu
distribut
profil
bronchial
respons
korean
gener
popul
relationship
clinic
allergi
method
birth
cohort
particip
invit
visit
region
studi
hospit
perform
skin
prick
test
standard
spirometri
bronchial
provoc
test
well
detail
histori
physic
examin
subject
bronchial
respons
categor
one
five
order
group
well
respons
dose
ratio
rdr
continu
marker
airway
respons
distribut
frequenc
preval
recent
wheez
baselin
lung
function
preval
atop
sensit
across
five
group
well
rdr
associ
clinic
allergi
assess
result
among
particip
children
visit
studi
hospit
subject
reliabl
complet
bronchial
provoc
test
ten
percent
total
popul
show
provoc
concentr
inhal
methacholin
caus
fall
forc
expiratori
volum
second
mgml
group
present
mgml
group
total
show
mgml
time
mgml
group
display
mgml
mgml
well
group
final
present
mgml
group
group
sampl
increas
proport
subject
wheezi
episod
last
year
decreas
p
trend
proport
subject
sensit
panel
allergen
decreas
p
trend
wherea
mean
baselin
increas
p
hand
rdr
present
signific
elong
current
asthmat
other
p
also
trend
toward
increas
rdr
across
control
allerg
rhiniti
asthma
combin
allerg
rhiniti
asthma
group
p
conclus
gener
popul
wide
spectrum
bronchial
respons
bronchial
respons
age
associ
clinic
allergi
name
neg
baselin
lung
function
posit
atop
sensit
keyword
asthma
bronchial
respons
child
gener
popul
respons
dose
ratio
clinic
implic
bilevel
posit
airway
pressur
ventil
children
sever
asthma
exacerb
intens
care
unit
kang
cm
wu
et
lu
f
chiang
bl
wang
cc
pediatr
nation
taiwan
univers
children
hospit
taipei
taiwan
background
increas
studi
demonstr
earli
initi
ventil
includ
use
bilevel
posit
airway
pressur
bipap
safe
manag
children
acut
respiratori
distress
syndrom
despit
proven
efficaci
pilot
studi
strategi
use
bipap
asthma
patient
sever
dyspnea
yet
thu
term
experiment
approach
guidelin
conduct
retrospect
studi
children
admit
pediatr
intens
care
unit
picu
diagnosi
sever
asthma
exacerb
statu
asthmaticu
treat
without
bipap
purpos
studi
assess
treatment
efficaci
toler
bipap
method
conduct
retrospect
studi
asthma
patient
admit
picu
januari
februari
patient
signific
comorbid
certain
identifi
respiratori
pathogen
exclud
patient
multipl
admiss
admiss
record
separ
medic
record
review
follow
characterist
age
present
clinic
symptom
heart
rate
hr
respiratori
rate
rr
oxygen
demand
partial
pressur
carbon
dioxid
serum
oxygen
satur
clinic
laboratori
data
chest
imag
admiss
data
group
accord
bipap
use
yesno
clinic
paramet
document
select
time
interv
intervent
intervent
hour
hour
hour
hour
hour
hour
time
zero
defin
initi
bipap
ventil
group
method
ventil
oxygen
support
picu
group
u
test
use
analyz
serial
data
amongst
bipap
group
analyz
intervent
use
pair
result
data
picu
admiss
obtain
four
exclud
reason
describ
data
admiss
differ
patient
analyz
bipap
without
bipap
mean
age
admiss
month
respiratori
rate
rr
significantli
differ
treatment
group
p
hour
treatment
p
bipap
group
higher
respiratori
rate
rr
improv
significantli
ensu
time
interv
bipap
group
heart
rate
hr
analysi
signific
differ
group
time
interv
rr
hr
level
show
declin
trend
treatment
group
bipap
group
decreas
level
show
statist
signific
level
improv
significantli
use
bipap
studi
none
receiv
invas
mechan
ventil
support
picu
stay
conclus
studi
found
signific
improv
respiratori
rate
patient
bipap
support
bipap
also
compar
mean
ventil
oxygen
support
nebul
mask
improv
trend
also
reflect
rr
hr
similarli
group
conclus
bipap
ventil
safe
effici
relief
respiratori
symptom
children
sever
asthma
attack
children
sever
acut
asthma
admit
dutch
picu
chang
landscap
boeschoten
sa
buyss
merku
van
wijngaarden
heisterkamp
de
jongst
van
rosmalen
otter
boehmer
de
hoog
pediatr
intens
care
erasmu
medic
centr
sophia
children
hospit
rotterdam
netherland
respiratori
medicin
depart
pediatr
radboudumc
amalia
children
hospit
nijmegen
netherland
pediatr
intens
care
emma
children
hospit
amsterdam
netherland
pediatr
erasmu
medic
centr
sophia
children
hospit
rotterdam
netherland
biostatist
erasmu
mc
univers
medic
center
rotterdam
netherland
pediatr
maasstad
hospit
rotterdam
netherland
accord
nationwid
databas
pediatr
intens
care
unit
picu
admiss
number
children
requir
intens
care
admiss
sever
acut
asthma
saa
increas
saa
potenti
progress
respiratori
failur
fatal
saa
requir
admiss
picu
repres
major
cost
burden
addit
picu
admiss
associ
greater
psycholog
morbid
children
parent
compar
admiss
gener
pediatr
ward
object
aim
studi
identifi
factor
explain
increas
picu
admiss
netherland
method
perform
multicent
retrospect
cohort
studi
across
tertiari
care
picu
netherland
retrospect
analyz
number
characterist
children
hospit
saa
picu
period
netherland
inclus
criteria
children
age
year
hospit
saa
picu
netherland
children
younger
year
includ
uncertainti
diagnosi
saa
diagnosi
confirm
picu
discharg
admiss
includ
studi
data
includ
demographi
saa
treatment
refer
hospit
picu
mortal
result
studi
period
children
admit
picu
total
admiss
picu
admiss
patient
studi
receiv
intraven
iv
salbutamol
dutch
asthma
guidelin
requir
picu
admiss
case
iv
salbutamol
given
patient
receiv
salbutamol
infus
rate
mcgkgmin
less
receiv
higher
infus
rate
mcgkgmin
per
cent
admit
children
year
old
children
admit
saa
number
remain
rel
stabl
sinc
annual
number
patient
admit
picu
gradual
increas
age
distribut
sever
saa
base
first
blood
ga
length
stay
picu
remain
unchang
number
children
asthma
tripl
sinc
year
proport
patient
admit
picu
increas
gradual
although
fewer
children
necessit
invas
ventil
nasal
cannula
optiflow
introduc
use
increas
significantli
follow
year
seven
patient
need
extracorpor
membran
oxygen
ecmo
mortal
n
conclus
last
decad
observ
threefold
increas
children
saa
admit
picu
netherland
age
distribut
sever
ill
remain
similar
new
nation
guidelin
picu
admiss
mandatori
use
iv
salbutamol
specul
observ
explain
implement
nation
saa
guidelin
increas
undertreat
inhal
steroid
reflect
concret
propos
action
prioriti
given
adequ
diagnosi
treatment
children
asthma
prevent
picu
admiss
carri
high
cost
associ
risk
posttraumat
stress
disord
prospect
studi
risk
factor
children
saa
requir
salbutamol
iv
need
safeti
salbutamol
iv
studi
need
picu
admiss
reconsid
assess
qualiti
life
children
suffer
asthma
bokonj
ivanov
mijov
jankov
pediatr
univers
clinic
hospit
foca
hospit
kasindol
east
sarajevo
univers
hospit
medic
faculti
foca
foca
medic
faculti
belgrad
belgrad
serbia
asthma
common
chronic
inflammatori
diseas
respiratori
tract
children
qualiti
life
children
suffer
asthma
subject
experi
satisfact
dissatisfact
live
main
aim
studi
verifi
connect
symptom
asthma
lung
function
qualiti
life
influenc
comorbid
asthma
qualiti
life
identifi
quantifi
psychosoci
area
children
perceiv
handicap
due
ill
verifi
degre
similar
percept
qualiti
life
parent
children
asthma
also
aim
studi
translat
adopt
valid
serbian
languag
junip
questionnair
name
paqlq
pediatr
asthma
qualiti
life
questionnair
standard
oper
variant
examin
questionnair
regard
qualiti
life
caregiv
children
asthma
pacqlq
pediatr
asthma
caregiv
qualiti
life
questionnair
use
questionnair
want
verifi
qualiti
life
children
asthma
parent
result
analyz
accord
sever
length
diseas
well
paramet
degre
diseas
accord
gina
spirometri
comorbid
etc
studi
includ
children
year
old
intermitt
persist
mild
moder
asthma
studi
patient
also
classifi
accord
asthma
control
score
diagnosi
asthma
establish
use
well
known
guidelin
diagnosi
manag
asthma
registr
detail
medic
histori
taken
physic
examin
perform
patient
well
pulmonari
function
measur
upon
arriv
control
examin
week
asthma
control
score
obtain
interview
children
asthma
parent
organ
paqlq
includ
question
divid
three
area
limit
activ
symptom
emot
function
pacqlq
contain
question
divid
two
main
area
restrict
perform
emot
question
questionnair
possibl
answer
grade
mean
without
symptom
complaint
grade
mean
promin
symptom
signific
correl
stage
asthma
symptom
lung
function
qualiti
life
children
involv
studi
clinic
pictur
significantli
affect
qualiti
life
children
children
poorer
control
diseas
poorer
qualiti
life
also
improv
diseas
control
asthma
control
score
led
improv
qualiti
life
particularli
area
symptom
f
p
emot
function
f
p
comorbid
asthma
allerg
diseas
much
present
children
isol
asthma
better
qualiti
life
children
asthma
allerg
rhiniti
vs
p
parent
children
percept
diseas
coeffici
correl
r
p
r
p
r
p
parent
assess
person
qualiti
life
significantli
wors
children
p
p
p
children
involv
studi
complaint
area
symptom
cough
limit
physic
activ
element
often
cite
emot
disturb
less
pronounc
sens
reject
significantli
perturb
patient
involv
studi
questionnair
assess
qualiti
life
children
asthma
translat
serbian
show
good
discrimin
capabl
high
reliabl
specif
cronbach
alpha
may
recommend
assess
qualiti
life
routin
medic
practic
clinic
trial
instrument
current
avail
use
children
research
encourag
verifi
valid
use
use
questionnair
comprehens
health
outcom
measur
children
result
obtain
studi
promot
introduct
tool
measur
qualiti
life
import
paramet
estim
stage
diseas
accept
asthma
symptom
patient
efficaci
tiotropium
therapi
children
adolesc
experienc
episod
asthma
worsen
four
phase
iii
studi
vogelberg
c
engel
el
azzi
dewberri
casal
bleecker
goldstein
szefler
hamelmann
pediatr
pulmonolog
allergi
univers
hospit
carl
gustav
caru
technic
univers
dresden
dresden
germani
respiratori
diseas
boehring
ingelheim
pharma
gmbh
co
kg
ingelheim
rhein
germani
biometr
data
scienc
boehring
ingelheim
pharma
gmbh
co
kg
biberach
der
riss
germani
allergi
immunolog
univers
south
florida
morsani
colleg
medicin
tampa
usa
genom
precis
medicin
depart
medicin
divis
pharmacogenom
center
appli
genet
genom
medicin
univers
arizona
health
scienc
tucson
usa
asthma
care
long
island
rockvil
center
usa
pediatr
children
hospit
colorado
univers
colorado
school
medicin
breath
institut
aurora
usa
kinder
und
jugendmedizin
evangelisch
klinikum
bethel
bielefeld
allergi
center
ruhr
univers
bochum
germani
background
asthma
lead
caus
childhood
morbid
episod
diseas
worsen
exacerb
lead
hospit
impact
qualiti
life
tiotropium
therapi
demonstr
improv
peak
trough
forc
expiratori
volum
second
adolesc
children
symptomat
asthma
despit
inhal
corticosteroid
ic
treatment
control
howev
clear
impact
episod
asthma
worsen
treatment
may
improv
describ
lung
function
outcom
pediatr
patient
experienc
episod
asthma
worsen
compar
phase
iii
trial
children
adolesc
method
post
hoc
analys
involv
phase
iii
random
trial
cover
patient
age
year
moder
sever
asthma
respect
year
moder
sever
asthma
respect
patient
receiv
tiotropium
placebo
deliv
puff
via
inhal
ic
control
primari
endpoint
studi
peak
chang
baselin
respons
within
hour
week
sever
moder
asthma
respect
secondari
endpoint
includ
trough
respons
key
measur
end
dose
interv
minut
next
dose
trial
medic
week
sever
moder
asthma
respect
peak
trough
respons
patient
experienc
episod
asthma
worsen
trial
compar
patient
experi
asthma
worsen
trial
asthma
worsen
defin
episod
progress
increas
asthma
symptom
compar
usual
asthma
symptom
consecut
day
decreas
patient
best
morn
pef
patient
mean
morn
pef
least
consecut
day
also
includ
definit
analys
use
restrict
maximum
model
repeat
measur
result
baselin
demograph
diseas
characterist
gener
balanc
experienc
episod
asthma
worsen
screen
treatment
period
studi
within
specifi
age
asthma
sever
group
across
studi
improv
baselin
peak
trough
respons
placebo
arm
improv
gener
lower
patient
experienc
episod
asthma
worsen
dose
tiotropium
improv
peak
trough
respons
excess
seen
placebo
observ
children
irrespect
whether
experienc
episod
asthma
worsen
studi
respons
slightli
variabl
studi
particularli
asthma
worsen
subgroup
possibl
due
low
number
patient
figur
overal
adolesc
improv
lung
function
observ
tiotropium
patient
studi
regardless
whether
experienc
episod
asthma
worsen
except
dose
group
studi
figur
conclus
tiotropium
ic
mainten
therapi
control
gener
improv
lung
function
patient
age
year
moder
sever
asthma
irrespect
whether
experienc
episod
asthma
worsen
trial
data
support
demonstr
broad
efficaci
tiotropium
age
group
indic
improv
lung
function
larg
consist
even
patient
experi
episod
diseas
worsen
figur
peak
respons
children
adolesc
without
episod
asthma
worsen
phase
iii
clinic
trial
figur
trough
respons
children
adolesc
without
episod
asthma
worsen
phase
iii
clinic
trial
improv
tiotropium
ad
inhal
corticosteroid
therapi
similar
pediatr
patient
asthma
vogelberg
c
goldstein
graham
szefler
el
azzi
kallsen
hamelmann
pediatr
pulmonolog
allergi
univers
hospit
carl
gustav
caru
technic
univers
dresden
dresden
germani
asthma
care
long
island
rockvil
centr
usa
pulmonolog
children
healthcar
atlanta
atlanta
usa
pediatr
children
hospit
colorado
univers
colorado
school
medicin
breath
institut
aurora
usa
respiratori
diseas
boehring
ingelheim
pharma
gmbh
co
kg
ingelheim
rhein
kinder
und
jugendmedizin
evangelisch
klinikum
bethel
bielefeld
allergi
center
ruhr
univers
bochum
germani
background
systemat
literatur
review
pediatr
patient
asthma
compar
improv
forc
expiratori
volum
second
tiotropium
ad
inhal
corticosteroid
ic
improv
report
laba
ad
ic
method
endpoint
select
comparison
peak
trough
respons
ie
chang
baselin
liter
systemat
literatur
search
perform
identifi
relev
public
report
random
control
trial
laba
ad
ic
least
week
adolesc
children
result
compar
result
phase
iii
trial
tiotropium
ad
ic
pediatr
patient
asthma
result
systemat
literatur
search
trial
investig
laba
ad
ic
pediatr
patient
identifi
relev
public
includ
cochran
detail
trial
trial
tiotropium
pediatr
patient
asthma
provid
tabl
laba
studi
mean
ic
dose
baselin
rang
budesonid
equival
fluticason
propion
tiotropium
studi
mean
ic
dose
baselin
rang
budesonid
equival
laba
studi
includ
cochran
present
combin
peak
trough
measur
articl
specifi
time
point
measur
taken
laba
ad
ic
versu
ic
cochran
studi
found
adjust
mean
improv
l
confid
interv
l
figur
newer
studi
found
increas
l
l
formoterol
ad
budesonid
versu
budesonid
benefit
vilanterol
ad
fluticason
propion
versu
fluticason
propion
outlier
vilanterol
studi
found
improv
small
n
salmeterol
studi
exclud
individu
studi
investig
laba
ic
gener
show
treatment
differ
l
l
magnitud
improv
tiotropium
ad
ic
similar
laba
ad
ic
tiotropium
versu
placebo
show
improv
l
l
peak
respons
improv
l
l
trough
respons
figur
compar
laba
vilanterol
tiotropium
show
greater
lung
function
respons
tiotropium
result
tiotropium
broadli
similar
tiotropium
conclus
result
systemat
literatur
review
suggest
tiotropium
therapi
provid
meaning
lung
function
improv
altern
laba
may
consid
ic
laba
adolesc
children
asthma
tabl
detail
trial
includ
analysi
csr
clinic
studi
report
forc
expiratori
volum
second
ic
inhal
corticosteroid
laba
na
applic
pef
peak
expiratori
flow
figur
treatment
differ
respons
laba
compar
placebo
ad
ic
includ
cochran
point
repres
mean
treatment
differ
versu
placebo
bar
repres
ci
treatment
differ
favor
laba
ad
ic
ic
alon
ci
confid
interv
ic
inhal
corticosteroid
laba
figur
treatment
differ
peak
trough
b
respons
tiotropium
placebo
ad
ic
point
repres
mean
treatment
differ
versu
placebo
bar
repres
ci
treatment
differ
favor
tiotropium
placebo
ci
confid
interv
safeti
efficaci
tiotropium
children
persist
asthmat
symptom
hamelmann
szefler
vrijlandt
harper
rupp
el
azzi
engel
vulcu
unseld
chaw
bisgaard
kinder
und
jugendmedizin
evangelisch
klinikum
bethel
bielefeld
allergi
center
ruhr
univers
bochum
germani
pediatr
children
hospit
colorado
univers
colorado
school
medicin
breath
institut
aurora
usa
pediatr
pulmonolog
pediatr
allergi
beatrix
children
hospit
univers
medic
center
groningen
netherland
allergi
asthma
charleston
usa
allergi
asthma
research
north
charleston
usa
respiratori
diseas
boehring
ingelheim
pharma
gmbh
co
kg
ingelheim
rhein
germani
ingelheim
pti
ltd
sydney
australia
pharmacovigil
boehring
ingelheim
pharma
gmbh
co
kg
ingelheim
rhein
germani
boehring
ingelheim
pharma
gmbh
co
kg
biberach
der
riss
germani
prospect
studi
asthma
childhood
copsac
herlev
gentoft
hospit
univers
copenhagen
copenhagen
denmark
background
littl
investig
safeti
efficaci
new
potenti
asthma
medic
young
children
year
evalu
safeti
efficaci
tiotropium
tior
inhal
corticosteroid
ic
without
mainten
therapi
patient
age
year
persist
asthmat
symptom
method
phase
iiiii
random
placebo
pbo
trial
patient
age
year
persist
asthmat
symptom
receiv
tiotropium
tior
tior
pbo
puff
daili
week
via
inhal
usual
mainten
therapi
ic
without
control
medic
primari
object
determin
safeti
tior
compar
advers
event
ae
tior
versu
pbo
primari
efficaci
endpoint
chang
weekli
mean
combin
daytim
asthma
symptom
score
baselin
week
respons
endpoint
peak
forc
expiratori
volum
second
within
hour
peak
respons
exploratori
analys
includ
composit
exacerb
endpoint
deriv
ae
treatment
comparison
report
hazard
ratio
hr
treatment
comparison
efficaci
endpoint
exploratori
formal
hypothesi
test
perform
result
patient
random
treat
complet
treatment
period
tior
n
tior
n
pbo
n
children
use
aerochamb
spacer
facilit
inhal
baselin
characterist
includ
concomit
diseas
background
therapi
similar
treatment
group
tabl
lower
percentag
children
report
ae
tior
group
tior
tior
pbo
group
children
pbo
group
report
asthma
exacerb
ae
versu
tior
tior
ae
lead
treatment
discontinu
death
report
ae
mild
moder
intens
seriou
ae
report
patient
pbo
group
improv
weekli
mean
combin
daytim
asthma
symptom
score
compar
group
patient
underw
lung
function
test
child
tior
group
increas
peak
week
howev
due
insuffici
patient
number
treatment
comparison
perform
exploratori
analys
found
signific
reduct
risk
ae
relat
asthma
exacerb
broad
worsen
follow
tior
treatment
hr
tior
confid
interv
ci
p
tior
ci
p
well
risk
asthma
exacerb
broad
pneumonia
asthma
worsen
tior
ci
p
tior
ci
p
figur
baselin
patient
use
agonist
week
treatment
less
half
patient
use
rescu
medic
use
rescu
medic
week
percentag
day
per
week
compar
group
median
howev
differ
upper
quartil
valu
treatment
group
tior
tior
pbo
indic
patient
use
rescu
medic
everi
second
day
tior
patient
use
rescu
medic
everi
third
day
conclus
result
suggest
tiotropium
therapi
similar
safeti
profil
pbo
preschool
children
persist
asthmat
symptom
treatment
tior
result
improv
efficaci
endpoint
includ
less
frequent
use
rescu
medic
compar
pbo
importantli
observ
signific
reduct
number
children
report
ae
relat
asthma
exacerb
worsen
tior
group
compar
pbo
point
toward
increas
diseas
control
addit
trial
need
confirm
find
tabl
baselin
characterist
daili
screen
treatment
baselin
random
budesonid
equival
dose
patient
receiv
saba
ic
baselin
fewer
patient
receiv
laba
month
screen
treatment
period
patient
switch
icslaba
combin
ic
monotherapi
week
visit
ic
inhal
corticosteroid
ige
immunoglobulin
e
laba
ltra
leukotrien
receptor
antagonist
saba
agonist
sd
standard
deviat
figur
overview
key
result
trial
hr
hazard
ratio
ic
inhal
corticosteroid
pbo
placebo
tior
tiotropium
effect
tiotropium
season
asthma
worsen
pediatr
patient
szefler
goldstein
graham
vogelberg
el
azzi
engel
hamelmann
pediatr
children
hospit
colorado
univers
colorado
school
medicin
breath
institut
aurora
usa
asthma
care
long
island
rockvil
center
usa
pulmonolog
children
healthcar
atlanta
atlanta
usa
pediatr
pulmonolog
allergi
univers
hospit
carl
gustav
caru
technic
univers
dresden
dresden
germani
respiratori
diseas
boehring
ingelheim
pharma
gmbh
co
kg
ingelheim
rhein
germani
boehring
ingelheim
pharma
gmbh
co
kg
biberach
der
riss
germani
kinder
und
jugendmedizin
evangelisch
klinikum
bethel
bielefeld
allergi
center
ruhr
univers
bochum
germani
background
asthma
exacerb
major
caus
morbid
increas
healthcar
cost
mani
patient
pattern
peak
certain
time
year
investig
asthma
exacerb
clinic
trial
difficult
especi
children
exacerb
trial
difficult
justifi
aim
investig
advers
event
ae
relat
asthma
exacerb
asthma
symptom
report
across
sever
pediatr
trial
investig
safeti
efficaci
tiotropium
particular
interest
identif
season
pattern
report
ae
whilst
also
ascertain
whether
tiotropium
efficaci
consist
throughout
year
method
pool
data
random
trial
investig
safeti
efficaci
tiotropium
pediatr
asthma
phase
iiiii
trial
patient
age
year
persist
asthmat
symptom
phase
iii
trial
patient
age
year
moder
symptomat
asthma
phase
iii
trial
patient
age
year
sever
symptomat
asthma
phase
iii
trial
patient
age
year
moder
symptomat
asthma
phase
iii
trial
patient
age
year
sever
symptomat
asthma
trial
patient
receiv
daili
tiotropium
placebo
deliv
via
inhal
puff
addit
inhal
corticosteroid
without
addit
control
ae
relat
asthma
exacerb
symptom
defin
use
composit
endpoint
accord
medic
dictionari
regulatori
activ
version
prefer
term
group
asthma
exacerb
symptom
number
asthma
exacerb
report
ae
plot
month
data
southern
hemispher
shift
month
align
season
northern
hemispher
june
month
southern
hemispher
decemb
month
result
overal
patient
age
year
includ
pool
analys
rate
patient
report
ae
relat
asthma
exacerb
symptom
number
patient
event
per
significantli
reduc
tiotropium
patient
event
per
compar
placebo
patient
event
per
rate
ratio
rr
confid
interv
ci
similar
trend
associ
tiotropium
dose
patient
event
per
compar
placebo
rr
ci
analyz
month
report
ae
relat
asthma
exacerb
symptom
greatest
placebo
group
spring
autumn
winter
figur
lowest
summer
dose
tiotropium
spring
autumn
peak
reduc
figur
number
report
ae
relat
asthma
exacerb
symptom
month
conclus
analysi
suggest
treatment
tiotropium
reduc
ae
relat
asthma
exacerb
symptom
pediatr
patient
particular
effect
reduc
spring
autumn
season
peak
asthma
exacerb
trial
pediatr
patient
remain
ethic
challeng
analysi
highlight
altern
endpoint
investig
efficaci
children
data
also
highlight
import
trial
time
account
season
exacerb
peak
studi
length
practic
improv
report
asthma
exacerb
efficaci
safeti
data
tiotropium
therapi
pediatr
patient
szefler
eickmeier
vogelberg
vrijlandt
engel
el
azzi
hamelmann
pediatr
children
hospit
colorado
univers
colorado
school
medicin
breath
institut
aurora
usa
allergolog
pulmonolog
cystic
fibrosi
goeth
univers
children
hospit
frankfurt
germani
pediatr
pulmonolog
allergi
univers
hospit
carl
gustav
caru
technic
univers
dresden
dresden
germani
pediatr
pulmonolog
pediatr
allergi
beatrix
children
hospit
univers
medic
center
groningen
netherland
respiratori
diseas
boehring
ingelheim
pharma
gmbh
co
kg
ingelheim
rhein
germani
boehring
ingelheim
pharma
gmbh
co
kg
biberach
der
riss
germani
kinder
und
jugendmedizin
evangelisch
klinikum
bethel
bielefeld
allergi
center
ruhr
univers
bochum
germani
background
recurr
asthma
symptom
exacerb
caus
substanti
morbid
pediatr
patient
asthma
therefor
primari
treatment
goal
prevent
occur
definit
exacerb
commonli
use
clinic
trial
worsen
asthma
symptom
reduct
lung
function
defin
period
sever
event
requir
system
steroid
treatment
andor
hospit
howev
definit
may
strict
pediatr
trial
sampl
size
trial
durat
limit
ethic
consider
advers
event
ae
relat
asthma
exacerb
worsen
symptom
also
record
among
safeti
assess
standard
clinic
trial
may
altern
endpoint
clinician
consid
assess
efficaci
term
exacerb
pediatr
patient
herein
compar
report
asthma
exacerb
efficaci
endpoint
use
standard
definit
report
ae
relat
exacerb
symptom
phase
iii
trial
tiotropium
children
adolesc
method
exploratori
analysi
phase
iii
trial
compris
patient
age
year
moder
sever
asthma
respect
age
year
moder
sever
asthma
respect
year
persist
asthmat
symptom
patient
receiv
tiotropium
placebo
puff
daili
via
inhal
inhal
corticosteroid
control
children
year
old
also
use
aerochamb
spacer
time
first
asthma
exacerb
studi
except
efficaci
endpoint
exacerb
defin
episod
progress
increas
asthma
symptom
last
consecut
day
andor
decreas
patient
best
morn
peak
expiratori
flow
pef
patient
mean
morn
pef
consecut
day
number
patient
report
ae
relat
asthma
exacerb
symptom
record
start
treatment
day
end
treatment
ae
use
analysi
fell
umbrella
term
relat
asthma
exacerb
symptom
defin
use
composit
endpoint
accord
medic
dictionari
regulatori
activ
version
prefer
term
relat
asthma
exacerb
symptom
analysi
time
first
asthma
exacerb
occurr
analyz
use
cox
proport
hazard
model
treatment
effect
ae
relat
asthma
exacerb
symptom
captur
safeti
report
analyz
produc
rate
ratio
rr
number
patient
event
per
risk
estim
confid
interv
ci
rr
base
test
stratifi
studi
case
analysi
pool
studi
studi
durat
vari
week
therefor
rr
valu
consid
rather
hazard
ratio
hr
alon
result
efficaci
endpoint
risk
exacerb
gener
reduc
tiotropium
treatment
compar
placebo
hr
tabl
although
chang
reach
statist
signific
tiotropium
numer
reduct
risk
exacerb
seen
trial
reach
signific
hr
ci
analyz
patient
report
ae
relat
asthma
exacerb
symptom
also
reduct
tiotropium
versu
placebo
across
trial
rr
tabl
reduct
reach
statist
signific
youngest
age
group
rr
ci
also
data
pool
across
trial
rr
ci
tiotropium
numer
reduct
ae
observ
trial
reach
statist
signific
rr
ci
rr
ci
conclus
overal
data
show
endpoint
exacerb
ae
relat
asthma
exacerb
symptom
align
treatment
differ
detect
use
ae
report
exacerb
data
efficaci
endpoint
collect
reduct
ae
relat
asthma
exacerb
symptom
safeti
report
may
consid
use
altern
endpoint
clinician
conduct
clinic
trial
assess
efficaci
term
exacerb
pediatr
trial
sampl
size
trial
durat
may
limit
tabl
children
adolesc
patient
report
exacerb
phase
iii
clinic
trial
tabl
children
adolesc
patient
report
ae
relat
asthama
exacerb
symptom
phase
iii
clinic
trial
review
clinic
trial
design
pediatr
patient
asthma
hamelmann
e
engel
el
azzi
vogelberg
szefler
kinder
und
jugendmedizin
evangelisch
klinikum
bethel
bielefeld
allergi
center
ruhr
univers
bochum
germani
respiratori
diseas
boehring
ingelheim
pharma
gmbh
co
kg
ingelheim
rhein
germani
pediatr
pulmonolog
allergi
univers
hospit
carl
gustav
caru
technic
univers
dresden
dresden
germani
pediatr
children
hospit
colorado
univers
colorado
school
medicin
breath
institut
aurora
usa
background
asthma
common
chronic
diseas
children
guidelin
therapi
often
result
partial
symptom
control
despit
high
unmet
need
new
treatment
rel
new
therapi
approv
age
group
within
last
decad
review
endpoint
current
use
clinic
trial
pediatr
patient
asthma
includ
lesson
tiotropium
asthma
clinic
program
aim
encourag
facilit
futur
clinic
trial
pediatr
patient
asthma
method
recent
literatur
field
pediatr
clinic
trial
asthma
review
particular
focu
place
find
tiotropium
pediatr
clinic
trial
program
patient
age
year
exampl
data
previou
adult
asthma
studi
extrapol
pediatr
asthma
clinic
trial
program
result
sever
feasibl
consider
identifi
literatur
influenc
pediatr
trial
design
rang
low
number
child
particip
clinic
research
poor
adher
clinic
trial
set
limit
resourc
research
center
lack
trial
network
pediatr
research
pediatr
trial
may
also
requir
valid
specif
endpoint
differ
age
group
associ
stage
develop
forc
expiratori
volum
second
well
accept
endpoint
clinic
trial
adult
patient
respons
alway
correl
asthma
symptom
often
appear
normal
children
tiotropium
asthma
clinic
trial
program
improv
peak
trough
follow
tiotropium
therapi
compar
rang
adult
patient
pediatr
patient
figur
altern
lung
function
measur
suggest
pediatr
patient
includ
forc
expiratori
flow
pulmonari
volum
reflect
small
airway
function
vital
capac
fvc
ratio
shown
associ
asthma
sever
children
pediatr
patient
tiotropium
therapi
consist
improv
trough
respons
versu
placebo
strong
associ
improv
trough
trough
pearson
correl
coeffici
improv
larg
pronounc
trough
improv
moreov
tiotropium
therapi
consist
improv
trough
ratio
versu
placebo
pediatr
patient
although
high
variabl
note
adolesc
patient
sever
asthma
addit
lung
endpoint
import
studi
outcom
exacerb
symptom
assess
endpoint
confirmatori
design
requir
larg
sampl
size
long
studi
durat
trial
would
requir
give
children
placebo
long
period
may
uneth
especi
pediatr
set
asthma
diseas
follow
similar
cours
adult
children
outcom
treatment
compar
partial
extrapol
concept
appli
tiotropium
asthma
clinic
trial
program
thu
adult
patient
lung
function
symptom
exacerb
endpoint
evalu
confirmatori
manner
pediatr
patient
lung
function
endpoint
evalu
confirmatori
manner
symptom
exacerb
endpoint
assess
exploratori
manner
adult
age
year
tiotropium
therapi
significantli
improv
pulmonari
function
asthma
control
reduc
exacerb
risk
versu
placebo
pediatr
patient
age
year
tiotropium
therapi
larg
improv
pulmonari
function
versu
placebo
trend
improv
asthma
control
reduc
exacerb
risk
versu
placebo
compar
rang
adult
patient
conclus
result
tiotropium
asthma
clinic
program
emphas
success
clinic
trial
pediatr
patient
asthma
perform
assess
lung
function
shown
reliabl
endpoint
addit
strong
posit
correl
trough
trough
respons
gener
pronounc
respons
tiotropium
asthma
clinic
program
also
demonstr
partial
extrapol
concept
may
appli
exacerb
symptom
endpoint
therebi
keep
sampl
size
studi
durat
reason
line
ethic
consider
bachari
lb
strunk
rc
mauger
white
lemansk
rf
jr
sork
ca
classifi
asthma
sever
children
mismatch
symptom
medic
use
lung
function
j
respir
crit
care
med
figur
improv
peak
trough
b
respons
predict
adult
adolesc
children
tiotropium
treatment
ci
confid
interv
tio
tiotropium
respimat
etiolog
aspect
asthma
exacerb
childhood
markova
r
pediatr
pediatr
consult
clinic
sofia
bulgaria
main
caus
asthma
exacerb
childhood
viral
infect
etiolog
profil
signific
epidemiolog
therapeut
valu
materi
method
clinic
survey
period
patient
bronchial
asthma
follow
age
year
patient
investig
accord
clinic
function
laboratori
paramet
order
assess
certain
etiolog
aspect
asthma
exacerb
serolog
test
perform
elisa
test
rsv
adenoviru
chlamydia
pneumonia
mycoplasma
pneumonia
influenza
viru
parainfluenza
viru
igm
igg
antibodi
result
result
evalu
use
statist
method
spss
softwar
result
demonstr
asthmat
acut
rsv
infect
found
posit
igm
antibodi
data
past
rsv
infect
posit
igg
antibodi
patient
acut
adenoviru
infect
posit
igg
antibodi
detect
asthmat
posit
igg
titer
chlamydia
pneumonia
found
patient
result
pneumonia
prove
igm
igg
asthmat
includ
clinic
investig
serolog
diagnosi
influenza
viru
posit
igg
viru
posit
igg
conclus
serolog
test
reveal
lead
role
past
rsv
infect
asthma
exacerb
investig
group
asthmat
follow
adenoviru
infect
parainfluenza
viru
infect
exhal
nitric
oxid
among
bulgarian
children
asthma
exacerb
markova
r
pediatr
pediatr
consult
clinic
sofia
bulgaria
exhal
nitric
oxid
import
marker
bronchial
inflamm
children
asthma
aim
studi
investig
exhal
nitric
oxid
feno
valu
among
patient
asthma
exacerb
follow
period
evalu
certain
clinic
laboratori
function
paramet
correl
feno
method
feno
measur
measur
laboratori
test
includ
leukocyt
count
esr
crp
total
ige
level
analyz
elisa
pulmonari
function
test
pft
perform
patient
blood
sputum
nasal
eosinophil
count
serolog
test
respiratori
virus
perform
elisa
result
feno
significantli
higher
asthmat
group
compar
control
group
posit
linear
correl
age
feno
valu
male
gender
domin
posit
famili
histori
observ
half
asthmat
patient
upper
respiratori
airway
involv
allerg
rhino
sinus
number
asthmat
long
durat
bronchial
asthma
year
mean
total
ige
valu
increas
group
asthmat
feno
major
paramet
clinic
studi
mean
valu
show
signific
decreas
mean
feno
valu
serolog
viral
test
reveal
lead
role
past
rsv
infect
follow
adenoviru
parainfluenza
viru
conclus
present
data
regard
feno
valu
bulgarian
asthmat
combin
clinic
laboratori
function
paramet
effect
variant
antitrypsin
genotyp
frequenc
wheez
breathless
first
three
year
life
alspac
birth
cohort
valiuli
clinic
children
diseas
vilniu
univers
vilniu
lithuania
background
antitrypsin
aat
common
genet
caus
chronic
obstruct
pulmonari
diseas
asid
import
function
inhibitor
proteinas
aat
also
implic
modul
immun
reaction
inflamm
preschool
wheez
suggest
first
manifest
copd
also
pilot
data
suggest
variant
aat
genotyp
may
predispos
children
sever
episod
wheez
earli
childhood
case
children
may
identifi
earli
life
wheez
characterist
intervent
measur
might
appli
prevent
develop
chronic
obstruct
pulmonari
diseas
materi
method
chose
analyz
data
alspac
cohort
aat
genotyp
determin
imput
genom
data
common
variant
snp
pi
piz
data
wheez
characterist
obtain
via
questionnair
sever
time
point
first
year
life
associ
among
common
variant
aat
genotyp
pimz
pizz
pim
piss
pisz
wheez
characterist
onset
number
wheez
episod
durat
wheez
breathless
episod
wheez
analyz
result
total
children
complet
genet
data
select
snp
least
one
wheez
episod
experienc
breathless
due
wheez
first
three
year
life
wheez
preval
children
variant
aat
genotyp
compar
children
normal
aat
genotyp
similarli
breathless
differ
group
variant
normal
aat
genotyp
neither
wheez
breathless
due
wheez
ci
ci
respect
associ
variant
genotyp
aat
final
proport
wheez
day
per
year
well
preval
breathless
wheez
attack
similar
normal
aat
variant
aat
group
conclus
data
alspac
birth
cohort
show
variant
aat
genotyp
associ
wheez
breathless
first
three
year
life
characterist
use
identifi
children
variant
aat
genotyp
three
oxygen
satur
target
discharg
children
wheez
observ
studi
unger
j
christi
cunningham
paediatr
royal
hospit
sick
children
edinburgh
unit
kingdom
life
health
univers
edinburgh
edinburgh
unit
kingdom
object
assess
potenti
effect
three
guidelin
discharg
oxygen
satur
target
length
hospit
admiss
children
acut
wheez
method
patient
children
age
year
year
admit
wheez
requir
supplementari
oxygen
assess
air
everi
h
nine
month
time
admiss
becom
stabl
least
h
record
addit
time
clinic
stabil
also
collect
defin
requir
frequenc
four
hourli
salbutamol
inhal
less
result
children
median
age
year
includ
median
length
stay
hour
h
five
children
admit
high
depend
percent
viral
bacteri
agent
identifi
detail
inhal
frequenc
miss
five
children
eleven
children
receiv
inhal
salbutamol
admiss
becam
stabl
least
h
iqr
iqr
iqr
target
respect
time
achiev
stabl
median
iqr
sooner
respect
time
lag
children
target
target
median
time
lag
children
iqr
iqr
respect
median
time
stabil
inhal
frequenc
children
record
n
iqr
children
reach
stabil
inhal
frequenc
achiev
stabl
children
time
lag
differ
oxygen
satur
target
reach
stabil
inhal
frequenc
achiev
stabl
discuss
reflect
result
show
reduc
target
could
potenti
reduc
length
stay
approxim
children
year
age
acut
wheez
howev
children
clinic
stabil
defin
requir
regular
four
hourli
salbutamol
inhal
reach
achiev
stabl
reduc
potenti
number
children
fit
earlier
discharg
lower
target
target
respect
result
indic
need
ensur
wheez
control
achiev
potenti
discharg
lower
accept
target
conclus
allow
lower
discharg
target
could
reduc
length
stay
around
quarter
children
wheez
although
target
level
shown
safe
infant
bronchiol
safeti
effect
clinic
statu
post
discharg
need
studi
older
children
acut
wheez
random
control
trial
merit
answer
question
heterogen
childhood
asthma
korea
cluster
analysi
children
asthma
korean
childhood
asthma
studi
ka
eom
ej
yoon
kim
jung
suh
kim
lim
kim
kim
shin
baek
woo
shin
yoo
kim
park
kwon
lee
yang
lee
seo
jang
kim
song
yu
institut
life
scienc
univers
ulsan
colleg
medicin
seoul
south
korea
pediatr
childhood
asthma
atopi
center
asan
medic
center
univers
ulsan
colleg
medicin
seoul
south
korea
pediatr
seoul
nation
univers
colleg
medicin
seoul
south
korea
pediatr
pusan
nation
univers
yangsan
hospit
yangsan
south
korea
pediatr
colleg
medicin
inha
univers
inchon
south
korea
pediatr
school
medicin
cathol
univers
korea
bucheon
st
mari
hospit
bucheon
south
korea
pediatr
school
medicin
cathol
univers
korea
uijeongbu
st
mari
hospit
uijeongbu
south
korea
pediatr
soonchunhyang
univers
school
medicin
bucheon
south
korea
pediatr
hallym
univers
kangdong
sacr
heart
hospit
seoul
south
korea
pediatr
colleg
medicin
chungbuk
nation
univers
cheongju
south
korea
pediatr
gangnam
cha
medic
center
cha
univers
school
medicin
seoul
south
korea
pediatr
korea
univers
anam
hospit
seoul
south
korea
pediatr
colleg
medicin
kangwon
nation
univers
kangwon
south
korea
pediatr
seoul
nation
univers
bundang
hospit
seoul
nation
univers
colleg
medicin
seongnam
south
korea
pediatr
chonnam
nation
univers
hospit
gwangju
south
korea
pediatr
pediatr
allergi
respiratori
center
soonchunhyang
univers
colleg
medicin
seoul
south
korea
pediatr
samsung
changwon
hospit
sungkyunkwan
univers
school
medicin
changwon
south
korea
pediatr
dankook
univers
hospit
cheonan
south
korea
pediatr
nation
health
insur
servic
ilsan
hospit
ilsan
south
korea
pediatr
inj
univers
seoul
paik
hospit
seoul
south
korea
pediatr
korea
univers
guro
hospit
seoul
south
korea
background
asthma
heterogen
airway
diseas
variou
clinic
phenotyp
children
import
clearli
identifi
clinic
phenotyp
achiev
better
asthma
manag
predict
prognosi
investig
asthma
phenotyp
remain
rare
understood
korea
studi
aim
identifi
phenotyp
asthma
korean
children
method
enrol
children
asthma
korean
childhood
asthma
studi
ka
cohort
prospect
studi
interv
everi
visit
questionnair
survey
pulmonari
function
test
conduct
methacholin
challeng
test
blood
test
skin
prick
test
conduct
first
time
visit
classifi
children
asthma
korean
childhood
asthma
studi
ka
cohort
cluster
use
hierarch
cluster
analysi
result
cluster
analysi
ka
cohort
indic
four
asthma
phenotyp
cluster
children
character
atop
asthma
cluster
atop
asthma
histori
bronchiol
subject
cluster
consist
atop
asthma
lowest
lung
function
cluster
associ
asthma
conclus
result
indic
korean
children
asthma
classifi
four
distinct
cluster
identif
asthma
phenotyp
may
facilit
predict
prognosi
respons
treatment
heterogen
phenotyp
asthma
fund
studi
support
grant
research
korea
center
diseas
control
prevent
republ
korea
key
word
asthma
children
cluster
analysi
classif
phenotyp
asthma
knowledg
attitud
practic
parent
asthmat
children
outpati
depart
tertiari
care
institut
antonio
ad
j
canonizado
r
pediatr
st
luke
medic
center
quezon
citi
philippin
introduct
bronchial
asthma
common
childhood
respiratori
condit
object
manag
patient
asthma
includ
decreas
exposur
environment
trigger
decreas
use
control
medic
knowledg
attitud
practic
kap
parent
asthmat
children
big
influenc
qualiti
life
asthmat
children
determin
care
give
object
studi
investig
asthma
kap
parent
asthmat
children
consult
outpati
depart
tertiari
hospit
determin
differ
asthma
kap
parent
children
control
versu
uncontrol
asthma
correl
asthma
kap
parent
asthmat
children
number
emerg
room
er
consult
hospit
admiss
asthma
immedi
past
year
method
descript
studi
parent
patient
older
diagnos
bronchial
asthma
past
six
month
includ
exclud
parent
younger
year
old
whose
children
activ
chronic
condit
asid
asthma
result
total
subject
particip
studi
partli
uncontrol
asthma
observ
subject
children
parent
good
knowledg
asthma
sign
symptom
manag
half
parent
anxiou
children
practic
physic
activ
fear
provok
asthmat
attack
major
parent
abl
initi
home
measur
administ
correct
drug
proper
time
seek
physician
earli
institut
earli
treatment
mild
symptom
adher
physician
medic
order
decreas
occurr
attack
differ
asthma
kap
parent
children
control
versu
uncontrol
asthma
among
subject
children
frequent
er
consult
hospit
admiss
asthma
kap
score
higher
er
consult
hospit
admiss
although
variabl
statist
signific
conclus
parent
asthmat
children
tertiari
hospit
good
level
kap
bronchial
asthma
compar
countri
asthma
kap
parent
children
whose
asthma
control
differ
whose
children
uncontrol
asthma
frequent
er
consult
hospit
admiss
may
provid
parent
opportun
achiev
higher
asthma
kap
score
preval
passiv
smoke
impact
childhood
asthma
symptom
dc
pilato
e
filla
na
pediatr
depart
feder
univers
curitiba
brazil
introduct
asthma
chronic
frequent
diseas
high
morbid
childhood
indoor
exposur
allergen
irrit
includ
cigarett
smoke
affect
control
asthma
symptom
object
aim
verifi
preval
passiv
smoke
repercuss
childhood
asthma
symptom
method
sampl
consist
asthmat
patient
age
year
complet
interview
child
hisher
parent
regard
asthma
symptom
treatment
use
exacerb
hospit
well
clinic
evalu
perform
social
econom
aspect
also
evalu
result
exposur
passiv
smoke
present
children
household
agglomer
lower
famili
incom
lower
level
matern
patern
school
significantli
observ
expos
group
expos
popul
show
higher
frequenc
asthma
classifi
moder
greater
use
inhal
corticosteroid
greater
frequenc
diurnal
symptom
present
least
week
patient
conclus
preval
asthmat
children
expos
passiv
smoke
high
low
socioeconom
condit
confirm
expos
group
moder
sever
greater
use
inhal
corticosteroid
greater
frequenc
diurnal
symptom
observ
expos
group
effect
measur
combat
passiv
smoke
taken
immedi
essenti
strategi
control
childhood
asthma
clinic
function
sputum
cytolog
evalu
patient
bronchiol
obliteran
dc
maia
sa
bitencourt
e
cunha
r
eli
riedi
ca
hj
na
pediatr
depart
feder
univers
curitiba
brazil
introduct
bronchiol
obliteran
rare
lung
diseas
occur
sever
insult
small
airway
caus
viral
bronchiol
viral
pneumonia
year
age
character
respiratori
symptom
compat
lower
airway
obstruct
lung
function
test
lft
demonstr
obstruct
pattern
tomograph
chang
mosaic
attenu
bronchial
thicken
bronchiectasi
atelectasi
object
aim
studi
evalu
clinic
find
lung
function
sputum
cytolog
patient
bronchiol
obliteran
attend
outpati
clinic
method
patient
age
less
diagnos
bronchiol
obliteran
invit
particip
underw
lft
ct
scan
skin
prick
test
spt
aeroallergen
induc
sputum
use
pizzichini
et
al
methodolog
classifi
accord
spanevello
et
al
result
thirteen
patient
includ
sign
consent
underw
lft
induc
sputum
sampl
collect
three
sputum
sampl
discard
due
low
cellular
viabil
five
patient
report
daili
symptom
report
symptom
physic
activ
patient
show
tomograph
alter
mosaic
pattern
bronchial
thicken
nine
demonstr
obstruct
ventilatori
disord
posit
bronchodil
lft
four
sputum
sampl
show
neutrophil
cytolog
pattern
eosinophil
mix
eight
patient
report
associ
allerg
diseas
posit
spt
conclus
correl
demonstr
daili
symptom
exercis
sever
obstruct
ventilatori
disord
tomograph
find
cytolog
sputum
pattern
possibl
asthma
bronchiol
obliteran
coexist
vitamin
level
asthmat
healthi
children
singapor
lim
mt
lee
tj
ramamurthi
mb
goh
dy
khoo
teck
univers
children
medic
institut
nation
univers
hospit
singapor
singapor
background
asthma
one
common
chronic
diseas
affect
children
much
interest
relationship
vitamin
asthma
symptom
vitamin
involv
support
immun
regul
regul
action
lymphocyt
mast
cell
cell
structur
cell
dampen
excess
inflammatori
respons
establish
causal
relationship
vitamin
asthma
could
result
simpl
yet
import
prevent
therapeut
strategi
manag
asthma
sever
studi
show
vitamin
insuffici
preval
among
asthmat
children
howev
lack
uniform
among
studi
current
literatur
bodi
demonstr
correl
vitamin
level
control
asthma
obtain
local
data
preval
vitamin
insuffici
asthmat
control
popul
import
justifi
research
relationship
current
unknown
singapor
hypothesi
asthmat
children
significantli
lower
vitamin
level
control
method
conduct
studi
design
children
age
year
age
attend
pediatr
outpati
clinic
tertiari
hospit
singapor
children
recruit
case
fulfil
follow
criteria
diagnosi
asthma
made
clinic
ground
either
uncontrol
asthma
defin
asthma
control
test
score
less
asthma
requir
control
least
inhal
dose
per
day
time
entri
studi
serum
vitamin
vitamin
level
measur
hospit
laboratori
blood
sampl
taken
venepunctur
children
vitamin
level
categor
suffici
greater
insuffici
defici
control
select
match
age
gender
ethnic
case
children
exclud
histori
consumpt
calcium
vitamin
supplement
drug
modul
vitamin
level
histori
signific
chronic
medic
diseas
asthma
case
famili
histori
vitamin
defici
result
case
children
asthma
fulfil
inclus
criteria
recruit
studi
group
compris
male
femal
nine
children
chines
ethnic
malay
ethnic
indian
ethnic
age
rang
year
month
year
month
men
age
year
month
control
group
consist
healthi
children
age
gender
ethnic
match
age
rang
year
month
year
month
mean
age
year
month
signific
differ
household
incom
two
group
p
mean
vitamin
level
asthma
group
rang
standard
deviat
mean
level
healthi
control
rang
standard
deviat
signific
differ
vitamin
level
two
group
p
children
vitamin
level
fell
threshold
suffici
children
asthma
group
show
vitamin
defici
healthi
control
show
vitamin
defici
discuss
recent
systemat
review
vitamin
level
asthma
children
found
mean
vitamin
level
pool
studi
shown
significantli
lower
vitamin
level
asthmat
children
compar
children
howev
taken
separ
five
studi
show
signific
differ
vitamin
level
asthmat
children
data
show
signific
differ
vitamin
level
asthmat
children
consist
find
studi
therefor
shown
associ
vitamin
level
asthma
studi
popul
sampl
size
small
may
account
statist
associ
studi
show
howev
high
preval
vitamin
insuffici
defici
studi
popul
regardless
whether
children
asthmat
data
higher
end
spectrum
preval
vitamin
defici
insuffici
compar
studi
literatur
bodi
look
vitamin
defici
among
asthmat
children
preval
slightli
higher
previou
studi
singapor
show
preval
vitamin
insuffici
defici
adult
studi
look
vitamin
defici
tropic
countri
sever
factor
postul
contribut
poor
vitamin
food
local
diet
lack
sun
exposur
due
lifestyl
habit
two
like
factor
may
account
high
preval
vitamin
insuffici
found
studi
particip
children
singapor
tend
spend
time
indoor
outsid
home
due
hot
weather
high
humid
investig
factor
studi
therefor
draw
conclus
data
conclus
signific
differ
vitamin
level
asthmat
children
compar
healthi
control
popul
howev
preval
vitamin
insuffici
high
studi
need
investig
vitamin
insuffici
highli
preval
children
live
tropic
countri
singapor
inflammatori
phenotyp
instabl
induc
sputum
inflamm
children
sever
asthma
studi
souza
rg
roncada
c
santo
g
jp
wiemann
g
pinto
la
jone
mh
stein
r
pitrez
pm
infant
center
universidad
rio
grand
sul
porto
alegr
brazil
background
induc
sputum
import
tool
assess
airway
inflamm
children
asthma
howev
pattern
airway
inflamm
children
sever
asthma
stra
wide
studi
report
studi
characterist
inflammatori
pattern
granulocyt
cell
count
children
sever
asthma
compar
mild
moder
asthma
includ
sequenti
sputum
procedur
method
children
adolesc
year
stra
mild
moder
asthma
mma
select
accord
gina
ersat
criteria
induc
sputum
collect
patient
repeat
month
subject
type
inflamm
granulocyt
cell
count
instabl
inflamm
induc
sputum
analyz
associ
inflammatori
cell
count
lung
function
result
also
assess
result
subject
select
mean
age
year
femal
subject
stra
n
mma
n
induc
sputum
procedur
perform
success
rate
group
stra
children
exhibit
follow
inflammatori
phenotyp
eosinophil
neutrophil
mix
paucigranulocyt
signific
differ
inflammatori
phenotyp
eosinophil
number
neutrophil
count
induc
sputum
stra
mma
group
abnorm
lung
function
select
neutrophil
count
significantli
neg
correl
r
p
stra
children
sequenti
sputum
perform
subject
chang
inflammatori
phenotyp
children
neutrophil
sputum
respond
clinic
trial
macrolid
therapi
conclus
inflammatori
phenotyp
induc
sputum
children
asthma
heterogen
regardless
sever
diseas
children
stra
chang
inflammatori
phenotyp
sequenti
induc
sputum
procedur
role
induc
sputum
manag
children
stra
still
unclear
understand
neutrophil
inflamm
better
explor
group
patient
defin
diagnos
asthma
infant
preschool
systemat
review
j
moral
asencio
de
la
cruz
pharmacolog
pediatr
radiolog
univers
sevil
universidad
de
sevilla
la
candelaria
health
sevilla
spain
allergi
pneumolog
unit
reina
univers
hospit
spain
pneumolog
unit
allergi
univers
gener
hospit
alicant
alicant
spain
medic
surgic
center
andorra
spain
pediatr
allergi
unit
sabadel
hospit
univers
hospit
parc
sabadel
spain
pulmonolog
allergi
unit
depart
pediatr
obstetr
gynecolog
univers
valencia
univers
hospit
dr
peset
faculti
medicin
univers
valencia
valencia
spain
diagnost
scienc
univers
salamanca
pizarral
health
center
salamanca
spain
introduct
disagr
among
spanish
pediatrician
expert
rel
asthma
diagnosi
infant
preschool
present
result
systemat
review
asthma
guidelin
answer
key
question
regard
diagnosi
asthma
infant
preschool
preliminari
step
reach
consensu
among
spanish
pediatrician
subject
method
key
question
specif
definit
asthma
children
year
old
possibl
diagnos
asthma
age
includ
first
year
life
necessari
perform
pulmonari
function
test
order
make
diagnosi
asthma
children
year
age
defin
object
criteria
diagnosi
asthma
children
year
old
possibl
diagnos
asthma
preschool
even
though
diseas
may
remit
year
age
later
search
strategi
perform
systemat
search
scientif
literatur
publish
identifi
select
clinic
practic
guidelin
cpg
relat
asthma
manag
initi
search
databas
clinic
guidelin
trip
databas
us
nation
librari
medicin
databas
medlin
pubm
use
combin
term
correspond
medic
subject
head
mesh
term
limit
result
filter
retriev
guidelin
follow
practic
guidelin
guidelin
practic
guidelin
guidelin
consensu
develop
confer
practic
guidelin
topicmesh
asthma
mesh
asthma
ti
without
restrict
languag
manual
search
subsequ
perform
inclus
exclus
criteria
includ
cpg
aim
provid
diagnost
therapeut
recommend
care
children
andor
adolesc
adult
document
consid
guidelin
met
follow
criteria
provid
practic
clinic
recommend
children
adolesc
adult
collect
relat
document
support
materi
exclud
document
without
inform
regard
concept
diagnosi
asthma
childhood
includ
first
year
life
analysi
guidelin
includ
review
subject
sever
exploratori
analys
conduct
lm
particip
research
given
descript
natur
section
relat
concept
diagnosi
asthma
questionnair
design
find
guidelin
consid
diagnosi
asthma
young
children
especi
term
age
could
establish
diagnosi
premis
clinic
criteria
complementari
test
make
diagnosi
author
respond
questionnair
contribut
comment
via
clarifi
discrep
discrep
resolv
agreement
among
review
result
obtain
refer
initi
search
trip
databas
pubm
figur
manual
search
ad
guid
final
document
analyz
group
guid
given
guid
consid
integr
differ
document
whose
content
judg
complementari
nine
guidelin
refer
patient
age
pediatr
dedic
exclus
preschool
regard
question
result
guidelin
concept
definit
asthma
close
link
diagnosi
gener
guidelin
distinct
made
definit
adult
pediatr
asthma
asthma
guidelin
recogn
gener
implicitli
age
limit
establish
diagnosi
asthma
highlight
difficulti
establish
diagnosi
year
spirometri
consid
essenti
establish
diagnosi
preschool
although
difficulti
carri
inconveni
make
difficult
confirm
diagnosi
guidelin
asthma
diagnosi
preschool
children
base
subject
interpret
pediatrician
make
clinic
find
treatment
respons
exclus
altern
diagnos
also
reli
perform
complementari
test
rule
increas
probabl
diagnosi
er
guidelin
preschool
wheez
one
indic
disappear
symptom
later
year
distinguish
realli
suffer
asthma
guidelin
accept
asthma
may
remit
time
exampl
icon
japan
child
therefor
would
impedi
establish
diagnosi
conclus
appar
agreement
among
nation
intern
guidelin
consid
diagnosi
asthma
preschool
child
syndrom
establish
age
even
though
respiratori
function
test
perform
reflect
believ
therefor
good
basi
perform
consensu
formal
find
review
random
trial
arginin
adjunct
therapi
pediatr
patient
pneumonia
sanchez
e
tuazon
depart
pediatr
section
pulmonolog
philippin
gener
hospit
manila
philippin
background
research
made
regard
immunomodulatori
properti
amino
acid
possess
pharmacolog
effect
pathophysiolog
abnorm
amino
acid
includ
arginin
glutamin
amino
acid
gardin
barbul
amino
acid
use
sepsi
burn
surgic
trauma
patient
present
signific
decreas
plasma
arginin
level
correl
state
immunosuppress
incur
initi
insult
studi
evalu
arginin
supplement
adjuv
therapeut
option
among
patient
pneumonia
potenti
agent
specif
alter
inflammatori
respons
immun
function
individu
diseas
process
measur
indirectli
solubl
human
leukocyt
antigen
type
dr
level
object
determin
effect
adjunct
arginin
therapi
immun
statu
pediatr
patient
diagnos
pneumonia
studi
design
random
trial
method
patient
age
month
old
year
old
admit
pediatr
er
ward
trauma
burn
unit
diagnos
first
bout
pneumonia
regardless
current
hospit
stay
empir
treat
iv
antibiot
enter
nutrit
either
per
orem
feed
tube
includ
studi
patient
enrol
studi
random
two
group
mean
random
tabl
one
group
receiv
dietari
supplement
placebo
dietari
supplement
group
receiv
mgkgday
three
time
day
per
orem
day
adjunct
appropri
intraven
antibiot
exceed
gramsday
blood
sampl
collect
recruit
subject
baselin
level
plasma
arginin
serum
repeat
blood
extract
day
supplement
treatment
pneumonia
data
encod
microsoft
excel
analyz
use
spss
variabl
numer
variabl
express
mean
standard
deviat
variabl
underw
numer
variabl
pearson
correl
also
use
test
relationship
plasma
level
level
dietari
supplement
placebo
group
result
total
patient
recruit
studi
seven
subject
withdrawn
studi
five
due
protocol
two
deceas
due
acut
respiratori
failur
complic
underli
diseas
thu
subject
includ
subject
recruit
respect
supplement
placebo
group
signific
differ
two
group
term
age
weight
gender
use
oxygen
support
arginin
level
day
supplement
placebo
group
show
signific
differ
p
valu
arginin
level
day
supplement
group
howev
higher
level
compar
placebo
group
statist
signific
p
valu
regard
level
group
supplement
group
lower
level
day
well
supplement
day
compar
level
placebo
group
level
two
group
statist
signific
howev
level
group
set
threshold
level
henc
group
low
level
analysi
data
compar
arginin
level
day
level
supplement
day
show
supplement
group
arginin
level
baselin
day
supplement
increas
statist
signific
p
valu
placebo
group
arginin
level
baselin
day
supplement
also
increas
howev
significantli
differ
p
valu
data
arginin
level
baselin
day
day
supplement
day
compar
although
show
correl
level
arginin
group
pearson
r
valu
less
conclusionrecommend
studi
data
patient
analyz
gener
trend
correl
arginin
level
solubl
level
baselin
day
supplement
conclus
arginin
supplement
adjunct
iv
antibiot
improv
immun
statu
patient
pneumonia
studi
need
focus
dietari
intak
subject
prior
supplement
well
durat
therapi
recommend
futur
studi
longer
durat
supplement
intak
furthermor
arginin
level
monitor
even
day
supplement
well
greater
number
patient
subject
recruit
studi
lobectomi
procedur
follow
necrot
pneumonia
toddler
case
studi
ashkenazi
pessach
rubinshtein
jacobson
paret
pediatr
intens
care
edmond
lili
safra
children
hospit
sheba
medic
center
ramat
gan
israel
thorac
surgeri
sheba
medic
center
ramat
gan
israel
pediatr
intens
care
sheba
medic
center
ramat
gan
israel
diagnost
imag
sheba
medic
center
ramat
gan
israel
necrot
pneumonia
sever
form
pneumonia
caus
highli
virul
bacteria
mainli
streptococcu
pneumonia
staphylococcu
aureu
treatment
primarili
conserv
surgic
intervent
still
controversi
report
uniqu
case
necrot
pneumonia
due
group
streptococcu
infect
boy
sever
respiratori
failur
requir
extracorpor
membran
oxygen
ecmo
support
bridg
recoveri
follow
surgic
lobectomi
child
wean
ecmo
recov
unev
case
necrot
pneumonia
requir
ecmo
support
present
uniqu
clinic
challeng
conserv
approach
includ
watch
wait
respiratori
improv
ecmo
support
howev
altern
approach
stipul
surgic
intervent
facilit
ecmo
withdraw
patient
necrot
pneumonia
success
treat
surgic
lobectomi
ecmo
support
thu
suggest
surgic
lobectomi
suitabl
option
select
case
necrot
pneumonia
respond
conserv
medic
treatment
preval
extrapulmonari
tuberculosi
among
patient
age
year
admit
govern
hospit
retrospect
studi
losa
p
pediatr
ospit
ng
maynila
medic
center
manila
philippin
background
tuberculosi
tb
infecti
diseas
caus
bacteria
call
mycobacterium
tuberculosi
curabl
prevent
tb
eptb
refer
tuberculosi
involv
organ
lung
accord
depart
health
doh
philippin
tuberculosi
remain
major
public
health
problem
countri
tb
rank
lead
caus
mortal
across
age
death
everi
popul
account
total
death
may
also
increas
risk
case
eptb
countri
studi
aim
provid
overview
preval
eptb
among
pediatr
patient
help
increas
awar
magnitud
problem
order
improv
manag
tuberculosi
program
among
pediatr
popul
countri
object
describ
preval
extrapulmonari
tuberculosi
among
pediatr
patient
age
year
old
tertiari
govern
hospit
studi
design
retrospect
descript
studi
chart
review
set
tertiari
govern
hospit
manila
ospit
ng
maynila
medic
center
popul
patient
diagnos
extrapulmonari
tuberculosi
age
year
old
admit
tertiari
hospit
studi
method
permiss
obtain
ospit
ng
maynila
medic
center
consent
patient
admit
ospit
ng
maynila
medic
center
diagnosi
extrapulmonari
tb
year
obtain
chart
patient
file
retriev
medic
record
demograph
featur
clinic
find
laboratori
treatment
outcom
inform
obtain
data
arrang
tabl
express
proport
percentag
result
studi
show
preval
rate
extrapulmonari
tb
among
pediatr
admiss
year
major
case
children
age
year
old
mean
age
year
old
appear
sex
predilect
regard
extrapulmonari
tb
major
case
known
tb
diseas
tb
exposur
common
case
eptb
includ
tb
mening
present
chang
behavior
decreas
sensorium
gastrointestin
tb
present
abdomin
distent
one
case
tb
uveiti
present
whitish
lesion
cornea
eye
among
patient
discharg
improv
includ
die
tb
mening
patient
conclus
data
say
need
strengthen
nation
tb
program
term
activ
case
find
decreas
transmiss
tb
countri
initi
earli
treatment
also
need
educ
health
care
worker
identifi
possibl
case
eptb
prevent
possibl
fatal
outcom
sinc
tb
mening
poor
outcom
health
care
profession
vigil
aggress
treat
case
effect
passiv
smoke
exposur
develop
childhood
pneumonia
ill
sever
sismanlar
eyuboglu
aslan
kose
pekcan
gulbahar
demirdag
tezer
budakoglu
pulmonolog
dr
sami
ulu
matern
children
research
train
hospit
ankara
turkey
pulmonolog
gazi
univers
hospit
ankara
turkey
pulmonolog
erciy
univers
faculti
medicin
kayseri
turkey
pulmonolog
necmettin
erbakan
univers
meram
faculti
medicin
konya
turkey
biochem
gazi
univers
faculti
medicin
ankara
turkey
diseas
gazi
univers
faculti
medicin
ankara
turkey
educ
gazi
univers
faculti
medicin
ankara
turkey
object
previou
research
shown
passiv
smoke
exposur
associ
wheez
chronic
cough
asthma
bronchiol
children
research
studi
pneumonia
limit
base
questionnair
studi
sinc
smoke
cessat
begun
appli
close
area
turkey
previou
studi
urin
cotinin
creatinin
threshold
valu
show
passiv
smoke
exposur
children
evalu
ng
mg
countri
aim
object
evalu
effect
passiv
smoke
pneumonia
develop
ill
sever
childhood
method
decemb
april
children
age
pneumonia
healthi
control
includ
studi
three
pediatr
pulmonolog
center
questionnair
appli
parent
regard
demograph
data
smoke
statu
home
urin
cotinin
creatinin
level
measur
object
indic
passiv
smoke
exposur
pneumonia
group
group
mild
sever
accord
diseas
sever
data
patient
control
group
well
children
mild
sever
pneumonia
pneumonia
group
compar
result
children
studi
group
children
control
group
overal
children
studi
group
children
control
group
passiv
smoke
exposur
urin
cotinin
creatinin
level
children
expos
passiv
smoke
higher
unexpos
children
signific
differ
studi
control
group
term
age
monthli
incom
number
peopl
live
home
age
mother
father
time
spent
outsid
home
p
cotinin
creatinin
level
studi
group
higher
control
group
signific
differ
age
urin
cotinin
creatinin
level
mild
sever
case
studi
group
p
children
smoke
exposur
sever
pneumonia
mild
pneumonia
roc
analysi
reveal
urin
cotinin
creatinin
threshold
ng
mg
passiv
smoke
exposur
discuss
object
shown
passiv
smoke
exposur
associ
develop
sever
pneumonia
children
present
find
consid
promis
given
threshold
valu
passiv
smoke
exposur
smoke
cessat
countri
consider
lower
previou
studi
necrot
pneumonia
caus
refractori
mycoplasma
pneumonia
pneumonia
children
zhang
yy
wang
children
hospit
zhejiang
univers
school
medicin
hangzhou
china
care
children
hospit
zhejiang
univers
school
medicin
hangzhou
china
object
aim
evalu
clinic
featur
necrot
pneumonia
np
caus
refractori
mycoplasma
pneumonia
pneumonia
rmpp
method
retrospect
observ
studi
np
case
caus
rmpp
hospit
hospit
januari
decemb
conduct
clinic
manifest
laboratori
data
imag
perform
hospit
cours
outcom
analyz
result
total
np
case
caus
rmpp
identifi
median
age
year
mean
length
total
fever
day
hospit
stay
day
patient
day
day
respect
abnorm
laboratori
find
elev
protein
crp
lactat
dehydrogenas
ldh
interleukin
il
interferon
gamma
observ
mani
patient
meanwhil
pleural
fluid
characterist
associ
np
present
studi
particularli
high
valu
pleural
fluid
cell
count
ldh
protein
also
observ
patient
studi
associ
pleural
effus
high
incid
lobar
atelectasi
pulmonari
consolid
interestingli
mean
delay
time
detect
necrot
lesion
onset
symptom
day
eighti
percent
patient
administ
corticosteroid
patient
underw
bronchoalveolar
lavag
bal
patient
present
pleural
effus
thoracocentesi
alon
chest
drainag
patient
receiv
prolong
cours
antibiot
day
discharg
without
death
studi
show
patient
recov
without
surgic
intervent
chest
radiograph
reveal
resolut
minim
residu
fibrot
chang
within
month
conclus
np
caus
rmpp
recogn
sever
yet
revers
diseas
appropri
manag
determin
pulmonari
complic
childhood
mycoplasma
pneumonia
pneumonia
park
hj
kim
hy
depart
pediatr
pusan
nation
univers
yangsan
hospit
south
korea
background
mycoplasma
pneumonia
mp
major
pathogen
caus
pneumonia
children
although
mycoplasma
pneumonia
pneumonia
mpp
usual
benign
may
develop
pulmonari
complic
aim
studi
elucid
clinic
laboratori
characterist
patient
pleural
effus
necrot
pneumonia
acut
respiratori
failur
bronchiectasi
bronchiol
obliteran
pulmonari
complic
mpp
method
retrospect
analysi
perform
children
mpp
admit
hospit
januari
decemb
total
patient
respect
earli
pulmonari
complic
result
median
age
higher
patient
complic
ecx
without
ecx
differ
patient
without
complic
lcx
median
level
lactat
dehydrogenas
ldh
protein
ferritin
motif
ligand
motif
ligand
interleukin
il
median
percentag
neutrophil
patient
ecx
higher
without
ecx
logist
regress
analysi
ferritin
pgml
ci
pgml
ci
increas
risk
ecx
ldh
ci
increas
risk
lcx
cox
regress
analysi
show
macrolid
treatment
day
hr
ci
ldh
hr
ci
signific
determin
lcx
conclus
cours
mpp
ferritin
pgml
pgml
may
promot
time
recognit
complic
ldh
might
signific
predictor
complic
congenit
dissemin
tuberculosi
rare
case
report
indonesia
sudarwati
wulandari
indriyani
sa
olivianto
nataprawira
kartasasmita
respirolog
divis
depart
child
health
hasan
sadikin
gener
hospit
faculti
medicin
universita
padjadjaran
bandung
indonesia
respirolog
divis
depart
child
health
west
nusa
tenggara
provinc
gener
hospit
faculti
medicin
universita
mataram
mataram
indonesia
respirolog
divis
depart
child
health
saiful
anwar
gener
hospit
faculti
medicin
universita
brawijaya
malang
indonesia
introduct
recent
although
childhood
mdr
tuberculosi
tb
increas
indonesia
congenit
mdr
tb
howev
still
rare
report
late
diagnos
congenit
dissemin
mdr
tb
case
increas
awar
particularli
countri
tb
case
case
present
girl
infant
admit
hasan
sadikin
gener
hospit
respiratori
distress
abdomin
distent
hepatosplenomegali
poor
feed
failur
weight
gain
refer
privat
hospit
bandung
dissemin
tb
improv
month
standard
tb
treatment
mother
die
month
postpartum
mening
tb
low
count
neg
hiv
statu
tuberculosi
hiv
screen
famili
member
result
neg
babi
normal
exhibit
fever
abdomin
distent
month
birth
diagnos
pneumonia
hospit
day
without
improv
lead
father
bring
hospit
hospit
diagnos
pulmonari
tb
treat
antituberculosi
drug
furthermor
hospit
sever
time
pneumonia
recurr
pleural
effus
also
miliari
tb
antituberculosi
hepatotox
adih
also
low
neg
hiv
statu
anemia
thrombocytopenia
hypoalbuminemia
high
protein
crp
level
mri
ct
scan
show
bilater
pulmonari
tb
pleural
effus
multipl
lymphadenopathi
hepatosplenomegali
multipl
nodul
central
necrot
area
adren
tb
spondyl
tb
xpert
mtbrif
result
induc
sputum
fece
specimen
mycobacterium
tuberculosi
detect
rifampicin
resist
although
afb
smear
result
neg
day
admiss
respiratori
distress
worsen
accompani
decreas
hemoglobin
level
sepsi
thu
blood
antibiot
prc
transfus
given
sensori
neural
hear
loss
snhl
found
audiometri
screen
result
capreomycin
chosen
inject
drug
combin
levofloxacin
ethionamid
cycloserin
ethambutol
pyrazinamid
mdr
tb
regimen
day
mdr
tb
treatment
respiratori
distress
decreas
hepatomegali
smaller
bodyweight
increas
final
discharg
hospit
month
mdr
regimen
continu
conclus
tb
screen
pregnanc
infant
born
mother
suspect
tb
import
mdr
tb
suspect
infant
unrespons
pneumonia
standard
tb
treatment
born
mother
deceas
due
tb
late
diagnosi
dissemin
tb
mdr
result
poor
prognosi
congenit
tb
case
keyword
multipl
drug
resist
congenit
tuberculosi
dissemin
tuberculosi
infant
miliari
tuberculosi
associ
factor
jasin
mr
kaswandani
n
pediatr
cipto
mangunkusumo
hospit
jakarta
indonesia
background
indonesia
one
highest
tuberculosi
incid
global
miliari
tuberculosi
sever
form
tuberculosi
due
lymphohematogen
spread
miliari
tuberculosi
occur
often
younger
immunocompromis
children
howev
miliari
tuberculosi
older
age
group
rare
report
object
investig
epidemiolog
characterist
miliari
tuberculosi
children
indonesian
top
referr
hospit
cipto
mangunkusumo
hospit
cmh
method
retrospect
studi
perform
investig
profil
miliari
tuberculosi
children
result
children
treat
tuberculosi
miliari
tuberculosi
diagnos
children
among
femal
year
age
major
older
year
old
bcg
vaccin
administ
children
percent
mildli
malnourish
sever
malnourish
hiv
infect
found
patient
genexpert
posit
children
underw
tuberculin
test
yield
posit
result
child
mortal
rate
among
miliari
tuberculosi
children
conclus
miliari
tuberculosi
preval
among
children
older
year
old
adolesc
children
femal
vaccin
bacteriolog
confirm
perform
miliari
tuberculosi
patient
sinc
posit
result
high
almost
case
result
mortal
may
rais
notion
prophylaxi
among
adolesc
high
endem
countri
keyword
tuberculosi
miliari
adolesc
pulmonari
tuberculosi
scrofuloderma
marasm
kwashiorkor
children
case
report
sofiah
f
yangtjik
k
aruf
simanjuntak
yr
depart
child
health
medic
school
sriwijaya
univers
dr
mohammad
hoesin
hospit
palembang
indonesia
background
pulmonari
tuberculosi
tb
extrapulmonari
tb
sometim
simultan
occur
especi
child
malnutrit
scrofuloderma
one
form
cutan
tb
whose
infect
rout
alway
endogen
usual
secondari
joint
lymph
node
tb
depend
individu
immun
environment
factor
clinic
lesion
appear
nodul
gumma
ulcer
due
fistula
occur
children
young
peopl
pediatr
patient
pulmonari
tb
scrofuloderma
report
case
boy
refer
depart
child
health
short
breath
abdomin
enlarg
swell
leg
normal
urin
defec
week
histori
low
grade
fever
chronic
cough
loss
appetit
decreas
bodi
weight
nodul
neck
armpit
upper
chest
pain
sinc
year
month
nodul
becam
reddish
ruptur
discharg
pu
nodul
start
appear
found
sign
dyspnea
rale
multipl
hypertroph
crust
ulcer
skin
tract
colli
axilla
infraclavicular
region
abdomin
enlarg
due
ascit
edema
leg
clinic
marasm
kwashiorkor
tuberculin
skin
hiv
rapid
test
neg
rapid
molecular
test
detect
low
mycobacterium
tuberculosi
mtb
hypoalbuminemia
skin
biopsi
show
specif
chronic
inflammatori
granulomat
therapi
att
albumin
antibiot
nutrit
therapi
administ
signific
improv
observ
week
treatment
discuss
world
popul
infect
mtb
global
burden
diseas
continu
grow
depend
individu
immun
environment
factor
children
typic
patient
adolesc
malnutrit
low
socioeconom
condit
crowd
environ
present
case
specif
scrofuloderma
lesion
skin
biopsi
result
posit
rapid
molecular
mtb
test
good
respons
att
favor
diagnosi
pulmonari
tb
scrofoluderma
marasm
kwashiorkor
child
scrofuloderma
must
differenti
similar
lesion
sporotrichosi
hidraden
suppurativa
skin
biopsi
keyword
pulmonari
tuberculosi
scrofuloderma
marasm
kwashiorkor
children
pneumolog
endosonographi
child
tuberculosi
case
report
schmidt
zimmermann
grabitz
haas
siebolt
eisenmann
oper
conserv
child
adolesc
medicin
univers
hospit
hallesaal
germani
patholog
univers
hospit
hall
hallesaal
germani
intern
medicin
section
pulmonolog
univers
hospit
hallesaal
germani
background
endobronchi
ultrasound
ebu
essenti
part
bronchoscop
diagnosi
lung
cancer
mediastin
lymphoma
especi
sarcoidosi
tuberculosi
date
possibl
use
children
explor
limit
number
individu
case
report
one
prospect
multicent
studi
one
retrospect
analysi
methodolog
report
boy
mitochondriopathi
suspect
tuberculosi
due
contact
tuberculosi
patient
prolong
cough
diagnosi
reveal
posit
tuberculin
skin
test
right
lobe
atelectasi
bilater
hilum
promin
gastric
aspir
remain
without
germ
detect
despit
tripl
therapi
inh
rmp
pza
increas
stenosi
left
main
bronchu
develop
month
bronchoscop
lymph
node
penetr
caus
stenosi
endosonograph
ebu
pentax
possibl
visual
patholog
lymph
node
via
ebu
eu
mediastin
left
posit
perform
transesophag
posit
result
bronchoalveolar
lavag
show
bacilli
pcr
tuberculosi
complex
posit
reveal
granulomat
inflamm
tb
type
well
molecular
patholog
evid
tuberculosi
resist
found
escal
therapi
emb
passabl
prednisolon
local
find
clinic
pictur
improv
conclus
cours
show
ebu
help
pediatr
pulmonolog
howev
transesophag
punctur
prefer
small
patient
reduc
possibl
complic
especi
bleed
account
devic
limit
limit
airway
diamet
diagnosi
mediastin
lymphoma
also
possibl
children
recommend
due
broad
rang
possibl
caus
literatur
gilbert
et
al
pediatr
pulmonolog
dhooria
et
al
pediatr
clinic
featur
tuberculosi
pediatr
andarini
iandarini
depart
pediatr
dr
moewardi
hospit
surakarta
indonesia
background
tuberculosi
tb
infect
diseas
still
global
health
problem
indonesia
especi
children
clinic
present
childhood
tb
may
vari
depend
epidemiolog
situat
tb
object
studi
clinic
featur
investig
profil
pediatr
tb
patient
variou
age
method
retrospect
analysi
children
tb
admit
dr
moewardi
hospit
novemb
novemb
includ
studi
clinic
featur
investig
profil
patient
obtain
result
overal
pediatr
tb
patient
male
femal
pulmonari
tb
common
extrapulmonari
tb
bcg
scar
present
case
histori
tb
contact
present
common
symptom
fever
cough
malnutrit
tuberculin
skin
test
posit
genexpert
posit
conclus
fever
common
present
pediatr
tb
specif
symptom
genexpert
tuberculin
skin
test
import
diagnost
tool
characterist
tuberculosi
children
kariadi
hospit
semarang
indonesia
anam
msanam
dadiyanto
sidhartani
divis
child
health
depart
faculti
medicin
diponegoro
universitykariadi
hospit
semarang
indonesia
health
depart
faculti
medicin
diponegoro
universitykariadi
hospit
semarang
indonesia
background
tuberculosi
tb
still
remain
major
problem
indonesia
especi
children
characterist
diseas
may
differ
region
well
site
infect
object
report
characterist
pulmonari
extrapulmonari
tb
children
method
retrospect
descript
studi
undertaken
children
age
year
admit
kariadi
hospit
data
regard
tb
nutrit
statu
histori
contact
demograph
sputum
smear
genexpert
result
hiv
statu
tuberculin
skin
test
tst
record
perform
analyz
variabl
result
children
admit
tb
show
pulmonari
tb
extrapulmonari
tb
male
femal
median
age
year
rang
year
nutrit
statu
sever
malnourish
hiv
statu
posit
pulmonari
tb
histori
tb
contact
posit
tst
posit
sputum
smear
found
case
genexpert
posit
rifampicin
resist
statist
differ
pulmonari
extrapulmonari
tb
regard
histori
contact
p
percent
children
extrapulmonari
tb
compar
year
old
year
old
respect
p
conclus
incid
extrapulmonari
tb
found
higher
adolesc
histori
contact
higher
pulmonari
tb
keyword
pulmonari
tb
extrapulmonari
tb
children
dissemin
tuberculosi
boy
hiv
sidhartani
msidhartani
leresati
anam
dadiyanto
health
depart
faculti
medicin
diponegoro
universitykariadi
hospit
semarang
indonesia
divis
child
health
depart
faculti
medicin
diponegoro
universitykariadi
hospit
semarang
indonesia
background
hiv
alter
pathogenesi
tb
increas
risk
develop
sever
dissemin
tb
object
describ
case
dissemin
tuberculosi
boy
hiv
case
boy
refer
kariadi
hospit
swell
left
knee
chronic
diarrhea
sever
malnutrit
physic
examin
oral
thrush
multipl
cervic
lymphadenopathi
diffus
rale
crackl
inflam
left
knee
ulcer
necrot
tissu
pu
tst
neg
anthropometr
score
show
sever
chronic
malnutrit
waz
sd
haz
sd
whz
sd
normocyt
normochrom
anemia
grdl
count
cell
ul
hiv
screen
indetermin
although
hiv
viral
load
level
copiesml
sputum
smear
reveal
afb
cultur
show
klebsiella
pneumonia
esbl
left
knee
result
suspect
periost
osteomyel
sonographi
suggest
septic
arthriti
periost
reaction
wound
swab
smear
reveal
posit
afb
knee
effus
stain
posit
afb
xpert
high
detect
mtb
rifampicin
resist
biopsi
left
knee
result
chronic
inflamm
wound
cultur
blood
cultur
reveal
staphylococcu
aureu
mrsa
stool
smear
posit
afb
cryptosporidium
sp
cyst
patient
treat
cefoperazon
sulbactam
vancomycin
intraven
rhze
art
zidovudin
lamivudin
efaviren
azithromycin
paromomycin
cryptosporidiosi
cotrimoxazol
program
debrid
drainag
applic
back
slab
splint
week
child
discharg
improv
condit
month
tb
treatment
left
knee
longer
inflam
wound
improv
show
periost
inflamm
although
remain
joint
effus
afb
detect
wound
swab
smear
physiotherapi
subsequ
program
still
continu
mainten
phase
tb
treatment
art
keyword
dissemin
tb
hiv
children
outcom
children
hospit
pneumonia
west
nusa
tenggara
provinc
gener
hospit
indonesia
indriyani
saindriyani
dewi
respirolog
divis
depart
child
health
west
nusa
tenggara
provinc
gener
hospit
faculti
medicin
universita
mataram
mataram
indonesia
depart
mataram
univers
hospit
mataram
indonesia
background
pneumonia
major
caus
death
children
younger
year
old
particularli
develop
countri
asid
high
mortal
rate
pneumonia
also
caus
signific
number
hospit
conduct
studi
present
outcom
children
hospit
pneumonia
west
nusa
tenggara
provinc
gener
hospit
method
respirolog
registri
children
age
month
year
age
admit
pneumonia
januari
decemb
retrospect
review
demograph
data
physic
examin
laboratori
radiolog
find
outcom
carri
children
admit
pneumonia
result
children
admit
pneumonia
admit
major
male
age
month
fe
defici
anemia
nine
sever
pneumonia
admit
sever
pneumonia
hospit
day
averag
length
hospit
stay
day
day
overal
mortal
rate
respect
eighteen
age
month
admit
sever
pneumonia
sever
pneumonia
two
conclus
although
mortal
rate
children
hospit
pneumonia
hospit
increas
averag
length
stay
hospit
nevertheless
declin
find
highlight
need
prospect
studi
identifi
risk
factor
prolong
hospit
stay
mortal
poor
outcom
children
hospit
pneumonia
keyword
outcom
pneumonia
hospit
children
characterist
children
close
contact
mdr
tb
patient
persahabatan
hospit
sagoro
tksagoro
tk
pediatr
respirolog
persahabatan
gener
hospit
jakarta
indonesia
background
increas
mdr
tb
case
indonesian
adult
render
need
children
close
contact
mdr
tb
case
close
observ
risk
contract
mdr
tb
adult
patient
object
examin
pediatr
popul
household
adult
mdr
tb
patient
method
observ
studi
held
januari
februari
persahabatan
gener
hospit
jakarta
indonesia
involv
household
children
mdr
tb
adult
patient
examin
children
includ
care
histori
exposur
physic
examin
tuberculin
skin
test
tst
chest
children
sign
symptom
tuberculosi
acid
fast
bacilli
stain
examin
sputum
cultur
resist
test
genexpert
sputum
test
also
ad
result
children
children
diagnos
tb
although
none
mdr
tb
children
diagnos
tb
chronic
cough
posit
tst
children
prolong
subfebril
fever
children
multipl
lymphadenopathi
children
poor
hous
ventil
parent
compli
wear
surgic
mask
transmiss
prevent
bcg
scar
child
suggest
tb
chest
children
tb
prophylaxi
administ
children
year
old
close
observ
maintain
children
conclus
children
household
adult
tb
mdr
diagnos
tb
none
mdr
tb
viral
pneumonia
identif
late
complic
portugues
tertiari
pediatr
hospit
tavar
jtavar
soar
silva
pediatr
servic
pediatr
depart
hospit
univers
center
coimbra
portug
coimbra
portug
pediatr
outpati
clinic
pediatr
depart
hospit
univers
center
coimbra
portug
coimbra
portug
pulmonolog
unit
pediatr
depart
hospit
univers
center
coimbra
portug
coimbra
portug
introduct
viral
pneumonia
vari
mild
ill
diseas
morbid
high
evalu
childhood
pneumonia
intervent
includ
potenti
impact
long
term
respiratori
sequela
like
children
requir
hospit
admiss
identif
agent
also
import
sinc
differ
virus
differ
rate
complic
adenoviru
pneumonia
associ
highest
risk
sequela
commonli
isol
virus
childhood
pneumonia
requir
hospit
respiratori
syncyti
viru
rsv
rhinoviru
human
metapneumoviru
adenoviru
influenza
virus
parainfluenza
coronaviru
studi
intend
evalu
children
viral
pneumonia
requir
hospit
tertiari
pediatr
hospit
well
long
term
respiratori
complic
particularli
bronchiol
obliteran
usual
sever
major
impact
children
famili
method
retrospect
studi
clinic
record
children
admit
portugues
tertiari
pediatr
hospit
juli
june
whose
diagnosi
time
discharg
viral
pneumonia
children
previous
known
comorbid
exclud
diagnosi
viral
infect
establish
clinic
imag
featur
suggest
viral
infect
bilater
interstiti
infiltr
alveolar
infiltr
quantit
polymeras
chain
reaction
nasopharyng
swab
specimen
virus
mycoplasma
pneumonia
perform
children
demograph
clinic
data
imag
laboratori
result
treatment
clinic
cours
hospit
analyz
identif
late
sequela
also
studi
result
total
children
fulfil
studi
criteria
median
age
month
girl
frequent
identifi
viru
rsv
n
follow
adenoviru
n
rhinoviru
n
parainfluenza
n
influenza
n
metapneumoviru
coronaviru
n
mycoplasma
identifi
two
children
patient
one
viru
identifi
three
children
identifi
pathogen
median
time
hospit
five
day
rang
one
day
children
treat
support
measur
three
children
need
mechan
ventil
children
hospit
still
follow
pulmonolog
outpati
clinic
bronchiol
obliteran
diagnos
clinic
ct
scan
remain
recurr
wheez
andor
cough
present
pneumonia
remain
children
maintain
primari
care
local
hospit
none
identifi
respiratori
sequela
conclus
virus
common
pathogen
childhood
pneumonia
need
hospit
common
sampl
two
children
develop
bronchiol
obliteran
children
maintain
recurr
respiratori
symptom
find
highlight
children
viral
pneumonia
need
hospit
consid
risk
long
term
complic
requir
polyseros
tuberculosi
teenag
mesquita
david
franco
molinaro
amolinaro
pinha
ramo
montesanto
rocha
santo
penna
alv
alv
rangel
pulmonolog
jesu
municip
hospit
rio
de
janeiro
brazil
pediatrician
jesu
municip
hospit
rio
de
janeiro
brazil
gastroenterolog
jesu
municip
hospit
rio
de
janeiro
brazil
radiolog
jesu
municip
hospit
rio
de
janeiro
brazil
introduct
tuberculosi
still
remain
seriou
public
health
problem
worldwid
especi
third
world
countri
estim
world
popul
alreadi
infect
koch
bacillu
polyseros
tuberculosa
uncommon
condit
form
extrapulmonari
tuberculosi
occur
age
young
children
adult
particularli
suscept
children
tuberculosi
manifest
extrapulmonari
form
penetr
bodi
via
respiratori
tract
mycobacterium
tuberculosi
spread
settl
organ
either
first
infect
specif
immun
yet
develop
thereaft
time
abil
host
maintain
bacillu
implant
site
definit
diagnosi
extrapulmonari
tuberculosi
difficult
presumpt
long
condit
exclud
treatment
consist
ripe
regimen
rifampicin
isoniazid
pyrazinamid
ethambutol
start
presumpt
diagnosi
assist
complet
definit
diagnosi
object
work
report
case
teenag
tuberculosi
polyseros
case
report
jvmm
teenag
male
black
rio
de
brazil
admit
jesu
municip
hospit
rj
decemb
ascit
symptom
investig
mother
report
affect
fever
nausea
vomit
day
sought
immedi
medic
attent
releas
intramuscular
benzathin
penicillin
inject
without
improv
sought
new
care
follow
day
given
diagnosi
urinari
infect
dose
ceftriaxon
administ
sent
home
cours
ciprofloxacin
prescript
respons
medic
fourth
day
treatment
ciprofloxacin
start
ascit
seventh
day
treatment
ascit
alreadi
larg
previou
symptom
fever
night
sweat
persist
sought
emerg
care
hospit
refer
unit
investig
physic
examin
admiss
thin
eupneic
fr
good
perfus
acyanot
hypocort
massiv
ascit
abdomin
circumfer
measur
cm
remaind
exam
without
abnorm
ciprofloxacin
maintain
complementari
examin
demonstr
blood
count
hsv
mm
tgo
tgp
dhl
ul
fa
albumin
neg
rapid
test
dengu
neg
tuberculin
test
neg
serolog
hepat
hiv
imag
exam
chest
small
calcifi
lymph
node
mediastinum
abdomin
usg
prove
volumin
ascit
chest
ct
perform
day
hospit
demonstr
extens
pleural
effus
left
hemithorax
transthorac
echocardiogram
demonstr
compact
cardiomyopathi
patient
start
captopril
diagnost
punctur
ascit
fluid
perform
show
increas
cell
mononuclear
predomin
adenosina
deaminas
ada
justifi
empir
treatment
ripe
rifampicin
isoniazid
pyrazinamid
ethambutol
clinic
improv
observ
quickli
patient
longer
fever
day
treatment
present
drastic
reduct
ascit
go
cm
abdomin
circumfer
cm
conclus
case
describ
import
draw
attent
differenti
diagnosi
ascit
present
case
famili
histori
tuberculosi
neg
howev
due
high
preval
diseas
brazil
tuberculosi
investig
inflammatori
tuberculosi
effus
also
occur
serou
caviti
pleural
pericardi
periton
clinic
present
polyseros
sum
symptom
involv
serou
risk
factor
sever
commun
acquir
pneumonia
among
children
age
month
admit
nation
children
hospit
costa
rica
pediatr
hospit
nacion
de
san
jose
respiratori
medicin
hospit
nacion
de
san
jose
costa
rica
depart
hospit
nacion
de
san
jose
costa
rica
pediatr
respiratori
medicin
hospit
cima
san
jose
san
jose
costa
rica
introduct
commun
acquir
pneumonia
cap
lead
caus
childhood
morbid
mortal
worldwid
incom
countri
lmic
pneumonia
biggest
killer
young
children
global
account
nearli
one
five
death
among
children
age
less
year
nonetheless
pneumonia
repres
import
burden
morbid
develop
world
particular
sever
pneumonia
although
mortal
low
clinic
epidemiolog
inform
crucial
character
patient
sever
pneumonia
given
highest
risk
death
report
low
resourc
set
risk
factor
sever
pneumonia
children
includ
malnutrit
lack
breastfeed
indoor
air
pollut
caus
cook
heat
biomass
fuel
live
crowd
home
parent
smoke
hand
month
breastfeed
routin
vaccin
common
childhood
ill
identifi
major
role
decreas
mortal
rate
better
understand
risk
factor
associ
child
pneumonia
sever
pneumonia
utmost
import
sinc
primari
prevent
strategi
like
achiev
major
reduct
morbid
mortal
children
object
studi
sought
identifi
risk
factor
sever
pneumonia
among
children
year
age
costa
rica
method
case
control
studi
conduct
includ
children
year
old
admit
children
hospit
costa
rica
januari
januari
sampl
size
calcul
perform
assum
level
confid
margin
error
estim
total
patient
overal
conveni
sampl
techniqu
use
select
children
sever
pneumonia
case
children
pneumonia
control
match
age
case
control
defin
clinic
criteria
follow
recommend
medic
record
review
collect
data
nutrit
statu
risk
factor
result
mean
age
patient
month
rang
month
without
signific
differ
case
control
slight
predomin
male
sex
observ
within
sever
pneumonia
group
versu
control
group
p
ethnic
also
found
highli
associ
sever
pneumonia
sinc
patient
sever
pneumonia
group
indigen
compar
none
control
group
p
bivari
analysi
malnutrit
ci
p
prematur
ci
p
weight
ci
p
lack
breastfeed
least
month
ci
p
p
significantli
associ
sever
pneumonia
total
case
expos
passiv
smoke
versu
control
increas
trend
sever
pneumonia
observ
among
children
expos
tobacco
smoke
parent
although
statist
signific
ci
p
associ
found
sever
pneumonia
environment
factor
exposur
cook
smoke
prenat
smoke
live
crowd
home
within
asthma
ci
p
condit
associ
sever
pneumonia
children
month
breastfeed
p
routin
pneumococc
vaccin
ci
p
protect
factor
sever
pneumonia
proport
patient
tachypnea
p
nasal
flare
p
chest
retract
p
grunt
p
cyanosi
p
alter
mental
state
p
shock
p
dehydr
p
hypoxia
p
significantli
associ
sever
pneumonia
identif
microorgan
possibl
case
control
ns
group
respiratori
syncyti
viru
rsv
common
isol
pathogen
follow
metapneumoviru
influenza
staphylococcu
aureu
length
hospit
stay
significantli
higher
sever
pneumonia
group
mean
day
compar
control
group
mean
day
p
death
result
multipl
organ
system
failur
occur
sever
case
linear
logist
regress
show
indigen
independ
risk
factor
develop
sever
pneumonia
p
conclus
studi
found
malnutrit
lack
breastfeed
modifi
risk
factor
relat
sever
pneumonia
young
children
factor
highli
associ
sever
pneumonia
ethnic
prematur
weight
although
passiv
smoke
signific
risk
factor
gener
preval
found
group
higher
mean
preval
smoke
costa
rica
hand
adequ
vaccin
least
month
breastfeed
associ
mild
diseas
better
outcom
mortal
rate
cohort
low
compar
studi
lmic
viral
infect
present
high
proport
patient
cap
studi
sinc
sever
pneumonia
prevent
clinician
public
health
author
play
signific
role
reduc
occurr
health
promot
educ
activ
effect
child
health
program
particularli
high
risk
group
pulmonari
nocardiosi
immunocompet
adolesc
soar
dsoar
ferraz
vaz
pediatr
centro
hospitalar
vila
nova
de
gaia
espinho
porto
portug
pediatr
hospit
integrado
centro
hospitalar
porto
portug
pneumolog
unit
hospit
integrado
centro
hospitalar
porto
portug
introduct
nocardia
bacterium
genu
aerob
actinomycet
found
soil
abil
caus
local
suppur
diseas
mostli
pulmonari
central
nervou
system
cutan
lymphocutan
involv
system
diseas
current
speci
nocardia
caus
diseas
human
despit
associ
immunodefici
one
third
patient
immunocompet
author
report
case
pulmonari
abscess
previous
healthi
adolesc
caus
nocardia
polymeras
chain
reaction
pcr
confirm
purpos
case
case
emphas
import
consid
nocardia
differenti
diagnosi
pulmonari
abscess
especi
absenc
respons
empir
therapi
case
report
report
case
previous
healthi
adolesc
admit
er
histori
fever
odynophagia
vomit
cough
thorac
pain
patient
day
amoxicillinclavulan
pultac
tonsil
admiss
exud
observ
tonsil
sign
peritonsillar
abscess
pulmonari
auscult
normal
blood
test
total
white
cell
count
neutrophil
lymphocyt
serum
protein
crp
mgl
heterophil
antibodi
test
neg
chest
reveal
interstiti
infiltr
right
upper
lobe
patient
discharg
increas
dose
amoxicillinclavulan
adolesc
return
er
eight
day
later
recrudesc
fever
dyspnea
thorac
pain
blood
test
total
white
cell
count
neutrophil
lymphocyt
crp
mgl
chest
show
cavitari
lesion
right
upper
lobe
pulmonari
computer
tomographi
ct
scan
reveal
lesion
measur
mm
mediastin
hilar
lymphadenopathi
empir
antimicrobi
therapi
intraven
iv
ceftriaxon
clindamycin
initi
without
evid
clinic
improv
biopsi
lesion
conduct
mycobacteri
aerob
anaerob
cultur
pulmonari
tissu
blood
cultur
neg
histopatholog
analysi
biopsi
exclud
malign
pcr
biopsi
reveal
nocardiosi
pcr
studi
neg
autoimmun
diseas
immunodefici
exclud
normal
find
includ
neg
serum
examin
pcr
detect
hiv
brain
ct
echocardiogram
cervic
doppler
ultrasound
normal
treatment
chang
iv
imipenem
oral
sulfamethoxazoletrimethoprim
tmpsmx
two
week
total
therapi
period
month
tmpsmx
full
clinic
recoveri
patient
appoint
schedul
discuss
present
case
pulmonari
nocardiosi
immunocompet
adolesc
clinic
present
pulmonari
nocardiosi
chest
radiograph
normal
reveal
lesion
superior
lobe
often
attribut
caus
delay
correct
diagnosi
difficult
isol
bacteri
agent
slow
growth
cultur
make
challeng
diagnosi
case
lack
respons
empir
antibiot
therapi
justifi
invas
procedur
pulmonari
biopsi
obtain
new
sampl
vitro
cultur
pcr
posit
pcr
result
nocardia
sp
led
final
diagnosi
pulmonari
nocardiosi
cultur
neg
improv
cultur
rate
identif
nocardia
necessari
notifi
laboratori
regard
clinic
suspicion
allow
establish
adequ
incub
time
avoid
use
decontamin
solut
toxic
nocardia
sp
document
case
pulmonari
nocardiosi
affect
adult
immunocompet
patient
usual
associ
pulmonari
chronic
diseas
knowledg
first
report
pulmonari
nocardiosi
previous
healthi
pediatr
patient
clinic
case
highlight
key
point
consid
pediatr
pneumologist
similar
context
consid
unusu
agent
caus
pulmonari
abscess
even
absenc
known
risk
factor
recogn
import
use
pcr
especi
antibiot
treatment
previous
initi
promot
close
partnership
attend
clinician
microbiologist
effici
explor
sampl
obtain
patient
extrapulmonari
tuberculosi
children
year
old
costa
rica
retrospect
studi
rare
patholog
low
countri
morera
hernandez
de
mezervil
hoepker
brene
pediatr
hospit
san
carlo
san
carlo
costa
rica
pediatr
hospit
nacion
de
san
jose
costa
rica
infect
control
hospit
nacion
de
san
jose
costa
rica
respiratori
medicin
hospit
nacion
de
san
jose
costa
rica
background
tuberculosi
tb
childhood
clinic
challeng
prevent
treatabl
diseas
common
form
pediatr
tb
pulmonari
diseas
howev
extrapulmonari
form
tb
miliari
lymphat
mening
other
also
common
particularli
children
accord
costa
rica
consid
low
tb
incid
countri
case
per
nevertheless
diseas
consid
public
health
threat
countri
costa
rica
epidemiolog
clinic
inform
relat
pediatr
extrapulmonari
tuberculosi
eptb
scarc
aim
describ
clinic
characterist
epidemiolog
diagnost
approach
laboratori
studi
treatment
extrapulmonari
miliari
tuberculosi
children
year
old
method
retrospect
studi
children
year
old
suspect
extrapulmonari
tuberculosi
costa
nation
children
hospit
undertaken
inform
regard
clinic
patholog
histori
laboratori
complementari
studi
treatment
obtain
medic
record
laboratori
databas
case
defin
base
world
health
organ
recommend
diagnosi
base
clinic
data
contact
posit
case
laboratori
radiolog
histopatholog
find
associ
presenc
mycobacterium
tuberculosi
confirm
posit
auramina
ziehl
neelsen
stain
posit
cultur
medium
specif
tissu
fluid
result
total
case
diagnos
extrapulmonari
diseas
identifi
miliari
tb
follow
case
mening
tuberculosi
tubercul
lymphaden
pleural
tb
osteoarticular
tb
gastrointestin
skin
involv
equal
proport
patient
mean
age
diagnosi
year
rang
year
slight
predomin
male
sex
preval
observ
comparison
femal
distribut
expect
major
patient
costa
rica
immigr
also
common
region
cohort
panama
case
nicaragua
case
extrapulmonari
tb
among
indigen
popul
came
panama
hiv
posit
case
found
malnutrit
present
case
inform
collect
regard
adult
index
case
avail
patient
posit
index
case
frequent
symptom
fever
miliari
case
pleural
tuberculosi
mening
present
ganglionar
diseas
miliari
tuberculosi
chronic
cough
present
case
weight
loss
case
respiratori
distress
enlarg
liver
case
lymph
node
tuberculosi
character
weight
loss
sweat
patient
cervic
lymphadenopathi
mening
present
seizur
main
symptom
case
vomit
either
alter
mental
statu
loss
appetit
patient
cranial
nerv
focal
chronic
cough
present
pleural
tuberculosi
associ
chest
pain
fever
poor
appetit
moreov
weight
loss
abdomin
pain
bloodi
stool
document
gastrointestin
tuberculosi
case
skin
bone
tuberculosi
specif
symptom
present
latter
associ
edema
erythema
local
elev
temperatur
chest
abnorm
patient
abnorm
miliari
pleural
case
mening
osteoarticular
tb
ganglionar
diagnosi
tuberculin
skin
test
tst
posit
case
posit
patient
bone
skin
pleural
tuberculosi
posit
mening
diseas
lymph
node
tb
miliari
gastric
lavag
posit
patient
miliari
tb
highest
posit
result
total
amount
posit
cultur
document
miliari
diseas
case
molecular
studi
posit
miliari
present
also
observ
bronchoalveolar
lavag
total
case
analyz
posit
cultur
posit
pcr
tuberculosi
patient
complet
direct
observ
treatment
dot
per
recommend
cohort
one
patient
die
mening
tb
conclus
epidemiolog
character
pediatr
patient
extrapulmonari
tb
help
achiev
better
diagnost
approach
popul
clear
bacteri
confirm
difficult
children
dissemin
diseas
therefor
contact
histori
clinic
featur
radiolog
tst
may
suffici
establish
diagnosi
initi
treatment
studi
although
microbiolog
isol
low
slightli
higher
similar
report
role
molecular
biolog
tb
diagnosi
import
develop
howev
studi
techniqu
avail
whole
studi
period
found
prompt
diagnosi
depend
high
index
suspicion
clinic
sign
may
microbiolog
confirm
difficult
furthermor
tuberculin
skin
test
chest
radiograph
may
initi
neg
mani
pediatr
patient
treatment
well
toler
patient
lung
diseas
adolesc
male
asherova
popov
ilina
children
clinic
hospit
yaroslavl
russia
patholog
univers
hospit
wale
cardiff
unit
kingdom
ii
mechnikov
state
medic
univers
ministri
health
rf
russia
diseas
recent
recogn
system
condit
character
lymphoplasmacyt
infiltr
variou
organ
plasma
cell
differ
degre
fibrosi
oblit
phlebiti
elev
serum
level
patient
lung
involv
rare
difficult
diagnos
mimic
primari
lung
malign
imag
adolesc
signific
past
medic
histori
incident
found
bilater
nodular
lesion
right
lower
lobe
upper
lobe
left
lung
chest
radiograph
perform
follow
posit
test
mantoux
patient
complaint
physic
examin
reveal
abnorm
comput
tomographi
ct
demonstr
nodul
right
lung
maximum
size
cm
larg
petrif
left
fig
b
patient
underw
right
bilobectomi
assumpt
malign
inflammatori
pseudotumor
initi
histolog
diagnosi
howev
due
high
clinic
suspicion
primari
lung
malign
combin
partial
resect
left
lung
perform
second
revis
histolog
materi
suggest
fungal
natur
diseas
sporotrichosi
despit
absenc
clinic
sign
immunodefici
mycolog
examin
conduct
bal
microscopi
pcr
bacteriolog
cultur
galactomannan
test
revis
histolog
materi
specif
grocott
stain
perform
ct
examin
nodul
left
upper
lobe
found
fig
specif
process
postop
chang
found
differenti
diagnosi
third
expert
patholog
review
histolog
sampl
request
histolog
examin
reveal
signific
lymphoplasmacyt
infiltr
lymphoid
follicl
format
peribronchi
fibrosi
vascular
obliter
fig
immunostain
show
infiltr
interstitium
plasma
cell
mean
number
plasma
cell
per
high
power
field
hpf
within
diagnosi
lung
diseas
made
understand
etiolog
nodul
left
lung
positron
emiss
tomographi
perform
lesion
lung
organ
includ
pancrea
kidney
thyroid
salivari
gland
identifi
patient
serum
level
gl
normal
refer
rang
gl
recent
intern
consensu
manag
diseas
state
symptomat
subset
asymptomat
patient
requir
treatment
diseas
show
good
respons
steroid
therapi
may
requir
addit
immunosuppress
agent
rituximab
time
present
patient
care
clinic
surveil
treatment
conclus
diseas
rare
diseas
especi
case
lung
involv
mimic
malign
infect
inflammatori
disord
isol
pulmonari
diseas
frequent
seen
middl
age
older
men
young
peopl
also
present
diseas
biopsi
requir
diagnosi
diseas
morpholog
featur
diseas
includ
dens
lymphoplasmacyt
infiltr
storiform
fibrosi
oblit
phlebiti
immunohistolog
express
plasma
cell
awar
patholog
allow
avoid
unjustifi
surgic
intervent
clinic
manifest
pediatr
mediastin
tumor
lin
ch
wu
chen
pediatr
pulmonolog
china
medic
univers
children
hospit
taichung
taiwan
pediatr
children
hospit
china
medic
univers
taichung
taiwan
background
mediastin
tumor
uncommon
children
may
potenti
caus
seriou
consequ
owe
cardiopulmonari
compromis
predict
outcom
initi
clinic
manifest
may
contributori
clinic
studi
aim
analyz
clinic
present
variou
type
pediatr
mediastin
tumor
develop
use
predict
prognost
factor
method
patient
year
age
diagnosi
mediastin
tumor
china
medic
univers
children
hospit
enrol
studi
patient
gender
age
diseas
onset
initi
clinic
symptom
sign
outcom
hospit
cours
review
analyz
result
total
patient
enrol
studi
median
onset
age
mediastin
tumor
around
male
femal
ratio
overal
mortal
rate
two
case
benign
origin
common
tumor
type
lymphoma
follow
germ
cell
tumor
neuroblastoma
thymoma
neuroblastoma
preval
girl
younger
initi
present
patient
includ
respiratori
distress
product
cough
pleural
effus
superior
vena
cava
svc
syndrom
neck
mass
airway
compress
fever
chest
pain
pericardi
effus
lymphoma
compar
type
tumor
like
accompani
neck
mass
p
svc
syndrom
vs
p
yet
better
one
rate
vs
p
conclus
pediatr
mediastin
tumor
often
involv
respiratori
system
overal
lymphoma
highli
suspect
children
present
neck
mass
svc
syndrom
common
male
teenag
lymphoma
also
better
prognosi
compar
type
malign
neuroblastoma
posterior
mediastin
origin
consid
prioriti
among
children
younger
year
old
pleural
effus
displac
shunt
pediatr
case
report
review
literatur
porcaro
fporcaro
f
paglietti
mg
petreschi
f
schiavino
cutrera
r
respiratori
unit
academ
depart
pediatr
bambino
children
hospit
ircc
rome
itali
introduct
thorac
complic
vp
shunt
rare
report
includ
pleural
effus
bronchial
perfor
pneumothorax
pneumonia
complic
occur
period
time
procedur
three
possibl
mechan
postul
intrathorac
trauma
shunt
placement
disloc
periton
cathet
chest
fluid
shift
periton
caviti
pleural
caviti
case
report
herein
report
case
caucasian
femal
patient
pfeiffer
syndrom
hydrocephalu
admit
respiratori
unit
irrit
tachypnea
need
mechan
ventil
increas
baselin
oxygen
requir
vomit
afebril
cardiovascular
examin
unremark
normal
lung
sound
good
ventil
note
bilater
dull
percuss
report
remaind
physic
examin
neg
result
venou
blood
ga
routin
blood
test
normal
thorax
show
complet
opacif
right
hemithorax
mild
associ
compress
atelectasi
larg
pleural
effus
detect
thorax
ct
scan
abdomen
ct
scan
reveal
disloc
distal
tip
vp
shunt
figur
thoracentesi
perform
analysi
pleural
fluid
confirm
csf
leakag
right
recurr
effus
distal
end
vp
shunt
posit
back
abdomen
va
shunt
establish
order
prevent
recurr
pleural
effus
discuss
pleural
effus
due
vp
shunt
insert
rare
potenti
condit
suspect
patient
vp
shunt
respiratori
failur
overal
studi
publish
pediatr
age
time
occurr
chest
complic
variabl
disloc
distal
tip
vp
shunt
preval
transferrin
assay
radionuclid
shuntographi
use
techniqu
diagnos
csf
leakag
verifi
shunt
patenc
cours
diagnost
also
includ
investig
exclud
fistula
thoracentesi
use
tool
treat
massiv
pleural
effus
defin
sourc
revis
distal
tip
vp
cathet
may
suffici
malfunct
suspect
especi
effus
massiv
clinic
pictur
suggest
cathet
infect
remov
pleural
space
reposit
back
abdomen
right
atrium
consid
disloc
show
csf
hydrothorax
recurr
posit
pressur
ventil
also
report
possibl
therapeut
approach
effect
convers
neg
intrathorac
pressur
posit
prevent
fluid
shift
refer
doh
jw
bae
hg
lee
ks
yun
ig
byun
bj
hydrothorax
intrathorac
migrat
ventriculoperiton
shunt
cathet
surg
neurol
taub
e
lavyn
mh
thorac
complic
ventriculoperiton
shunt
case
report
review
literatur
neurosurgeri
dean
df
keller
ib
cerebrospin
fluid
ascit
complic
ventriculoperiton
shunt
j
neurol
neurosurg
psychiatri
takahashi
k
chin
k
sumi
k
nakamura
matsumoto
h
niimi
ikai
mishima
resist
hepat
hydrothorax
success
case
treatment
ncpap
respir
med
figur
figur
chest
ct
scan
demonstr
larg
right
pleural
effus
caus
mediastin
shift
compress
heart
b
abdomen
ct
scan
reconstruct
show
distal
end
vp
shunt
situat
diaphragmat
cupola
within
pleural
caviti
pulmonari
atelectasi
childhood
difficulti
diagnosi
treatment
sismanlar
eyuboglu
aslan
derinkuyu
boyunaga
pulmonolog
dr
sami
ulu
matern
children
research
train
hospit
ankara
turkey
pulmonolog
gazi
univers
hospit
ankara
turkey
gazi
univers
faculti
medicin
ankara
turkey
introduct
atelectasi
lung
parenchyma
occur
sever
caus
children
diagnosi
treatment
import
caus
lung
damag
aim
aim
evalu
etiolog
diagnost
method
treatment
outcom
patient
atelectasi
childhood
method
data
children
atelectasi
tertiari
pediatr
pulmonolog
center
evalu
result
period
patient
diagnos
atelectasi
mean
age
year
common
complaint
cough
patient
pneumonia
patient
acut
asthma
exacerb
diagnosi
underli
diseas
asthma
primari
ciliari
dyskinesia
neuromuscular
diseas
hypotonia
myopathi
congenit
heart
diseas
bronchopulmonari
dysplasia
trachealbronchomalacia
cystic
fibrosi
rare
caus
diagnosi
made
via
bilater
chest
patient
comput
tomographi
common
atelectasi
observ
right
middl
lobe
present
underli
condit
treat
patient
treat
chest
physiotherapi
mucolyt
treatment
patient
bronchoscopi
dornas
alpha
treatment
addit
treatment
patient
recurr
atelectasi
patient
atelectasi
resolv
conclus
import
clinician
keep
mind
atelectasi
may
differ
radiolog
find
recogn
radiolog
find
import
treatment
unnecessari
studi
involv
radiat
patient
impair
mucociliari
function
may
recurr
atelectasi
tracheomalacia
children
retrospect
clinic
kusak
b
e
u
li
g
depart
pediatr
chair
pediatr
jagiellonian
univers
medic
colleg
krakow
poland
introduct
tracheomalacia
tm
fairli
common
airway
disord
identifi
children
moreov
tm
diagnos
increas
last
decad
improv
imagin
capabl
fiberobronchoscopi
radiolog
procedur
grow
awar
disord
among
clinician
tm
establish
primari
secondari
eg
secondari
trachea
compress
great
arteri
regardless
pathophysiolog
tracheal
wall
softer
normal
tm
suscept
collaps
clinic
symptom
due
dynam
narrow
trachea
usual
observ
intrathorac
pressur
exce
intralumin
pressur
trachea
mostli
seen
vigor
exercis
prolong
forc
expir
cough
clinic
tm
produc
recurr
cough
wheez
stridor
thu
symptom
commonli
seen
children
respiratori
disord
believ
tm
mild
diseas
tendenc
resolv
spontan
first
two
year
life
howev
recent
studi
indic
tm
symptom
cough
exert
prolong
cough
respiratori
tract
infect
exert
dyspnea
could
observ
even
older
children
aim
studi
character
clinic
featur
children
tm
period
method
children
tm
identifi
dataset
fiberobronchoscop
examin
perform
univers
children
hospit
krakow
children
tracheostomi
immun
defici
disord
cystic
fibrosi
exclud
analysi
parent
children
older
year
survey
authori
questionnair
ask
presenc
type
sever
respiratori
symptom
children
point
first
year
tm
diagnosi
last
year
preced
survey
request
evalu
children
respiratori
problem
relat
gener
judgment
concern
health
condit
construct
question
variou
yesno
question
multipl
choic
question
open
question
question
graphic
scale
identifi
children
tm
constitut
studi
group
boy
children
tm
diagnos
median
age
year
interquartil
rang
iqr
survey
conduct
median
age
year
iqr
thu
median
period
year
iqr
primari
tm
children
secondari
tm
children
vascular
ring
child
surgeri
esophag
atresia
tracheoesophag
fistula
children
accompani
andor
bronchomalacia
identifi
laryngomalacia
bronchomalacia
note
group
children
parent
return
questionnair
n
significantli
differ
studi
group
term
gender
boy
p
median
age
time
tm
diagnosi
year
iqr
p
ratio
primari
secondari
tm
primari
tm
children
secondari
tm
children
vascular
ring
children
surgeri
esophag
atresia
tracheoesophag
fistula
p
coexist
bronchomalacia
laryngomalacia
bronchomalacia
p
result
parent
report
high
frequenc
respiratori
tract
infect
first
year
tm
diagnosi
children
last
year
preced
survey
comparison
first
year
tm
diagnosi
respiratori
tract
infect
last
year
preced
survey
report
less
frequent
children
less
sever
common
respiratori
tract
infect
diagnos
physician
viral
wheezi
bronchiti
studi
children
recurr
acut
bronchiol
rhinosinus
cough
children
regardless
tm
asthma
diagnosi
addit
establish
children
treatment
prescrib
inhal
corticosteroid
montelukast
promin
postinfecti
cough
last
less
week
report
parent
children
first
year
tm
diagnosi
still
report
last
year
preced
survey
p
moreov
exert
dyspnea
exercis
intoler
observ
parent
children
cough
hand
children
could
manag
strenuou
physic
activ
without
disturb
respiratori
symptom
children
parent
describ
cough
respiratori
infect
bark
unusu
sound
howev
report
characterist
cough
period
outsid
infect
conclus
clinic
symptom
tm
complet
resolv
child
age
earli
school
age
common
persist
symptom
promin
postinfecti
cough
character
bark
unusu
sound
one
third
children
tm
exercis
intoler
due
cough
also
present
respiratori
tract
infect
diminish
frequenc
sever
child
age
primari
care
physician
awar
evolut
tm
symptom
avoid
unnecessari
treatment
need
investig
children
tm
histori
area
pulmonari
function
test
includ
consid
exercis
challeng
test
behind
uncontrol
asthma
clinic
case
late
diagnos
congenit
anomali
miteva
perenovska
p
papochieva
v
petrova
g
pediatr
clinic
univers
hospit
alexandrovska
medic
univers
sofia
sofia
bulgaria
accord
asthma
common
chronic
diseas
among
children
therefor
surpris
child
present
chronic
respiratori
symptom
physician
latter
first
thought
probabl
therapeut
manag
would
asthma
present
case
girl
refer
clinic
treat
asthma
without
success
year
label
difficult
treat
uncontrol
asthma
past
medic
histori
follow
find
notabl
aspir
age
day
confirm
hypoventil
left
lung
esophag
strictur
surgic
correct
age
month
recurr
wheez
sinc
infanc
food
allergi
pet
allergi
famili
histori
elder
brother
confirm
cf
girl
born
screen
cf
test
carrier
elder
sister
epilepsi
admiss
notabl
find
differ
circumfer
thorax
left
larger
right
diminish
lung
sound
right
crackl
rale
test
found
neg
bronchodilatatori
respons
predomin
restrict
spirometri
right
lung
smaller
size
compar
left
lung
cat
confirm
suspect
diagnosi
lung
hypoplasia
therapi
modifi
accord
confirm
diagnosi
asthma
control
medic
discontinu
follow
month
signific
medic
problem
note
well
asthma
exacerb
present
case
illustr
difficult
treat
asthma
patient
realli
stricken
asthma
correct
diagnosi
requir
comprehens
histori
physic
examin
pulmonari
function
studi
laboratori
studi
endoscopi
special
studi
eg
allergi
test
methacholin
challeng
ph
probe
late
sequela
foreign
bodi
aspir
bronchial
tree
tzotcheva
lazova
parina
petrova
g
shivachev
zlatareva
perenovska
clinic
univers
hospit
alexandrovska
medic
univers
sofia
sofia
bulgaria
surgeri
univers
hospit
pirogov
medic
univers
sofia
sofia
bulgaria
diagnost
imag
univers
hospit
alexandrovska
medic
univers
sofia
sofia
bulgaria
tracheobronchi
foreign
bodi
aspir
common
caus
pulmonari
complic
especi
toddler
delay
diagnosi
associ
increas
incid
complic
signific
morbid
mortal
affect
children
present
girl
chronic
symptom
daili
spasmat
cough
preced
protract
pneumonia
girl
normal
neurolog
develop
neg
famili
histori
parent
report
child
consum
whole
nut
emphat
declin
choke
episod
symptom
start
year
ago
prior
admiss
depart
roentgenolog
clinic
sign
infiltr
pneumonia
right
lower
lobe
confirm
clinic
diagnosi
without
suspicion
complic
foreign
bodi
aspir
aggress
antibiot
treatment
led
temporari
improv
follow
asymptomat
period
last
nine
month
child
daili
morn
paroxysm
dri
cough
expector
low
amount
viscou
mucoid
sputum
difficult
clear
child
treat
antihistamin
ltra
nasal
corticosteroid
antibiot
without
improv
adenectomi
perform
clinic
child
present
clinic
roentgenolog
sign
right
lower
lobe
pneumonia
suspect
bronchiectasi
moder
elev
inflammatori
marker
sputum
cultur
show
h
parainfluenza
mantoux
test
sweat
test
neg
immun
defici
exclud
hrct
contrast
demonstr
exacerb
chronic
pneumonia
middl
lower
right
lobe
zone
hypoventil
atelectasi
bronchiectasi
visibl
foreign
bodi
right
intermediari
bronchu
rigid
flexibl
bronchoscopi
perform
four
small
particl
whole
sunflow
seed
extract
foreign
bodi
extract
complex
conserv
treatment
bronchiectasi
chronic
wet
cough
provid
child
still
follow
tracheobronchi
aspir
children
still
consid
one
import
diagnost
therapeut
challeng
physician
case
without
histori
choke
incid
earli
diagnosi
state
art
consumpt
whole
nut
toddler
one
lead
caus
foreign
bodi
aspir
geograph
region
often
miss
clue
point
correct
diagnosi
delay
foreign
bodi
extract
could
lead
lung
damag
chronic
purul
inflamm
unusu
caus
pulmonari
cavitari
lesion
commun
bronchopulmonari
foregut
malform
boy
lam
shang
leen
j
ong
ly
thoon
kc
goh
en
tan
yh
teoh
oh
depart
pediatr
medicin
kk
women
children
hospit
singapor
singapor
background
commun
bronchopulmonari
foregut
malform
cbpfm
congenit
anomali
character
patent
commun
portion
lung
esophagu
stomach
spectrum
rang
esophag
atresia
commun
distal
esophagu
sequestr
lung
type
immatur
lung
mass
form
distal
esophagu
type
ii
connect
sequest
lung
lobe
esophagu
stomach
type
iii
commun
esophagu
bronchial
system
type
iv
cbpfm
rare
major
case
present
symptom
infanc
report
case
cbpfm
unusu
present
pulmonari
cavitari
lesion
late
childhood
case
report
boy
present
hemoptysi
day
prolong
cough
month
fever
constitut
symptom
loss
weight
loss
appetit
night
sweat
pulmonari
tuberculosi
contact
antenat
histori
signific
matern
sever
fetal
intrauterin
growth
retard
born
week
gestat
birth
weight
gram
respiratori
symptom
neonat
period
child
also
histori
asthma
allerg
rhiniti
first
wheez
episod
month
old
subsequ
wheez
episod
time
year
wheez
episod
preced
fever
upper
respiratori
tract
infect
symptom
respons
bronchodil
asymptomat
wheez
episod
start
inhal
corticosteroid
ic
age
year
old
return
review
present
admiss
asthma
exacerb
year
old
spirometri
demonstr
mild
bronchodil
respons
restart
ic
although
ic
wheez
episod
infrequ
grandfath
asthma
allerg
rhiniti
smoke
home
physic
examin
includ
respiratori
system
unremark
digit
club
lymphadenopathi
abdomin
organomegali
chest
reveal
right
upper
lobe
cavitari
lesion
rais
concern
pulmonari
tuberculosi
blood
sputum
investig
bacteri
fungal
mycobacteri
infect
neg
mantoux
test
human
immunodefici
viru
screen
neg
hypochrom
microcyt
anemia
hemoglobin
gdl
note
secondari
iron
defici
low
serum
iron
ferritin
elev
serum
transferrin
occult
blood
posit
stool
blood
coagul
profil
normal
treat
empir
cavitari
pneumonia
cours
antibiot
chest
show
persist
cavitari
lesion
comput
tomographi
ct
thorax
reveal
lesion
area
consolid
dilat
air
space
note
medial
end
branch
airway
cavitari
pneumonia
show
connect
trachea
right
bronchu
instead
direct
toward
esophagu
esophagu
also
show
tubular
right
later
aspect
suspici
bronchopulmonari
malform
commun
esophagu
contrast
swallow
perform
demonstr
contrast
opacifi
cranial
angul
tubular
branch
structur
aris
right
anterior
aspect
esophagu
consist
type
iii
cbpfm
child
underw
resect
cbpfm
flexibl
bronchoscopi
show
absenc
right
upper
lobe
bronchu
esophagogastroduodenoscopi
demonstr
acut
angul
fistula
right
side
mid
esophagu
purul
fluid
note
entri
esophagu
open
thoracotomi
confirm
type
iii
cbpfm
esophag
commun
cbpfm
resect
complic
histolog
confirm
find
cbpfm
presenc
pneumonia
format
bronchiectasi
sign
malign
child
recov
well
surgeri
resolut
chronic
cough
discuss
wide
spectrum
diseas
rang
infect
malign
chronic
system
diseas
congenit
malform
cbpfm
may
caus
cavitari
lesion
lung
case
highlight
pitfal
reli
classic
chest
find
histori
make
correct
diagnosi
pulmonari
tuberculosi
malign
would
top
differenti
given
histori
prolong
cough
hemoptysi
cavitari
lesion
chest
caus
turn
rare
condit
care
unbias
histori
take
import
retrospect
review
case
note
show
initi
complaint
hematemesi
emerg
depart
triag
retrospect
clarif
parent
reveal
prolong
cough
tempor
relat
feed
histori
find
would
fit
better
cbpfm
chest
suggest
cavitari
lesion
ct
thorax
reveal
sever
bronchiectasi
sequest
upper
lobe
resembl
cavitari
lesion
care
review
airway
anatomi
import
find
bronchiectasi
absenc
right
upper
lobe
bronchu
led
identif
possibl
commun
esophagu
contrast
studi
help
delin
commun
cbpfm
although
symptom
cbpfm
usual
present
infanc
diagnosi
delay
child
cbpfm
diagnos
late
childhood
adulthood
possibl
relat
symptom
vagu
present
clear
asthma
symptom
wheez
child
relat
cbpfm
although
featur
atopi
symptom
pulmonari
function
help
clarifi
conclus
cbpfm
rare
condit
may
diagnos
late
unusu
present
care
thorough
histori
physic
examin
review
investig
critic
make
diagnosi
autoimmun
hemolyt
anemia
dissemin
childhood
tuberculosi
khalsi
fkhalsi
f
hadj
hassin
belhadj
ben
romdhan
tinsa
f
brini
hamouda
boussetta
k
pediatr
depart
b
children
hospit
tuni
tuni
tunisia
introduct
tuberculosi
tb
mycobacteri
infecti
diseas
wide
rang
manifest
anemia
commonli
seen
manifest
patient
tb
howev
hemolyt
anemia
rare
caus
anemia
report
case
autoimmun
hemolyt
anemia
aiha
associ
childhood
dissemin
tuberculosi
method
retrospect
studi
includ
case
dissemin
tuberculosi
associ
autoimmun
hemolyt
anemia
result
total
case
dissemin
tuberculosi
dt
associ
aiha
hospit
depart
year
respect
age
year
month
two
children
histori
dt
one
child
lymph
node
tb
one
child
one
year
hospit
initi
present
includ
fever
asthenia
pallor
case
differ
local
tb
pulmonari
patient
pericardi
patient
abdomin
patient
lymph
node
patient
mening
patient
initi
laboratori
test
show
hemoglobin
level
gdl
direct
coomb
test
posit
igg
case
indic
warm
aiha
children
transfus
least
two
patient
need
recurr
transfus
aiha
respond
well
specif
antibiot
treatment
two
patient
corticosteroid
therapi
necessari
two
patient
tubercular
mening
start
along
corticosteroid
simultan
aiha
respond
well
cours
treatment
direct
coomb
test
turn
neg
patient
conclus
associ
aiha
tuberculosi
extrem
rare
case
aiha
associ
tb
report
literatur
pediatr
case
import
recogn
complic
given
sever
implic
moreov
tb
consid
caus
aiha
especi
area
diseas
common
relationship
nutrit
statu
diseas
sever
patient
child
emiralioglu
eryilmaz
cinel
tugcu
gharibzadeh
dogru
ozcelik
gries
kiper
nkiper
n
pulmonolog
hacettep
univers
faculti
medicin
ankara
turkey
pulmonolog
ankara
children
hematolog
oncolog
train
research
hospit
ankara
turkey
pneumolog
dr
von
hauner
children
hospit
munich
germani
aim
pediatr
interstiti
lung
diseas
child
associ
high
morbid
mortal
previou
studi
suggest
outcom
may
poor
especi
infant
young
children
due
failur
thrive
weight
loss
group
anorexia
difficulti
feed
increas
energi
expenditur
increas
work
breath
may
lead
failur
thrive
weight
loss
therefor
import
know
detail
effect
nutrit
mortal
morbid
child
aim
studi
assess
relationship
nutrit
statu
pulmonari
exacerb
lung
function
test
sever
diseas
child
method
patient
ild
enter
child
registri
januari
septemb
hacettep
univers
depart
pediatr
chest
diseas
recruit
bodi
mass
index
bmi
pulmonari
exacerb
fan
point
sever
scale
lung
function
test
radiolog
find
record
correl
analysi
use
show
relationship
bmi
paramet
result
studi
period
patient
includ
registri
mean
diagnost
age
year
year
malefemal
ratio
first
evalu
mean
fvc
dlco
respect
patient
pulmonari
exacerb
rang
total
diagnosi
ild
bmi
moder
neg
signific
correl
fan
sever
score
bmi
moder
posit
signific
correl
oxygen
satur
bmi
signific
correl
number
pulmonari
exacerb
lung
function
test
cohort
howev
bmi
moder
posit
correl
dlco
conclus
cohort
show
nutrit
statu
signific
effect
diseas
sever
diffus
capac
oxygen
satur
patient
interstiti
lung
diseas
prospect
studi
includ
clinic
radiograph
patholog
correl
requir
evalu
prognost
valu
nutrit
statu
patient
child
cystic
lung
diseas
center
pekcan
spekcan
z
pediatr
pulmonolog
necmettin
erbakan
univers
meram
medic
school
konya
turkey
congenit
lung
anomali
compris
group
anatom
abnorm
respiratori
tree
includ
congenit
cystic
malform
bronchopulmonari
sequestr
bronchogen
cyst
bronchial
atresia
congenit
lobar
emphysema
present
studi
aim
determin
type
congenit
lung
diseas
cld
anomali
discuss
term
underli
etiolog
clinic
present
imag
character
emphasi
research
treatment
pediatr
patient
group
attend
hospit
obstetr
patient
group
evalu
cld
exist
variou
imag
techniqu
patient
type
cld
evalu
retrospect
time
period
patient
diagnos
cld
seven
patient
diagnos
ultrasonographi
patient
ultrasonographi
magnet
reson
imag
prenat
period
ten
patient
diagnos
comput
tomographi
postnat
period
earli
diagnosi
treatment
cld
import
given
fatal
progress
prenat
postnat
period
ten
patient
oper
oper
neonat
period
infanc
year
age
none
patient
develop
complic
postop
durat
rang
month
year
age
patient
accompani
diseas
vsd
hemivertebra
pectu
excavatu
pfo
iga
defici
milk
allergi
anomali
detect
increas
frequenc
sonographi
may
also
present
first
time
symptom
childhood
later
life
believ
intrauterin
diagnosi
import
patient
keutel
syndrom
partial
iga
defici
unusu
case
famili
keutel
syndrom
n
pediatr
pulmonolog
ankara
univers
school
medicin
ankara
turkey
introduct
keutel
syndrom
ks
autosom
recess
hereditari
syndrom
caus
homozyg
mutat
mgp
gene
encod
matrix
gla
protein
character
abnorm
cartilag
ossificationcalcif
peripher
pulmonari
stenos
pp
brachytelephalangia
inner
ear
deaf
patient
gener
respiratori
problem
partial
iga
defici
report
ks
previous
report
case
classic
ks
also
partial
iga
defici
born
famili
six
individu
ks
case
index
case
boy
admit
clinic
chronic
cough
brachytelephalang
pulmonari
stenosi
hypertens
mid
facial
retrus
muffl
voic
moder
hear
loss
tracheobronchi
calcif
observ
chest
thorax
computer
tomographi
mother
father
brother
sister
uncl
clinic
radiolog
featur
six
individu
diagnos
ks
genet
analysi
sister
girl
also
recurr
sinus
otiti
pneumonia
immunolog
evalu
reveal
partial
iga
defici
peripher
lymphocyt
subset
analysi
lymphocyt
activ
test
normal
put
antibiot
prophylaxi
infecti
episod
decreas
conclus
although
abnorm
tracheobronchi
cartilag
calcif
keutel
syndrom
often
caus
diseas
howev
recurr
upper
lower
respiratori
problem
common
therefor
immun
perform
patient
ks
clinic
present
outcom
surgic
repair
children
aortic
arch
anomali
capizzi
acapizzi
la
rosa
santoro
torr
tosca
silvestri
sacco
rossi
allergi
diseas
unit
cystic
fibrosi
center
depart
pediatr
istituto
giannina
gaslini
largo
g
gaslini
genoa
itali
pediatr
pulmonari
allergi
diseas
pediatr
unit
cystic
fibrosi
center
istituto
giannina
gaslini
largo
g
gaslini
genoa
itali
cardiovascular
diseas
istituto
giannina
gaslini
largo
g
gaslini
genoa
itali
team
unit
depart
pediatr
surgeri
istituto
giannina
gaslini
largo
ggaslini
genoa
itali
background
aortic
arch
anomali
repres
uncommon
reason
chronic
respiratori
gastroesophag
symptom
infant
young
children
sought
review
experi
infant
children
anatom
complet
vascular
ring
compar
clinic
present
outcom
doubl
aortic
arch
daa
right
aortic
arch
left
ligamentum
raa
patient
method
children
sever
chronic
respiratori
gastroesophag
symptom
two
aortic
arch
anomali
detect
flexibl
bronchoscopi
chest
ct
scan
evalu
age
symptom
onset
diagnosi
surgeri
symptom
frequenc
diagnosi
surgic
correct
evalu
compar
two
patient
group
result
children
doubl
aortic
arc
right
aortic
arch
right
aortic
associ
kommerel
diverticulum
whole
popul
median
age
symptom
onset
diagnosi
surgeri
month
old
respect
time
interv
age
symptom
onset
diagnosi
age
symptom
onset
surgeri
diagnosi
surgeri
significantli
lower
daa
group
raa
group
p
comparison
whole
popul
preval
manifest
diagnosi
chronic
cough
dyspnea
lrt
infect
dysphagiaregurgit
preval
dysphagiaregurgit
differ
two
group
higher
daa
raa
group
p
sever
symptom
lack
respons
medic
treatment
patient
underw
surgic
repair
resect
lesser
aortic
arch
daa
b
vascular
ring
releas
raa
resect
kommerel
diverticulum
present
follow
transposit
left
subclavian
arteri
left
carotid
arteri
addit
anterior
aortopexi
perform
patient
major
complic
report
surgic
treatment
group
morbid
chiefli
relat
tracheomalacia
bronchomalacia
prolong
postop
stay
evalu
median
month
surgeri
resolut
gastroesophag
symptom
improv
respiratori
symptom
well
patient
residu
airway
malacia
report
group
conclus
children
daa
raa
surgic
treatment
accomplish
low
morbid
essenti
mortal
good
clinic
outcom
inflammatori
pseudotumor
children
mesquita
apmesquita
david
franco
molinaro
mice
sutter
alvarez
fazeca
barboza
rosman
lemoin
arienti
carvalho
gome
pulmonolog
jesu
municip
hospit
rio
de
janeiro
brazil
radiolog
jesu
municip
hospit
rio
de
janeiro
brazil
jesu
municip
hospit
rio
de
janeiro
brazil
surgeri
jesu
municip
hospit
rio
de
janeiro
brazil
introduct
inflammatori
lung
pseudotumor
rare
benign
neoplasm
usual
manifest
solitari
pulmonari
nodul
endobronchi
present
infrequ
histolog
compos
lymphocyt
histiocyt
plasmocyt
myofibroblast
treatment
choic
remain
conserv
surgeri
one
alway
seek
obtain
free
margin
due
possibl
local
recurr
object
work
report
case
inflammatori
pseudotumor
caus
persist
pulmonari
imag
children
case
report
poa
year
old
schoolboy
male
rj
brazil
hospit
municip
jesu
hospit
rj
investig
persist
pulmonari
imag
hte
recurr
pneumonia
mother
report
day
fever
cough
treatment
amoxicillin
given
outpati
basi
improv
condit
evolv
abdomin
pain
vomit
weight
loss
declin
gener
state
health
note
report
two
previou
hospit
pneumonia
first
month
ago
left
pleural
effus
four
month
later
present
new
pneumonia
episod
locat
requir
immun
given
famili
histori
tuberculosi
mother
matern
grandfath
live
mother
grandfath
home
good
hygien
sanit
physic
examin
eutroph
eupneic
fr
good
perfus
acyanot
hypocort
bronchial
murmur
reduc
left
hemithorax
without
adventiti
nois
remaind
examin
went
without
notabl
issu
amoxicillin
clavulan
symptomat
treatment
initi
complementari
examin
demonstr
anemia
ht
hb
leukocytosi
left
shunt
stick
segment
hsv
mm
pcr
mgl
normal
biochemistri
two
neg
tuberculin
test
imag
exam
chest
hypotranspar
lower
hte
left
posterior
opac
neg
result
sputum
smear
microscopi
record
chest
tomographi
contrast
show
left
lung
volum
reduct
discret
deviat
mediastin
structur
consolid
heterogen
impregn
left
inferior
lobe
compat
mucocel
bronchoscopi
fragil
endobronchi
veget
lesion
segment
left
lower
lobe
bronchu
biopsi
spindl
cell
prolifer
low
mitot
index
associ
mild
lymphoplasmacyt
inflammatori
infiltr
compat
inflammatori
pseudotumor
favor
evolut
await
surgeri
conclus
case
describ
import
draw
attent
differenti
diagnosi
recurr
pneumonia
case
locat
present
case
due
famili
histori
tuberculosi
high
preval
diseas
brazil
tuberculosi
investig
howev
investig
neg
bronchoscopi
examin
biopsi
decis
diagnosi
young
patient
well
circumscrib
lung
mass
respiratori
symptom
diagnosi
inflammatori
pseudotumor
ipt
consid
neuroendocrin
cell
hyperplasia
infanc
associ
dermatofibrosarcoma
protuberan
case
report
velozo
ribeiro
aj
coelho
silva
mc
maia
filho
jh
melo
filho
aa
hirth
cg
holanda
araujo
freita
ae
calheiro
chave
gome
v
pulmonolog
albert
sabin
children
hospit
fortaleza
brazil
albert
sabin
children
hospit
fortaleza
brazil
coordin
pediatr
surgeri
albert
sabin
children
hospit
fortaleza
brazil
albert
sabin
children
hospit
fortaleza
brazil
coordin
pediatr
pulmonolog
albert
sabin
children
hospit
fortaleza
brazil
introduct
neuroendocrin
cell
hyperplasia
infanc
nehi
rare
form
childhood
interstiti
lung
diseas
undefin
etiolog
infant
affect
tend
present
dyspnea
tachypnea
persist
cough
failur
thrive
hypoxemia
poorli
understood
diseas
dermatofibrosarcoma
protuberan
dfsp
rare
skin
malign
high
probabl
recurr
origin
well
establish
present
firm
lesion
node
may
aris
diseas
prevail
second
fifth
decad
life
report
present
childhood
birth
dfsp
surgic
treatment
object
report
simultan
occurr
two
rare
diseas
nehi
dfsp
case
report
male
patient
year
old
hospit
month
age
histori
respiratori
distress
sinc
birth
sporad
dri
cough
failur
thrive
need
nocturn
supplement
oxygen
short
period
evalu
pediatr
pulmonolog
month
age
physic
examin
reveal
weight
lower
percentil
standard
growth
chart
absenc
toxemia
increas
anteroposterior
diamet
chest
pectu
carinatum
tachydyspnea
rest
normal
oxygen
satur
room
air
bibasilar
crackl
chest
radiographi
show
lung
hyperinfl
chest
hrct
scan
show
opacif
central
region
middl
lobe
lingula
lower
lobe
upper
lobe
air
trap
lower
lobe
upper
lobe
imag
b
nehi
confirm
base
clinic
tomograph
find
child
refer
dermatolog
assess
abdomin
macula
palpabl
subcutan
nodul
mother
notic
lesion
sinc
birth
histopatholog
immunohistochem
examin
antibodi
consist
dfsp
imag
c
tumor
resect
perform
ct
scan
perform
preoper
show
metastas
inguin
lymph
node
biopsi
show
sign
metastasi
discuss
import
report
case
associ
two
rare
patholog
alert
possibl
relationship
nehi
develop
malign
genet
basi
probabl
involv
diseas
due
fact
reveal
clinic
manifest
birth
case
descript
develop
diaphragm
eventr
infant
goldenhar
syndrom
associ
sever
laryngomalacia
chiu
pediatr
intens
care
unit
taichung
citi
taiwan
introduct
eventr
diaphragm
congenit
disord
part
diaphragmat
muscl
replac
fibroelast
tissu
weaken
diaphragm
may
displac
thorax
compromis
patient
breath
complet
eventr
almost
invari
occur
left
side
rare
right
side
present
prematur
femal
infant
whose
diaphragm
eventr
first
note
one
month
age
although
previou
cxr
film
show
normal
bilater
diaphragmat
level
case
report
femal
infant
histori
symmetr
sga
bityh
bodi
weight
g
week
gestat
multipl
congenit
anomali
refer
hospit
due
deterior
respiratori
distress
suffer
remark
chest
retract
admiss
loud
stridor
sound
cxr
show
increas
infiltr
bilater
lung
field
patch
rll
area
clinic
provid
support
nasal
cpap
chest
physiotherapi
respiratori
distress
stridor
sound
rll
patch
persist
therefor
arrang
bronchoscop
studi
note
sever
degre
laryngomalacia
also
examin
diaphragm
movement
fluoroscop
found
remark
eventr
deform
diaphragm
posterior
aspect
rib
space
paradox
movement
right
diaphragm
herniat
abdomin
content
thorac
caviti
laser
therapi
reconstruct
sever
laryngomalacia
right
diaphragm
plicat
via
abdomin
approach
pull
elev
diaphragm
undertaken
improv
breath
feed
began
gain
weight
afterward
discharg
smoothli
discuss
although
diaphragm
eventr
congenit
defect
case
present
display
late
develop
right
diaphragm
eventr
one
month
age
suspect
combin
effect
diaphragm
muscl
weak
right
side
high
neg
pleural
pressur
associ
sever
laryngomalacia
date
found
literatur
report
mention
type
late
develop
diaphragm
eventr
symptom
almost
normal
lung
function
good
exercis
capac
adolesc
born
moder
preterm
find
cohort
vrijlandt
e
reijneveld
bo
pulmonolog
beatrix
children
hospit
groningen
netherland
health
scienc
univers
medic
center
groningen
groningen
netherland
epidemiolog
bioinformat
univers
medic
center
groningen
groningen
netherland
pediatr
neonatolog
beatrix
children
hospit
umcg
groningen
netherland
introduct
pulmonari
outcom
children
mp
adolesc
unknown
aim
studi
determin
effect
moder
preterm
birth
respiratori
health
respiratori
symptom
allerg
symptom
lung
function
exercis
capac
first
studi
topic
method
prospect
cohort
studi
outcom
variabl
preval
respiratori
symptom
determin
isaac
questionnair
lung
function
paramet
fvc
lci
exercis
test
paramet
maxim
workload
maxim
breath
frequenc
ventilatori
reserv
borg
score
result
children
particip
measur
mp
ft
group
compar
age
height
weight
exercis
activ
differ
gestat
age
mp
week
ft
birth
weight
mp
ft
particip
report
mani
symptom
mp
adolesc
report
dri
cough
mp
vs
ft
p
hayfev
mp
vs
ft
p
ft
mp
report
wheez
dyspnea
asthma
eczema
last
twelv
month
lung
function
measur
includ
lci
within
normal
rang
group
except
pef
mp
pred
vs
ft
pred
p
mp
vs
ft
p
lower
limit
normal
mp
observ
differ
group
maxim
workload
maxim
breath
frequenc
ventilatori
reserv
borg
score
see
also
tabl
conclus
moder
preterm
birth
littl
impact
respiratori
health
adolesc
adolesc
born
mp
report
symptom
ft
mild
lung
function
abnorm
compar
ft
differ
maxim
exercis
test
physic
activ
level
tabl
patient
characterist
result
symptom
mention
questionnair
main
lung
function
exercis
test
paramet
result
shown
particip
answer
specif
question
congenit
thorac
malform
detect
prenat
ultrasound
incid
rise
gur
pollak
bronshtein
bentur
pulmonolog
institut
ruth
rappaport
children
hospit
rambam
health
care
campu
haifa
israel
pediatr
hospit
haifa
israel
obstetr
gynecolog
rambam
health
care
campu
haifa
israel
background
increas
earlier
use
prenat
ultrasound
facilit
detect
congenit
thorac
malform
ctm
pediatr
pulmonolog
institut
follow
increas
number
patient
ctm
sought
examin
increas
number
ctm
reflect
true
higher
incid
result
increas
earli
use
prenat
ultrasound
object
evalu
prenat
sonographi
detect
rate
ctm
estim
chang
detect
rate
period
year
method
retrospect
analysi
prenat
ultrasound
us
screen
test
carri
larg
clinic
compar
two
period
result
total
prenat
us
perform
median
rang
gestat
age
week
respect
prenat
ultrasound
test
detect
ctm
compar
ctm
test
twenti
ctm
mainli
congenit
diaphragmat
hernia
cdh
congenit
pleural
effus
cpe
associ
fetal
lesion
thirteen
congenit
pulmonari
airway
malform
cpam
detect
none
latter
associ
malform
detect
rate
chang
vs
p
conclus
ctm
diagnos
earlier
previous
report
cdh
cpe
tend
appear
multipl
lesion
warrant
attent
incid
rate
remain
stabl
compar
last
decad
previou
year
thu
increas
referr
ctm
attribut
increas
prenat
screen
studi
perform
rather
chang
detect
rate
trend
earli
lung
diseas
infant
children
cystic
fibrosi
vlott
b
ranganathan
turkov
pediatr
erasmu
medic
centr
rotterdam
netherland
pediatr
royal
children
hospit
melbourn
australia
respiratori
health
telethon
kid
institut
perth
australia
improv
surviv
continu
accru
peopl
cystic
fibrosi
cf
appear
evid
sequenti
birth
cohort
accumul
evid
point
import
earli
lung
diseas
cf
hypothes
whether
improv
also
reflect
earli
lung
diseas
outcom
pulmonari
inflamm
lung
function
lung
structur
infant
preschool
children
cf
pulmonari
inflamm
infect
lung
function
lung
structur
hospit
admiss
retrospect
assess
infant
preschool
children
cf
year
old
includ
earli
surveil
program
detail
program
protocol
publish
previous
analysi
compar
patient
treat
cohort
patient
treat
cohort
analyz
patient
time
routin
annual
bal
month
year
year
includ
control
group
inflamm
data
avail
longitudin
analysi
test
earli
lung
diseas
outcom
use
multivari
mix
effect
model
random
intercept
account
repeat
visit
model
adjust
age
test
center
infant
preschool
children
similar
age
gender
genotyp
cohort
analyz
proport
patient
detect
neutrophil
elastas
ne
bal
fluid
significantli
lower
recent
cohort
confid
interv
ci
p
differ
patient
age
month
n
ci
p
patient
age
year
n
ci
p
patient
age
year
n
proport
patient
detect
ne
control
group
show
signific
differ
cohort
vs
ci
p
cohort
respect
n
vs
ci
p
n
lung
structur
lung
function
outcom
show
signific
chang
two
cf
cohort
result
longitudin
analysi
similar
report
inflamm
data
show
reduc
inflamm
outcom
cohort
second
cohort
associ
lower
proport
ne
age
combin
first
studi
identifi
secular
chang
earli
pulmonari
inflamm
first
year
life
cf
find
suggest
enhanc
focu
surveil
earli
lung
diseas
past
decad
manifest
improv
earli
diseas
outcom
altern
trend
may
aris
due
improv
treatment
follow
diagnosi
occur
gener
unrel
increas
surveil
find
reduc
inflamm
potenti
associ
improv
even
enhanc
surviv
report
develop
earli
bronchiectasi
yet
shown
signific
downward
trend
therefor
necessari
evalu
potenti
reduc
inflamm
earli
life
subsequ
develop
bronchiectasi
later
life
refer
dodg
ja
lewi
pa
stanton
wilsher
j
cystic
fibrosi
mortal
surviv
uk
eur
respir
j
mar
sli
pd
gangel
cl
chen
l
ware
rs
ranganathan
mott
ls
et
al
risk
factor
bronchiectasi
children
cystic
fibrosi
n
engl
j
med
may
hall
gl
logi
km
parson
f
schulzk
sm
nolan
g
murray
c
air
trap
chest
ct
associ
wors
ventil
distribut
infant
cystic
fibrosi
diagnos
follow
newborn
screen
plo
one
sli
pd
brennan
gangel
c
de
klerk
n
murray
c
mott
l
et
al
lung
diseas
diagnosi
infant
cystic
fibrosi
detect
newborn
screen
american
journal
respiratori
critic
care
medicin
epub
relationship
first
isol
pseudomona
aeruginosa
preced
viral
infect
children
cystic
fibrosi
shaltoni
dshaltoni
narayan
student
dublin
ireland
medicin
royal
manchest
children
hospit
manchest
unit
kingdom
purpos
studi
identifi
pattern
first
isol
pseudomona
aeruginosa
pa
oropharyng
swab
preced
viral
infect
children
cystic
fibrosi
cf
children
first
five
year
life
acquir
sever
episod
viral
upper
lower
respiratori
tract
infect
end
present
hospit
support
treatment
method
retrospect
studi
royal
manchest
children
hospit
tertiari
center
cystic
fibrosi
children
cf
age
year
includ
studi
data
collect
use
electron
databas
januari
decemb
diagnosi
first
pa
isol
confirm
cough
oropharyng
swab
diagnosi
viral
infect
confirm
viral
pcr
nasopharyng
aspir
result
children
includ
studi
acquir
initi
pa
infect
first
year
life
children
preced
viral
infect
last
month
child
preced
viral
infect
last
year
might
due
undiagnos
viral
infect
occur
closer
initi
pa
infect
date
length
time
last
viral
infect
first
acquisit
pa
infect
vari
day
month
tempor
relationship
establish
variabl
common
viral
isol
rhino
viru
rsv
conclus
signific
number
p
preced
posit
viral
infect
first
pa
isol
nevertheless
difficult
find
causal
correl
viral
infect
initi
acquisit
pa
earli
year
cf
patient
earlier
acquisit
pa
infect
sever
lung
diseas
wors
prognosi
small
number
studi
made
difficult
identifi
particular
viral
infect
lead
increas
likelihood
pa
acquisit
discuss
antibodi
titer
certain
pa
antigen
diagnos
pa
pulmonari
infect
month
organ
isol
oropharyng
cultur
therefor
perform
titer
everi
viral
infect
may
better
demonstr
correl
viral
infect
initi
pa
acquisit
addit
might
provid
inform
type
viru
like
pave
way
pa
colon
lung
damag
respiratori
symptom
appear
might
role
vaccin
virus
children
cystic
fibrosi
galectin
correl
lung
function
declin
pulmonari
exacerb
cystic
fibrosi
pediatr
patient
szczepankiewicz
aszczepankiewicz
sobkowiak
pulmonolog
allergi
clinic
immunolog
poznan
univers
medic
scienc
poznan
poland
radiolog
poznan
univers
medic
scienc
poznan
poland
galectin
belong
famili
glycoprotein
interact
glycoconjug
present
cell
surfac
regul
prolifer
apoptosi
previou
studi
enhanc
galectin
breakdown
neutrophil
elastas
observ
neutrophil
inflamm
airway
hypothes
galectin
express
airway
peripher
blood
may
alter
upon
pulmonari
exacerb
cystic
fibrosi
analyz
cf
patient
healthi
control
age
year
patient
assess
twice
pulmonari
exacerb
pe
stabl
period
patient
assess
lung
function
sever
test
fvc
tlc
rv
rf
ax
cbc
crp
microbiolog
analysi
sputum
cultur
radiolog
analysi
sever
symptom
assess
use
shwachman
kulczycki
score
galectin
mrna
express
analyz
use
pcr
method
protein
concentr
serum
sputum
supernat
measur
use
elisa
kit
observ
galectin
protein
concentr
significantli
higher
cf
patient
exacerb
ngul
stabl
period
ngul
healthi
control
subject
ngul
p
valu
concentr
significantli
higher
sputum
blood
p
signific
correl
observ
concentr
diseas
sever
sk
score
level
correl
diseas
progress
exacerb
within
month
inclus
studi
chang
radiolog
pictur
lung
function
observ
signific
correl
fvc
declin
p
analyz
progress
marker
galectin
seem
relat
airway
inflamm
cf
may
marker
lung
function
declin
mainli
vital
capac
reduct
marker
futur
exacerb
work
support
nation
scienc
center
poland
grant
ventil
tracheobronchomalacia
children
hypophosphatasia
nissenbaum
jalisatgi
padidela
wilkinson
narayan
royal
manchest
children
hospit
manchest
unit
kingdom
endocrinolog
royal
manchest
children
hospit
manchest
unit
kingdom
respiratori
medicin
royal
manchest
children
hospit
manchest
unit
kingdom
introduct
hypophosphatasia
rare
genet
condit
caus
abnorm
develop
bone
teeth
due
mutat
tissu
alkalin
phosphatas
alp
gene
lead
low
activ
enzym
six
main
form
vari
sever
sever
form
perinat
autosom
recess
caus
markedli
impair
bone
miner
skelet
malform
nephrocalcinosi
cranial
synostosi
chest
wall
deform
underdevelop
lung
airway
malacia
potenti
fatal
condit
termin
often
previous
offer
howev
signific
develop
new
enzym
therapi
along
introduct
airway
support
mean
children
surviv
method
result
present
four
case
treat
endocrin
depart
enzym
replac
therapi
ert
form
asfotas
alpha
conjunct
respiratori
ent
intens
care
team
addit
team
facilit
tracheostomi
ventil
order
support
underdevelop
lung
malac
airway
initi
phase
treatment
children
recruit
part
clinic
trial
ert
one
patient
administ
treatment
compassion
ground
three
patient
malacia
complet
resolv
first
month
life
airway
support
discontinu
one
child
continu
long
term
ventil
due
comorbid
asfotas
alpha
shown
improv
skelet
miner
may
direct
impact
airway
malacia
although
fulli
investig
know
least
indirectli
aid
support
growth
child
therefor
airway
calib
cartilag
rigid
also
improv
age
conclus
demonstr
case
seri
show
children
good
prognosi
time
sometim
antenat
diagnosi
multidisciplinari
approach
novel
therapi
airway
support
via
long
term
ventil
mean
children
abl
surviv
infanc
respiratori
support
remov
grown
obes
hypothalam
dysfunct
hypoventil
autonom
dysregul
rohhad
syndrom
case
report
pulmonolog
hospit
sant
joan
de
deu
barcelona
spain
hospit
sant
joan
de
deu
barcelona
spain
hospit
sant
joan
de
deu
barcelona
spain
care
hospit
sant
joan
de
deu
barcelona
spain
object
purpos
case
report
summar
clinic
characterist
diagnost
workup
outcom
patient
affect
rohhad
syndrom
method
retrospect
review
patient
clinic
histori
introduct
obes
hypothalam
dysfunct
hypoventil
autonom
dysregul
rohhad
syndrom
infrequ
known
clinic
entiti
possibl
caus
consult
pediatr
pulmonolog
clinic
disord
consid
one
nocturn
hypoventil
differenti
might
also
present
chronic
progress
entiti
case
present
herein
highlight
diagnost
challeng
uncommon
diseas
case
report
boy
admit
clinic
due
mental
statu
obnubil
acut
respiratori
failur
hypercapn
hypoxem
context
acut
pneumonia
requir
noninvas
ventilatori
support
final
intub
ventil
patient
child
parent
neurolog
respiratori
diseas
previous
report
famili
earli
medic
histori
remark
earli
development
motor
delay
hypotonia
febril
seizur
poor
exercis
toler
also
report
due
central
obes
short
statur
delay
bone
age
sd
follow
endocrinologist
physic
examin
patient
present
gener
hypotonia
shallow
respiratori
effort
weak
gener
hyperreflexia
bilater
mydriasi
strabismu
palpebr
ptosi
also
observ
brain
spinal
cord
mri
normal
nerv
conduct
veloc
normal
includ
phrenic
nerv
stimul
pyridostigmin
test
central
nervou
system
infect
rule
toxic
urin
exclud
autoimmun
screen
neg
heart
function
normal
remark
hypernatremia
polyuria
found
spontan
resolv
criteria
diabet
insipidu
patient
respiratori
failur
improv
day
extub
ventil
niv
day
final
wean
day
hospit
admiss
present
mix
respiratori
failur
reintub
wean
niv
persist
hypoventil
hypercapnia
signific
dysautonomia
note
episod
hypothermia
bilater
mydriasi
cold
sweat
heart
rate
abnorm
holter
echocardiogram
normal
lactat
mildli
elev
context
respiratori
acidosi
vitamin
supplement
prescrib
suspect
mitochondri
chain
disord
subsequ
studi
mitochondri
respiratori
chain
enzymat
activ
genet
analysi
mitochondri
dna
normal
discharg
two
month
later
home
bilevel
niv
present
serial
episod
acut
respiratori
decompens
month
first
admiss
short
inpati
stay
routin
blood
test
hypernatremia
mmoll
detect
without
diabet
insipidu
criteria
resolv
spontan
holter
monitor
normal
age
move
itali
present
anoth
respiratori
failur
associ
respiratori
infect
need
higher
level
niv
support
thermal
dysregul
abnorm
sweat
note
believ
central
origin
polysomnographi
perform
absenc
niv
show
normal
sleep
architectur
without
sleep
disord
breath
ahi
supin
posit
mean
oxygen
satur
lowest
briefli
measur
sporad
central
event
hypopnea
one
apnea
late
onset
congenit
hypoventil
syndrom
suspect
gene
mutat
neg
time
start
growth
hormon
gh
gh
defici
neg
stimul
test
hypernatremia
elev
plasma
osmol
elev
urin
osmol
note
respond
fluid
intak
caus
nocturn
enuresi
distress
patient
hormon
studi
reveal
central
hypothyroid
lower
limit
cortisol
respond
acth
stimul
hyperprolactinemia
hypothalam
dysfunct
diagnos
control
brain
spinal
cord
mri
perform
result
normal
therefor
treat
hormon
replac
therapi
somatropin
gh
desmopressin
levothyroxin
hydrocortison
stress
situat
age
return
barcelona
polysomnographi
show
rapid
within
one
hour
mark
oxygen
desatur
mean
lowest
follow
obstruct
respiratori
event
peak
mmhg
studi
deem
posit
sever
hypoxemia
hypercarbia
continu
niv
normal
usual
home
pressur
ipap
epap
age
move
germani
present
anoth
hypercapn
respiratori
failur
context
pneumonia
requir
intub
two
week
episod
present
sever
central
obstruct
apnea
result
sever
bradycardia
av
nodal
escap
rhythm
asystolia
abnorm
low
heart
rate
detect
holter
studi
show
altern
sinu
rhythm
low
auricular
rhythm
compat
dysautonomia
nowaday
age
follow
clinic
keep
present
episod
daytim
sleepi
fatigu
speech
problem
crise
palpebr
pseudoptosi
spirometri
normal
fvc
mef
keep
use
home
niv
daytim
nap
nocturn
sleep
time
holter
monitor
show
normal
sinu
rhythm
altern
low
auricular
rhythm
sinc
atyp
narcolepsi
low
hypocretin
level
cerebrospin
fluid
describ
lumbar
punctur
perform
hypocretin
level
normal
oncolog
screen
protocol
neural
cell
tumor
neg
statur
cm
weight
kg
bodi
mass
index
bone
age
correspond
chronolog
age
tanner
puberti
stage
test
ml
sinc
puberti
delay
start
testosteron
hormon
replac
therapi
gh
hydrocortison
desmopressin
levothyroxin
neuropsycholog
studi
reveal
normal
intellig
quotient
difficulti
plan
immedi
visual
memori
hold
attent
orthographi
affect
symptom
difficulti
establish
relationship
conclus
rohhad
syndrom
clinic
diagnosi
lack
known
specif
gene
marker
includ
differenti
diagnosi
hypoventil
syndrom
congenit
central
hypoventil
syndrom
ondin
syndrom
prader
willi
syndrom
neuromuscular
diseas
structur
metabol
disord
especi
suspect
patient
obes
hypothalam
disord
publish
sign
symptom
appear
time
breath
disord
last
one
henc
endocrinologist
awar
featur
request
sleep
night
studi
regularli
rohaad
syndrom
suspect
pneumonia
clinic
present
cvid
oreor
mrkic
kobal
zvonar
nogalo
turkalj
allergolog
preschool
schoolchildren
children
hospit
srebrnjak
zagreb
croatia
physic
therapi
rehabilit
children
hospit
srebrnjak
zagreb
croatia
introduct
normal
resolut
pneumonia
easili
defin
may
vari
depend
upon
underli
caus
host
respons
pathogen
clinic
radiograph
indic
consid
defin
slow
resolut
radiograph
infiltr
clinic
symptom
despit
adequ
antibiot
therapi
sever
compon
success
resolut
includ
clinic
improv
radiograph
resolut
microbiolog
erad
improv
vital
paramet
usual
occur
day
patient
note
subject
improv
within
day
treatment
radiograph
resolut
pneumonia
estim
week
microbiolog
erad
variabl
depend
infecti
agent
resolut
pneumonia
appropri
addit
evalu
done
consid
fact
pneumonia
common
condit
comorbid
diseas
host
factor
associ
slower
resolut
infiltr
investig
case
report
boy
admit
hospit
diagnost
evalu
recurr
pneumonia
bronchiti
age
alreadi
treat
radiolog
clinic
confirm
pneumonia
treat
inpati
time
admit
plan
addit
diagnost
alreadi
adenoidectomi
previous
found
adenoid
hypertrophi
allergi
test
conduct
well
esophagu
imped
cardiolog
evalu
normal
chest
repeatedli
show
bilater
infiltr
flexibl
bronchoscopi
show
diffus
edemat
bronchial
mucosa
abund
turbid
secret
without
anatom
abnorm
foreign
bodi
immunoelectrophoresi
show
decreas
level
igg
gl
igm
gl
normal
level
iga
gl
consequ
immunolog
evalu
perform
lymphocyt
flow
cytometri
immunophenotyp
show
decreas
absolut
number
helper
cell
subtyp
normal
rang
flow
cytometri
immunophenotyp
b
lymphocyt
subpopul
show
decreas
level
plasmablast
doubl
neg
b
lymphocyt
assess
antibodi
hepat
b
surfac
antigen
antihb
titer
undetect
inadequ
antibodi
respons
vaccin
confirm
consid
result
diagnost
evalu
diagnosi
common
variabl
immunodefici
cvid
made
intraven
immunoglobulin
replac
therapi
start
sinc
boy
receiv
therapi
monthli
interv
new
pneumonia
verifi
conclus
present
cvid
boy
initi
diagnos
pneumonia
children
pneumonia
detail
immunolog
evalu
perform
key
word
cvid
pneumonia
children
immunodefici
respiratori
papillomatosi
coexist
pekcan
z
pediatr
pulmonolog
necmettin
erbakan
univers
meram
medic
school
konya
turkey
report
associ
immunodefici
juvenil
laryng
papillomatosi
jlp
patient
femal
patient
refer
anoth
center
suspicion
brochiectasi
tomographi
report
fibrot
chang
due
necrot
pneumonia
atyp
facial
appear
bilater
rale
rhonchi
physic
examin
learn
recurr
upper
respiratori
airway
infect
frequent
medic
histori
recurr
lung
infect
immunolog
investig
flexibl
bronchoscopi
gener
anesthesia
perform
show
vocal
cord
upper
trachea
normal
papillovesicular
lesion
extend
trachea
toward
right
main
bronchu
part
lesion
bundl
swab
sampl
lavag
test
immunolog
test
decreas
number
cd
cd
lymphocyt
peripher
blood
lymphocyt
well
immunoglobulin
particularli
mgdl
intraven
immunoglobulin
therapi
initi
investig
immunodefici
genet
juvenil
laryng
papillomatosi
may
present
cough
stridor
hoars
dysphagia
well
pneumonia
laryng
papillomatosi
common
benign
laryng
tumor
children
gener
diagnos
five
year
age
thought
caus
acquisit
human
papillomaviru
hpv
vertic
labor
infect
mother
genet
variabl
relat
immun
system
may
repres
one
effect
factor
develop
caus
hpv
due
local
detect
immunodefici
found
interest
airway
inflamm
injuri
children
preval
weakli
acid
gastroesophag
reflux
capizzi
sacco
silvestri
ghezzi
rossi
allergi
diseas
unit
cystic
fibrosi
center
depart
pediatr
istituto
giannina
gaslini
largo
g
gaslini
genoa
itali
asthma
cough
center
policlinico
san
pietro
bergamo
itali
background
children
gastroesophag
reflux
ger
acid
reflux
ar
weakli
acid
reflux
war
induc
respiratori
symptom
rs
method
order
character
airway
inflamm
children
preval
war
ar
defin
accord
roc
curv
analysi
perform
retrospect
review
medic
record
patient
underw
fiberopt
bronchoscopi
chronicrecurr
respiratori
symptom
posit
multipl
intralumin
esophag
imped
phmii
monitor
result
war
ar
children
number
cell
recov
bronchoalveolar
lavag
bal
similar
x
cell
x
cell
respect
p
neutrophil
alveol
elev
llm
index
detect
group
differ
found
neutrophil
lymphocyt
percentag
llm
index
war
ar
children
contrast
higher
bal
epitheli
cell
proport
seen
war
compar
ar
children
p
suggest
greater
airway
damag
former
whole
patient
popul
signific
correl
found
proport
bal
epitheli
cell
number
war
event
r
p
final
elev
bal
concentr
substanc
p
pepsin
observ
statist
differ
war
ar
group
conclus
patient
popul
war
event
associ
signific
airway
inflamm
injuri
biochem
mechan
involv
like
complet
prevent
andor
counteract
treatment
tracheal
stenosi
patient
mucopolysaccharidos
case
report
literatur
review
wang
xmwang
xm
zhang
hl
dong
l
pulmonolog
yuy
children
hospit
wenzhou
medic
univers
wenzhou
china
introduct
mucopolysaccharidos
mp
compris
hereditari
disord
differ
lysosom
storag
disord
join
errant
degrad
glycosaminoglycan
gag
main
accumul
storag
product
includ
gag
contain
heparan
keratan
dermatan
chondroitin
sulfat
substanc
ubiquit
connect
tissu
henc
manifest
broad
challeng
includ
upper
lower
airway
case
descript
boy
histori
mp
indirect
inguin
hernia
umbil
hernia
four
month
admit
counti
hospit
surgeri
indirect
inguin
hernia
repair
anesthesia
asphyxia
appear
emerg
treatment
recov
surgeri
cancel
present
clinic
depart
chief
complaint
slight
cough
histori
fever
day
treatment
chest
film
obtain
show
pneumonia
admit
pediatr
pulmonolog
depart
physic
examin
reveal
short
neck
growth
delay
abnorm
faci
reconstruct
deriv
chest
ct
scan
perform
show
laryngotrach
stenosi
electron
bronchofibroscopi
suggest
comprehens
evalu
upper
lower
airway
safe
airway
manag
howev
parent
reject
simultan
consid
risk
anesthesia
surgeri
also
reject
telephon
conduct
everi
month
parent
note
usual
state
health
except
intermitt
cough
difficult
recoveri
discuss
mp
mainli
mp
type
ii
vi
complic
sever
obstruct
upper
airway
tracheobronchi
malacia
andor
stenosi
lower
airway
result
abnorm
degrad
glycosaminoglycan
result
sever
potenti
fatal
difficulti
anesthet
procedur
signific
airway
compromis
may
occur
alreadi
earli
childhood
airway
obstruct
may
local
physiolog
airway
nose
peripher
bronchia
insuffici
understand
insuffici
emphasi
result
seriou
consequ
especi
hospit
safe
airway
manag
necessit
multidisciplinari
approach
combin
surgeri
ct
bronchoscopi
provid
quantit
morpholog
evalu
airway
stenosi
favor
airway
manag
mp
children
diffus
interstiti
lung
diseas
infant
stimul
interferon
gene
sting
vasculopathi
onset
infanc
savi
pulmonolog
section
hospit
universitario
vall
dhebron
barcelona
spain
rheumatolog
section
hospit
universitario
vall
dhebron
barcelona
spain
introduct
hereditari
autoinflammatori
disord
except
rare
caus
diffus
lung
diseas
children
case
report
show
infant
stimul
interferon
gene
sting
vasculopathi
onset
infanc
savi
whose
main
featur
system
inflamm
cutan
vasculopathi
pulmonari
diseas
object
review
manag
differenti
diagnosi
pulmonari
diseas
especi
associ
vasculit
skin
rash
persist
high
system
inflammatori
marker
case
report
boy
admit
evalu
failur
thrive
start
cow
milk
feed
month
age
examin
tachypnea
breathsmin
chest
abnorm
diffus
interstiti
pattern
full
term
newborn
previou
histori
interest
apart
choke
feed
cough
cyanosi
cri
mother
sister
grandmoth
celiac
mother
suffer
diabet
hypothyroid
studi
sweat
test
tuberculin
skin
test
echocardiographi
abdomin
ultrasound
normal
erythrocyt
sediment
rate
esr
mmh
igg
elev
mgdl
chest
ct
show
diffus
opac
septal
thicken
bronchoalveolar
lavag
bal
lymphocyt
neutrophil
found
esophag
show
sever
gastroesophag
reflux
thu
omeprazol
start
pulmonari
biopsi
month
age
reveal
septal
widen
lymphocyt
b
aggreg
interstitium
airway
serum
precipit
igg
antibodi
cow
milk
protein
posit
initi
tent
diagnosi
hypersensit
pulmonari
diseas
made
cow
diet
initi
improv
growth
administ
sever
bolus
steroid
signific
respiratori
improv
observ
age
month
start
macular
rash
cheek
ear
nodul
worsen
cold
follow
month
rash
extend
becam
skin
biopsi
show
leukocytoclast
vascul
interfac
dermat
esr
high
mmh
transaminas
also
increas
ast
iul
alt
iul
subsequ
studi
show
autoantibodi
posit
ana
sma
anticardiolipin
igg
g
uml
suspicion
system
lupu
erythemat
made
differ
treatment
tri
partial
improv
cutan
lesion
transaminas
azathioprin
anakinra
hydroxychloroquin
mycophenol
tacrolimu
monthli
administr
immunoglobulin
first
year
mild
tachypnea
subsequ
resolv
normal
normal
auscult
digit
club
appear
respiratori
auscult
alway
normal
never
need
oxygen
supplement
year
old
tocilizumab
start
clear
improv
clinic
blood
nonetheless
treatment
stop
due
muscular
toxic
month
six
year
age
public
new
entiti
n
engl
j
med
patient
found
mutat
gen
savi
syndrom
diagnos
sinc
age
asymptomat
respiratori
standpoint
dyspnea
heavi
exercis
current
year
old
follow
treatment
ruxolitinib
two
year
seem
good
clinic
respons
esr
still
increas
mmh
interstiti
diseas
chest
ct
persist
spirometri
show
alter
compat
mild
restrict
fvc
mmef
conclus
savi
syndrom
autoinflammatori
diseas
caus
mutat
provok
interferon
dysregul
lead
persist
system
inflamm
sign
peripher
vascular
inflamm
start
first
month
life
describ
pulmonari
featur
child
diseas
import
includ
interferonopathi
savi
syndrom
differenti
diagnosi
child
interstiti
lung
diseas
especi
associ
persist
increas
reactant
level
progress
skin
damag
daili
nocturn
respiratori
monitor
patient
duchenn
muscular
dystrophi
left
ventricular
assist
devic
caggiano
franzonello
chiarini
testa
paglietti
verrillo
pavon
cherchi
adorisio
amodeo
turchetta
cutrera
unit
pediatr
depart
bambino
children
hospit
ircc
rome
itali
pediatr
gaspar
rodolico
hospit
univers
catania
catania
itali
cardiolog
depart
bambino
children
hospit
ircc
rome
itali
pediatr
cardiolog
cardiac
surgeri
bambino
children
hospit
ircc
rome
itali
medicin
unit
bambino
children
hospit
ircc
rome
itali
background
duchenn
muscular
dystrophi
dmd
recess
disord
character
progress
skelet
muscl
weak
loss
ambul
death
secondari
cardiac
respiratori
failur
forc
vital
capac
fvc
effect
marker
respiratori
failur
evolut
fvc
peak
age
decreas
per
year
ventilatori
support
requir
surviv
noninvas
ventil
niv
effect
treatment
respiratori
failur
dilat
cardiomyopathi
dcm
frequent
find
dmd
patient
rare
candid
cardiac
transplant
thu
left
ventricular
assist
devic
lvad
use
destin
therapi
aim
studi
analyz
diurnal
nocturn
respiratori
assess
surviv
death
rate
caus
death
dmd
patient
lvad
method
fvc
polysomnographi
psg
nocturn
pulsoximetri
mean
transcutan
carbon
dioxid
surviv
caus
death
record
result
six
dmd
patient
age
year
lvad
placement
enrol
mean
fvc
calcul
patient
year
predict
valu
patient
psg
normal
outcom
pulsoximetri
perform
patient
show
normal
rang
year
mean
fvc
patient
minimum
maximum
patient
treat
nocturn
niv
introduc
month
lvad
patient
tracheostom
due
difficult
extub
start
nocturn
invas
ventil
patient
need
ventil
support
vfc
ventil
patient
show
normal
psg
nocturn
pulsoximetri
three
patient
die
year
averag
distanc
year
sinc
lvad
placement
caus
death
respect
brain
hemorrhag
anticoagul
treatment
septic
shock
lung
infect
iatrogen
tracheal
ruptur
anoth
hospit
three
patient
aliv
year
surgeri
conclus
lvad
affect
natur
declin
respiratori
function
dmd
patient
requir
niv
treat
ventilatori
failur
ensur
surviv
unusu
caus
atelectasi
chronic
inflamm
lung
daeleman
de
wachter
ernst
smet
casteel
vandenpla
malfroot
pediatr
universitair
ziekenhui
brussel
vrije
universiteit
brussel
vub
brussel
belgium
pediatr
pulmonolog
infectiolog
universitair
ziekenhui
brussel
vrije
universiteit
brussel
vub
brussel
belgium
radiolog
universitair
ziekenhui
brussel
vrije
universiteit
brussel
vub
brussel
belgium
thorac
surgeri
universitair
ziekenhui
brussel
vrije
universiteit
brussel
vub
brussel
belgium
pediatr
algemeen
stedelijk
ziekenhui
aalst
aalst
belgium
case
report
girl
present
fever
pneumonia
right
middl
lobe
rml
treat
antibiot
cefuroxim
rapid
clinic
improv
persist
atelectasi
rml
despit
physiotherapi
week
later
fever
relaps
demonstr
pneumonia
rml
bronchoscopi
perform
show
mucu
plug
rml
subsequ
remov
anatom
abnorm
seen
intrapulmonari
percuss
ventil
physiotherapi
start
howev
third
episod
cough
wheez
fever
seen
week
show
radiograph
abnorm
biochem
marker
inflamm
low
second
bronchoscopi
show
inflam
mucosa
purul
secret
right
bronchial
tree
especi
right
middl
upper
lobe
lavag
reveal
h
influenza
catarrhali
ct
scan
perform
exclud
bronchiectasi
instead
import
exostosi
costal
side
anterolater
arch
fourth
right
rib
observ
compress
part
rml
could
precis
demonstr
aspect
shorten
deform
rib
histori
thorac
trauma
suggest
congenit
rib
malform
avoid
complic
endoscop
surgeri
partial
rib
remov
plan
near
futur
conclus
congenit
rib
malform
rare
caus
compress
atelectasi
subsequ
chronic
inflamm
lung
case
emphas
import
also
consid
anatom
anomali
case
relaps
lung
problem
lobe
children
pectu
excavatum
experi
exercis
intoler
cardiopulmonari
function
rest
exercis
children
pectu
excavatum
akel
kakel
meizahav
freud
mussaffi
prai
stafler
levin
steuer
blau
institut
schneider
children
medic
center
petach
tikva
israel
surgeri
schneider
children
medic
center
israel
israel
introduct
patient
pectu
excavatum
pe
frequent
experi
short
breath
aerob
capac
limit
howev
unclear
whether
object
limit
cardiorespiratori
system
minim
invas
procedur
pe
repair
nuss
procedur
introduc
aim
studi
assess
whether
cardiorespiratori
limit
children
rest
exercis
method
retrospect
studi
demograph
paramet
clinic
symptom
pe
sever
children
assess
pe
schneider
children
medic
center
israel
extract
evalu
baselin
pulmonari
function
includ
volum
total
lung
tlc
forc
vital
residu
tidal
volum
flow
forc
expiratori
volum
one
maxim
voluntari
ventil
mvv
cardiopulmonari
exercis
test
perform
children
result
children
boy
mean
age
pe
assess
lung
volum
rest
flow
found
normal
differ
patient
chest
pain
exercis
intoler
asymptomat
patient
howev
sever
pe
associ
lower
lung
volum
lower
tidal
volum
rest
dead
space
volum
vd
rest
found
higher
group
vs
p
consumpt
maxim
exercis
within
normal
rang
larg
variabl
predict
maxim
load
achiev
predict
ventilatori
anaerob
threshold
appear
earlier
expect
case
ventilatori
breath
reserv
normal
children
puls
within
normal
rang
larg
variabl
predict
signific
heart
rhythm
abnorm
observ
vdvt
maxim
exercis
tidal
volum
maxim
exercis
increas
capac
suggest
less
effici
ventil
pe
patient
tend
tachypn
maxim
exercis
respiratori
predict
pulmonari
equival
maxim
exercis
elev
suggest
less
effect
ga
exchang
patient
sever
pe
associ
lower
maxim
load
differ
max
ventilatori
measur
respiratori
symptom
associ
lower
higher
respiratori
equival
compar
asymptomat
patient
conclus
children
pe
normal
pulmonari
function
rest
howev
show
maladapt
exercis
suggest
compromis
chest
wall
mechan
chang
might
role
discomfort
pe
patient
experi
exercis
sleep
disord
breath
children
congenit
myasthen
syndrom
clinic
present
manag
cassinello
cassinello
laverti
samuel
respiratori
medicin
complejo
asistenci
universitario
de
salamanca
salamanca
spain
sleep
medicin
great
ormond
street
hospit
children
london
unit
kingdom
background
congenit
myasthen
syndrom
cm
heterogen
group
inherit
disord
affect
neuromuscular
transmiss
character
fatig
weak
vari
sever
includ
respiratori
failur
presenc
sever
breath
sdb
poorli
document
popul
object
describ
clinic
present
role
cardiorespiratori
polygraphi
crp
includ
capnographi
determin
presenc
sdb
need
respiratori
intervent
includ
ventilatori
support
method
review
medic
record
crp
perform
embla
softwar
remlog
ver
children
cm
refer
sleep
unit
great
ormond
street
hospit
gosh
result
identifi
case
girl
cm
refer
neurologist
exclud
sdb
andor
hypoventil
children
establish
ventilatori
support
referr
crp
perform
median
age
first
crp
year
rang
year
crp
abnorm
case
show
six
case
sdb
five
hypoventil
three
show
symptom
obstruct
sdb
time
referr
three
case
hypoventil
without
obstruct
pressur
ventil
time
studi
start
posit
pressur
ventilatori
support
case
optim
patient
alreadi
establish
ventil
conclus
crp
capnographi
use
studi
order
determin
appropri
time
commenc
long
term
ventil
optim
ventil
set
patient
alreadi
establish
ventilatori
support
although
crp
may
predict
respiratori
crisi
cm
use
diagnosi
sdb
even
neg
clinic
histori
pediatr
pulmonologist
adher
tobacco
prevent
control
treatment
guidelin
urrego
f
thoma
pulmonolog
ochsner
children
new
orlean
usa
medicin
ochsner
new
orlean
usa
background
tobacco
use
world
lead
prevent
caus
death
children
expos
second
shse
third
hand
smoke
thse
risk
morbid
limit
option
avoid
exposur
tobacco
smoke
exposur
increas
risk
sudden
infant
death
syndrom
lower
respiratori
tract
infect
middl
ear
diseas
sever
asthma
slow
lung
everi
possibl
effort
made
decreas
burden
diseas
american
academi
pediatr
aap
american
colleg
chest
physician
accp
mani
intern
organ
publish
guidelin
assist
physician
tobacco
prevent
control
treatment
aap
recommend
pediatrician
screen
tobacco
smoke
exposur
everi
visit
offer
smoke
parent
counsel
treatment
referr
quit
unfortun
pediatrician
adher
guidelin
remain
may
attribut
lack
physician
awar
familiar
publish
guidelin
well
lack
knowledg
regard
avail
tool
essenti
pediatr
pulmonologist
manag
primarili
diseas
directli
affect
shse
adher
publish
guidelin
purpos
studi
data
regard
whether
pediatr
pulmonologist
adher
guidelin
lack
conduct
survey
assess
pediatr
pulmonologist
practic
respect
shse
screen
counsel
treatment
referr
cessat
servic
method
survey
question
includ
whether
respond
use
either
aap
juliu
b
richmond
center
excel
clinic
effort
second
hand
smoke
exposur
ceas
accp
smoke
particip
queri
whether
screen
counsel
treat
refer
caregiv
cessat
servic
time
alway
never
confid
smoke
cessat
promot
willing
attend
cours
offer
nation
meet
ask
questionnair
post
pediatr
pulmonolog
list
server
pedlung
pedlung
reach
pediatr
respiratori
physician
around
globe
survey
monkey
use
design
administ
questionnair
respons
anonym
result
compar
previou
data
gener
pediatrician
result
eighti
respons
obtain
state
alway
use
aap
accp
clinic
practic
guidelin
although
respond
report
alway
screen
counsel
refer
caregiv
zero
percent
respond
alway
prescrib
nicotin
replac
therapi
nrt
bupropion
vareniclin
respond
feel
comfort
treat
tobacco
depend
caregiv
respond
would
attend
cessat
train
cours
offer
nation
meet
conclus
discuss
compar
cohort
gener
pediatrician
rate
screen
counsel
respond
higher
rate
treatment
referr
despit
morbid
shse
common
pulmonari
diseas
like
bronchopulmonari
cystic
pediatr
pulmonologist
use
avail
tool
assist
smoke
caregiv
imper
physician
treat
children
respiratori
disord
feel
confid
treat
caregiv
tobacco
depend
revis
pediatr
pulmonari
train
program
curriculum
need
includ
tobacco
cessat
train
assur
graduat
abl
activ
involv
forefront
treat
tobacco
epidem
bibliographi
us
depart
health
human
servic
health
consequ
involuntari
exposur
tobacco
smoke
report
surgeon
gener
june
http
wwwsurgeongeneralgovlibraryreportssecondhandsmokeindexhtml
access
june
best
committe
environment
health
committe
nativ
american
child
health
committe
adolesc
american
academi
pediatr
technic
secondhand
prenat
tobacco
smoke
exposur
pediatr
nov
winickoff
jp
e
chang
et
al
implement
parent
tobacco
control
intervent
pediatr
practic
pediatr
june
american
colleg
chest
physician
tobacco
depend
toolkit
http
tobaccodependencechestnetorg
committe
environment
health
committe
substanc
abus
committe
adolesc
committe
nativ
american
child
health
academi
pediatr
polici
tobacco
use
pediatr
diseas
pediatr
nov
sim
th
committe
substanc
abus
american
academi
pediatr
technic
tobacco
substanc
abus
pediatr
nov
beati
dornel
ac
sahuqu
et
al
evalu
pediatrician
adher
tobacco
prevent
control
treatment
guidelin
educ
outreach
program
ochsner
journal
cawjwel
pb
lee
l
shearston
j
et
al
differ
decad
make
smoke
cessat
counsel
screen
pediatr
visit
nicotin
tobacco
research
pbert
l
farber
h
horn
k
et
al
state
art
offic
base
intervent
elimin
youth
tobacco
use
past
decad
pediatr
apr
american
academi
juliu
b
richmond
center
excel
ceas
toolkit
http
wwwaaporgenusadvocacyandpolicyaaphealthinitiativesrichmondcenterpagesdefaultaspx
collaco
jm
aherrera
breyss
pn
et
al
hair
nicotin
level
children
bronchopulmonari
dysplasia
pediatr
march
kopp
bj
ja
sadream
c
et
al
impact
secondhand
smoke
exposur
children
cystic
fibrosi
review
int
j
environ
re
public
health
hollenbach
jp
shifano
ed
hammel
c
et
al
exposur
secondhand
smoke
asthma
sever
among
children
connecticut
plo
one
random
trial
use
arginin
supplement
prevent
nosocomi
infect
critic
ill
patient
salis
r
tuazon
pediatr
univers
philippin
philippin
gener
hospit
manila
philippin
introduct
rational
healthcar
cost
increas
year
nosocomi
infect
increas
morbid
mortal
cost
length
stay
far
beyond
expect
base
underli
diseas
state
infect
gener
substanti
econom
burden
patient
hospit
resourc
well
import
find
way
prevent
nosocomi
infect
occur
first
place
b
object
main
object
studi
determin
supplement
arginin
effect
nosocomi
infect
rate
versu
placebo
critic
ill
pediatr
patient
c
signific
studi
efficaci
arginin
supplement
prevent
nosocomi
infect
among
critic
ill
children
well
establish
variou
studi
yield
contradictori
conclus
mostli
among
adult
methodolog
studi
design
random
doubl
blind
clinic
studi
b
studi
set
research
conduct
philippin
gener
hospit
pediatr
emerg
room
pediatr
ward
pediatr
intens
care
unit
c
studi
particip
elig
patient
age
year
old
critic
ill
necessit
icu
admiss
enrol
studi
follow
inclus
criteria
critic
ill
patient
necessit
icu
admiss
admit
least
day
abl
toler
oral
feed
malabsorpt
diseas
immunodefici
congest
heart
failur
well
nourish
sever
malnourish
sever
burn
nosocomi
infect
day
admiss
institut
allerg
arginin
e
statist
analysi
sampl
size
calcul
use
epi
info
softwar
version
base
assumpt
use
arginin
result
reduct
occurr
nosocomi
infect
estim
use
nosocomi
infect
rate
confid
interv
power
need
children
per
group
show
differ
allow
studi
withdraw
total
patient
recruit
patient
per
arm
data
analyz
use
epi
info
version
softwar
perform
compar
differ
mean
independ
sampl
compar
distribut
discret
variabl
two
group
test
fisher
exact
test
appropri
perform
bartlett
test
homogen
use
determin
group
test
perform
signific
level
p
result
total
patient
predict
sampl
size
critic
ill
patient
recruit
studi
patient
recruit
discharg
withdrawn
control
group
studi
due
mortal
anoth
also
withdrawn
arginin
group
due
mortal
patient
die
primari
diseas
pediatr
commun
acquir
pneumonia
less
hour
admiss
baselin
characterist
group
significantli
differ
age
height
weight
sex
chief
complaint
primari
diagnosi
statist
group
regard
primari
outcom
research
interest
note
none
patient
arginin
group
develop
nosocomi
infect
compar
placebo
group
wherein
patient
develop
nosocomi
infect
particularli
nosocomi
pneumonia
show
rel
risk
reduct
absolut
risk
reduct
number
need
treat
patient
promis
howev
result
fisher
test
mean
statist
differ
two
group
statist
analysi
also
show
statist
differ
arginin
level
arginin
group
placebo
group
supplement
use
bartlett
test
p
valu
respect
degre
freedom
lack
statist
signific
may
attribut
dose
given
subject
maximum
gram
day
review
perform
wijand
et
al
sever
studi
arginin
supplement
use
higher
dose
gram
day
show
posit
result
readmiss
advers
effect
note
conclus
recommend
arginin
supplement
effect
prevent
occurr
nosocomi
infect
patient
critic
ill
howev
studi
highli
recommend
use
higher
dose
arginin
supplement
gram
gram
encourag
reflect
even
low
dose
arginin
use
studi
result
promis
imper
perform
investig
use
high
dose
arginin
mayb
higher
dose
posit
effect
better
demonstr
statist
differ
achiev
prevent
nosocomi
infect
exposur
radiat
imag
sever
asthmat
children
hospit
concepcion
chile
soto
lavin
niklitschek
soto
fuent
fuent
cea
sepulveda
toledo
pulmonolog
unit
hospit
region
concepcion
chile
universidad
de
concepcion
concepcion
chile
faculti
universidad
de
concepcion
concepcion
chile
dept
hospit
de
concepcion
concepcion
chile
introduct
effect
ioniz
radiat
occur
certain
dose
latter
measur
msv
instantan
occur
decad
cancer
identifi
possibl
manifest
year
later
human
be
expos
radiat
stem
food
solar
wave
certain
equip
home
measur
msv
per
year
amount
increas
exposur
comput
tomographi
ct
age
type
irradi
tissu
import
children
sensit
life
expect
increas
possibl
effect
therefor
vital
import
correct
justif
optim
exam
diagnost
purpos
pediatr
materi
method
sever
asthmat
children
includ
hospit
pediatr
servic
octob
juli
chosen
group
children
exclud
due
incomplet
data
child
digit
file
program
call
synaps
file
review
standard
inform
msv
ct
scan
result
complet
medic
file
data
consolid
excel
statist
analysi
perform
result
age
patient
vari
year
median
year
total
radiolog
examin
perform
patient
correspond
ct
scan
frequent
irradi
area
thorax
limb
brain
skull
standard
radiat
receiv
patient
period
median
msv
eight
patient
exceed
msv
one
reach
valu
msv
conclus
sever
asthmat
children
hospit
concepcion
regist
medic
histori
receiv
quantiti
radiat
stem
mainli
chest
median
equal
annual
base
radiat
patient
must
follow
time
order
look
certain
secondari
effect
radiat
exposur
epidemiolog
studi
mycoplasma
pneumonia
infect
children
wang
chen
z
yang
pulmonari
depart
children
hospit
zhejiang
univers
school
medicin
hangzhou
china
correspond
author
chen
zhimin
drchenzm
object
mycoplasma
pneumonia
pneumonia
import
pathogen
caus
respiratori
tract
infect
adult
children
one
common
caus
pneumonia
cap
recent
year
epidemiolog
characterist
pneumonia
infect
chang
last
year
pneumonia
strain
also
becom
common
epidemiolog
studi
need
find
answer
phenomenon
method
studi
popul
patient
seen
fever
clinic
investig
pneumonia
respiratori
tract
infect
clinic
data
subject
obtain
questionnair
medic
histori
collect
physic
examin
assist
examin
pharyng
swab
acquisit
dna
detect
acquisit
pharyng
throat
swab
subject
detect
pcr
method
object
conduct
monitor
pharyng
swab
observ
carri
durat
pneumonia
infect
observ
relationship
progress
diseas
cultur
isol
pneumonia
strain
throat
swab
inocul
pneumonia
solid
medium
isol
liquid
cultur
pcr
valid
carri
drug
resist
analysi
mutat
detect
pneumonia
strain
isol
strain
detect
analyz
mutat
point
confirm
molecular
type
pneumonia
strain
isol
detect
mlva
molecular
genotyp
part
strain
also
detect
gene
type
two
type
molecular
genotyp
method
compar
also
explor
signific
mlva
type
molecular
charact
pneumonia
infect
result
total
patient
enrol
among
posit
posit
rate
found
pneumonia
infect
tend
occur
children
age
year
summer
autumn
epidem
season
pneumonia
common
form
pneumonia
infect
multipl
regress
analysi
found
pneumonia
infect
posit
correl
age
sever
diseas
multipl
sibl
neg
correl
runni
nose
nasal
symptom
past
histori
pneumonia
pneumonia
carri
time
vari
accord
differ
part
pneumonia
infect
pneumonia
longest
bronchiti
second
uri
shortest
total
pneumonia
strain
isol
posit
patient
isol
rate
mlva
type
distinguish
strain
type
except
strain
strain
strain
strain
special
mlva
type
conclus
pneumonia
infect
tend
occur
children
age
year
summer
autumn
epidem
season
pneumonia
common
form
pneumonia
infect
thu
pneumonia
import
pathogen
cap
age
sever
diseas
multipl
sibl
risk
factor
pneumonia
infect
strain
predomin
present
mlva
genotyp
may
molecular
epidemiolog
method
predict
strain
pneumonia
infect
key
word
mycoplasma
pneumonia
surveil
pcr
outbreak
mlva
genotyp
problemat
asthma
risk
factor
persist
symptom
assess
featur
distinguish
sever
asthma
negro
v
respiratori
unit
bambino
children
hospit
ircc
rome
itali
introduct
problemat
asthma
pa
character
appar
resist
therapi
inhal
corticosteroid
ic
control
although
pa
repres
small
percentag
case
asthma
sever
clinic
manifest
affect
qualiti
life
econom
impact
health
care
cost
addit
confirm
diagnosi
asthma
exclud
rare
case
asthma
asthma
da
must
distinguish
sever
asthma
sa
da
term
character
asthmat
patient
poor
control
symptom
depend
differ
factor
poor
complianc
environment
trigger
presenc
comorbid
sa
instead
present
adequ
control
asthma
achiev
ic
addit
control
inhal
beta
agonist
montelukast
andor
theophyllin
oral
corticosteroid
treatment
lost
treatment
reduc
at
er
guidelin
sa
underlin
import
discrimin
two
entiti
diagnost
therapeut
approach
differ
first
clinic
evalu
therefor
import
identifi
sever
marker
suggest
diagnost
procedur
undertaken
method
compar
group
patient
pa
n
refer
broncopneumolog
clinic
novemb
octob
group
patient
asthma
n
refer
clinic
aim
aim
studi
analyz
presenc
risk
factor
determin
persist
respiratori
symptom
identifi
anamnest
instrument
data
allow
earli
identif
da
sa
order
optim
therapi
direct
investig
warrant
result
pa
group
show
significantli
higher
number
hospit
admiss
p
presenc
smoke
parent
p
complianc
index
perform
therapi
statist
lower
p
analysi
subgroup
patient
suffer
sa
n
compar
da
group
n
show
first
group
higher
frequenc
hospit
admiss
p
presenc
food
allergi
first
month
life
p
reduct
respiratori
function
express
reduc
valu
forc
expiratori
volum
second
limit
statist
signific
p
conclus
identif
environment
instrument
anamnest
risk
factor
reduc
number
investig
address
case
warrant
facilit
earli
distinct
patient
da
sa
therapi
optim
reduc
sever
recurr
respiratori
symptom
consequ
need
addit
medic
care
subgroup
children
sever
asthma
cluster
data
mine
analysi
soto
lavin
ssoto
lavin
niklitschek
soto
pizarro
meza
silva
pulmonolog
unit
hospit
region
concepcion
chile
universidad
de
concepcion
concepcion
chile
faculti
udec
concepcion
chile
dept
udec
concepcion
chile
introduct
asthma
chronic
respiratori
manifest
includ
symptom
genet
aspect
differ
respons
treatment
guidelin
underdiagnos
childhood
produc
miss
day
school
expens
cost
undercontrol
preval
sever
asthma
high
risk
requir
emerg
manag
hospit
method
includ
children
year
old
hospit
pediatr
servic
hospit
region
concepcion
chile
hcrc
asthmat
crisi
octob
juli
children
situat
file
review
statist
analysi
made
cluster
data
mine
result
median
valu
age
year
old
differ
regard
gender
cough
day
mean
day
fever
day
less
mean
day
respiratori
distress
initi
satur
digit
equip
mean
white
cell
count
mean
neutrophil
mean
protein
pcr
normal
mean
day
pediatr
servic
hospit
day
mean
day
oxygen
requir
day
mean
day
analysi
separ
patient
subgroup
characterist
subgroup
group
character
age
urban
address
without
medic
control
oxygen
satur
day
cough
fever
wheez
viru
detect
indirect
immunofluoresc
adenoviru
influenza
respiratori
syncyti
viru
parainfluenza
metapneumoviru
polymeras
chain
reaction
mycoplasma
neg
white
cell
count
neutrophil
protein
pcr
normal
need
oxygen
day
day
hospit
chest
x
ray
without
pneumonia
atelectasi
pleural
reaction
use
clarithromycin
subgroup
ii
group
came
differ
area
mean
age
year
medic
supervis
cough
day
fever
day
respiratori
distress
wheez
white
cell
count
neutrophil
pcr
oxygen
suppli
day
day
hospit
chest
hyperinsuffl
subgroup
iii
mean
age
year
cough
day
without
fever
respiratori
distress
wheez
mean
oxygen
satur
viru
mycoplasma
mean
pcr
oxygen
suppli
day
day
hospit
without
abnorm
chest
mean
neutrophil
mean
eosinophil
subgroup
iv
came
mainli
one
area
chiguayant
age
vari
medic
supervis
famili
doctor
cough
day
without
fever
without
respiratori
distress
oxygen
satur
viru
mycoplasma
mean
neutrophil
pcr
oxygen
suppli
day
day
hospit
azithromicin
clarithromycin
chest
without
pneumonia
inflamm
sign
eosinophil
conclus
pediatr
patient
sever
asthma
crisi
hospit
hospit
de
concepcion
present
differ
characterist
form
subgroup
accord
cluster
data
mine
analysi
polysomnographi
import
method
diagnos
pediatr
sleep
problem
experi
one
children
hospit
lin
ch
hang
pediatr
pulmonolog
china
medic
univers
children
hospit
taichung
taiwan
medicin
center
depart
pulmonari
critic
care
medicin
china
medic
univers
hospit
taiwan
taichung
taiwan
background
sleep
problem
children
rel
fewer
adult
overlook
polysomnographi
psg
import
method
diagnos
sleep
problem
adult
could
also
use
children
collect
psg
data
analyz
share
experi
psg
children
method
result
psg
studi
children
year
old
sleep
problem
april
may
china
medic
univers
children
hospit
collect
analyz
retrospect
result
total
patient
male
femal
undergo
psg
collect
apnea
hypopnea
index
ahi
patient
follow
ahi
patient
patient
patient
final
diagnos
male
patient
follow
obstruct
snore
limb
movement
sleep
disord
insomnia
parasomnia
hypersomnia
breath
disord
central
narcolepsi
sleep
terror
sleep
seizur
final
diagnos
femal
patient
follow
obstruct
snore
limb
movement
sleep
disord
breath
disord
insomnia
central
parasomnia
hypersomnia
sleep
seizur
sleep
terror
manag
patient
patient
return
opd
follow
surgeri
adenoidectomi
tonsillectomi
patent
continu
posit
airway
pressur
cpap
patient
medic
treatment
observ
patient
conclus
major
caus
children
sleep
problem
obstruct
sleep
apnea
syndrom
osa
pediatr
osa
underw
surgeri
studi
underestim
sinc
children
osa
underw
surgeri
without
perform
psg
psg
may
help
detect
signific
problem
applic
psg
result
use
therapeut
decis
children
suggest
children
sleep
problem
accept
psg
studi
emerg
diagnost
therapeut
procedur
face
lung
collaps
fontan
patient
cohn
r
yoav
amirav
depart
pediatr
univers
alberta
stolleri
children
hospit
edmonton
canada
old
femal
histori
complex
congenit
heart
diseas
fontan
physiolog
present
institut
sever
respiratori
distress
diagnos
plastic
bronchiti
treat
manual
cast
remov
rigid
bronchoscopi
due
unstabl
condit
subsequ
treat
high
pressur
ventil
nitric
oxid
inotrop
facilit
potenti
cast
resolut
also
treat
tracheal
instal
tpa
well
alteplas
budesonid
inhal
howev
condit
improv
wide
varieti
imag
includ
chest
echocardiogram
cardiac
catheter
fail
identifi
etiolog
present
plastic
bronchiti
pb
rare
clinic
diseas
character
format
cast
obstruct
airway
lead
asphyxia
itkin
mg
et
al
plastic
bronchiti
associ
mani
condit
congenit
heart
diseas
fontan
physiolog
lymphat
abnorm
allergi
asthma
cystic
fibrosi
allerg
bronchopulmonari
aspergillosi
tuberculosi
influenza
viru
infect
pneumonia
sickl
cell
diseas
neoplast
infiltr
rheumatoid
arthriti
mani
case
still
label
idiopath
rubin
bk
new
recent
diagnost
techniqu
contrast
magnet
reson
lymphangiographi
identifi
abnorm
anatom
lymphat
variant
caus
cast
format
mani
previou
idiopath
case
dori
diagnost
techniqu
improv
understand
pb
enabl
new
optim
therapeut
approach
reason
new
procedur
becom
imag
techniqu
summar
tabl
patient
dcmrl
show
markedli
abnorm
intrathorac
lymphat
thorac
duct
td
dilat
tortuou
cours
toward
innomin
vein
left
addit
abnorm
perfus
affect
mostli
right
lung
larg
spare
left
lung
also
addit
accessori
thorac
duct
suppli
retrograd
flow
lung
last
flow
larg
supraclavicular
axillari
network
follow
diagnost
procedur
select
embol
lymphat
collater
distal
td
select
embol
left
side
duct
perform
procedur
symptom
resolv
abl
wean
medic
figur
dcmrl
show
bilater
duct
arrow
bilater
abnorm
pulmonari
mediastin
perfus
arrow
head
tabl
advantag
disadvantag
differ
lymphat
imag
procedur
case
highlight
new
approach
pb
base
role
lymphat
abnorm
etiolog
dcmrl
new
techniqu
detect
abnorm
pulmonari
lymphat
intervent
radiolog
new
way
treat
safe
success
correl
walk
lung
clearanc
index
qualiti
life
patient
bronchiol
obliteran
cystic
fibrosi
masarweh
k
gur
toukan
hakim
f
r
nir
v
bentur
l
pediatr
pulmonari
institut
cf
center
ruth
rappaport
children
hospit
rambam
health
care
campu
haifa
israel
background
lung
clearanc
index
lci
global
measur
ventil
inhomogen
recent
suggest
outcom
measur
clinic
trial
cystic
fibrosi
cf
howev
test
requir
expens
equip
expertis
walk
test
simpl
inexpens
tool
predict
outcom
pulmonari
hypertens
recent
use
cf
evalu
candid
lung
transplant
predict
exacerb
lci
found
use
marker
bronchiolit
obliteran
bo
bo
found
import
prognost
valu
demonstr
signific
correl
clinic
score
pulmonari
function
test
studi
cf
bo
evalu
correl
result
lci
qualiti
life
qol
correl
may
enabl
easi
test
resourc
limit
object
evalu
correl
lci
qualiti
life
patient
bo
cf
patient
method
prospect
studi
includ
patient
bo
cf
patient
perform
lci
test
spirometri
whole
bodi
plethysmographi
mvv
minut
ventilatori
ventil
qualiti
life
questionnair
primari
outcom
paramet
defin
group
correl
lci
pulmonari
function
test
qol
questionnair
sought
demograph
two
group
compar
unpair
fisher
exact
test
pearson
chi
squar
test
correl
perform
need
result
cf
male
mean
age
year
bo
patient
mean
age
year
recruit
statist
signific
differ
found
cf
bo
patient
pulmonari
function
test
lci
qol
questionnair
score
mean
score
similar
group
compar
cf
bo
patient
respect
p
cf
patient
score
correl
neg
percent
predict
lci
r
p
small
bo
group
correl
found
correl
found
score
qol
questionnair
score
cf
bo
patient
conclus
correl
percent
predict
lci
cf
patient
may
help
evalu
cf
patient
countri
limit
resourc
avail
lci
larger
studi
need
evalu
role
chronic
diseas
bo
lung
ultrasound
reliabl
method
mileva
petrova
g
yankova
isaev
v
kabakchieva
r
pediatr
depart
alexandrovska
hospit
medic
univers
sofia
bulgaria
background
bronchiol
diagnosi
base
clinic
criteria
aim
studi
evalu
feasibl
ultrasound
diagnosi
bronchiol
materi
method
observ
studi
infant
mo
age
averag
age
hospit
alexandrovska
pediatr
clinic
bronchiol
period
decemb
ultrasound
scan
perform
patient
first
hour
admiss
linear
transduc
mhz
portabl
ultrasound
chest
children
test
respiratori
virus
pcr
method
undertaken
patient
result
lung
ultrasound
find
depend
etiolog
agent
p
children
without
chest
chang
normal
ultrasound
find
case
patient
sever
bronchiol
oxygen
treatment
ultrasonograph
chang
record
p
correl
length
hospit
stay
degre
ultrasound
chang
p
lung
ultrasound
enabl
identif
infant
underli
radiolog
chang
specif
c
sensit
cl
posit
predict
valu
cl
neg
predict
valu
cl
conclus
thorac
ultrasonographi
reliabl
tool
altern
chest
infant
bronchiol
advantag
risk
irradi
possibl
dynam
keyword
lung
ultrasound
bronchiol
infant
studi
express
signal
pathway
develop
pulmonari
hypertens
secondari
left
ventricular
dysfunct
dai
zkdai
zk
chen
ic
liu
ic
hsu
jh
pediatr
kaohsiung
medic
univers
hospit
kaohsiung
taiwan
background
pulmonari
hypertens
ph
progress
pulmonari
vascular
disord
character
increas
pulmonari
vascular
resist
pulmonari
arteriolar
remodel
wnt
signal
control
cellular
function
embryon
develop
injuri
acquir
tissu
central
mediat
wnt
signal
pathway
control
transcript
gene
normal
malign
develop
recent
gene
express
analysi
pulmonari
arteri
resist
vessel
reveal
differenti
regul
canon
noncanon
wnt
gene
pah
aim
studi
attempt
investig
alter
express
wnt
protein
lung
rat
ph
secondari
left
ventricular
dysfunct
aortic
band
group
ii
ph
materi
method
util
ph
rat
model
creat
ascend
aortic
band
day
week
studi
alter
express
mrna
protein
express
canon
wnt
ligand
wnt
wnt
ligand
lung
rat
compar
rat
addit
immunohistolog
stain
lung
also
perform
group
result
lung
rat
significantli
increas
protein
express
significantli
decreas
protein
express
contrast
increas
mrna
express
wnt
ltb
decreas
mrna
express
wif
interestingli
decreas
stain
endothelium
lung
rat
discuss
group
ii
ph
secondari
left
ventricular
dysfunct
develop
ph
close
relat
wnt
pathway
promin
rather
canon
wnt
pathway
result
compat
rho
express
lung
rat
previou
studi
possibl
predict
airway
basement
membran
thick
paramet
koucki
vkoucki
uhlik
pohunek
pediatr
faculti
medicin
charl
univers
motol
univers
hospit
pragu
czech
republ
histolog
embryolog
faculti
medicin
charl
univers
pragu
czech
republ
airway
remodel
occur
variou
chronic
respiratori
diseas
basement
membran
bm
thicken
one
appar
sign
chang
found
differ
form
chronic
bronchiti
easili
object
quantifi
make
conveni
surrog
paramet
airway
wall
remodel
howev
clinic
use
hamper
invas
procedur
requir
obtain
sampl
endobronchi
biopsi
consequ
possibl
predict
remodel
paramet
would
great
clinic
valu
manag
patient
chronic
respiratori
diseas
work
aim
studi
relationship
bm
thick
anthropometr
andor
function
paramet
januari
decemb
prospect
enrol
patient
chronic
bronchiti
cb
group
includ
cystic
fibrosi
primari
ciliari
dyskinesia
form
chronic
bronchiti
eg
relat
primari
immunodefici
underw
clinic
indic
flexibl
bronchoscopi
addit
control
co
group
patient
bronchoscopi
acut
condit
foreign
bodi
aspir
stridor
chronic
respiratori
patholog
enrol
age
patient
rang
year
median
year
first
patient
underw
lung
function
test
use
nitrogen
multipl
breath
washout
test
tidal
breath
analysi
relev
intern
recommend
adher
patient
older
year
perform
test
full
conscious
activ
cooper
younger
children
lung
function
test
perform
tidal
breath
intraven
anesthesia
propofol
immedi
bronchoscopi
flexibl
bronchoscopi
endobronchi
forcep
biopsi
perform
session
addit
inhal
anesthesia
sevofluran
sampl
process
light
microscopi
stain
bm
width
measur
one
investig
vk
use
comput
imag
analysi
softwar
ni
element
two
studi
group
compar
use
welch
test
relationship
paramet
anthropometr
function
bm
width
analyz
whole
studi
group
cb
co
group
first
spearmen
correl
coeffici
use
evalu
relationship
singl
paramet
bm
width
next
advanc
approach
princip
compon
analysi
least
angl
regress
method
enabl
analysi
multipl
predictor
simultan
employ
evalu
possibl
make
bm
width
predict
use
paramet
time
differ
age
rel
weight
height
bmi
patient
enrol
cb
co
group
complet
lung
function
morpholog
data
avail
patient
patient
cb
group
significantli
greater
bm
width
bm
width
p
wors
lung
function
compar
control
analyz
separ
none
anthropometr
paramet
alon
weight
height
bmi
correl
significantli
bm
width
anthropometr
paramet
taken
account
simultan
small
signific
part
bm
width
variabl
p
could
explain
lung
function
paramet
individu
significantli
correl
bm
width
p
scond
r
p
tpteft
r
p
simultan
analysi
function
paramet
increas
predict
power
allow
explain
bm
width
variabl
p
anthropometr
function
paramet
combin
togeth
predict
power
model
clearli
increas
p
work
focus
bm
width
sign
airway
wall
remodel
wide
age
spectrum
group
patient
investig
relationship
anthropometr
lung
function
paramet
may
determin
measur
data
show
clear
correl
airway
wall
remodel
lung
function
anthropometr
paramet
find
contrast
sever
previou
studi
hilliard
et
al
thorax
found
signific
relationship
lung
function
measur
spirometri
inflamm
occur
airway
lumen
assess
bronchoalveolar
lavag
fluid
hand
chang
occur
airway
wall
bm
width
reflect
spirometri
contrarili
prove
signific
relationship
ventil
inhomogen
assess
bm
width
discrep
may
partli
explain
higher
sensit
earli
stage
chronic
respiratori
diseas
similarli
previou
work
address
anthropometr
paramet
determin
bm
width
reveal
relationship
approach
howev
studi
addit
anthropometr
paramet
bm
width
determin
simultan
inde
abl
explain
small
signific
part
bm
width
variabl
way
hypothes
relationship
complex
describ
one
determin
consequ
combin
anthropometr
function
paramet
one
predict
model
increas
predict
power
model
bm
width
variabl
reach
opinion
predict
power
suffici
high
consid
clinic
relev
howev
still
remain
signific
variabl
explain
paramet
eg
diagnosi
find
requir
research
implement
routin
care
patient
chronic
bronchiti
impuls
oscillometri
preschool
age
strong
predictor
lung
function
spirometri
adolesc
lauhkonen
elauhkonen
riikonen
koponen
nuolivirta
helminen
toikka
korppi
center
child
health
research
tamper
univers
univers
hospit
tamper
finland
central
hospit
finland
clinic
physiolog
tamper
univers
hospit
turku
univers
hospit
tamper
finland
background
transit
earli
childhood
wheez
persist
asthma
link
lung
function
impair
time
littl
known
method
use
studi
lung
function
differ
age
correl
longitudin
method
children
histori
hospit
bronchiol
six
month
age
prospect
studi
impuls
oscillometri
io
mean
age
year
preschool
io
result
compar
spirometri
fv
measur
mean
age
year
result
baselin
respiratori
system
resist
hz
show
modest
statist
signific
correl
baselin
fv
paramet
except
fvc
show
modest
statist
signific
correl
increas
show
modest
statist
signific
correl
percent
decreas
baselin
respiratori
reactanc
hz
show
modest
statist
signific
correl
baselin
fv
paramet
except
respect
show
even
strong
correl
fvc
adjust
linear
regress
preschool
remain
statist
signific
independ
predictor
fv
paramet
adolesc
decreas
preschool
predict
lower
lower
fvc
lower
express
paramet
conclus
persist
small
airway
impair
children
histori
bronchiol
detect
io
preschool
age
predict
fv
result
measur
earli
adolesc
util
flexibl
bronchoscopi
children
cancer
naseeb
anaseeb
toorani
chong
narayan
royal
colleg
surgeon
ireland
medic
univers
bahrain
manchest
unit
kingdom
univers
malaya
kuala
lumpur
malaysia
paediatr
royal
manchest
children
hospit
manchest
unit
kingdom
introduct
flexibl
bronchoscopi
wide
recogn
import
diagnost
therapeut
procedur
util
pulmonologist
worldwid
allow
physician
perform
wide
rang
intervent
includ
obtain
sampl
lavag
bal
flexibl
bronchoscopi
rel
safe
procedur
complic
report
literatur
includ
standard
risk
anesthesia
oxygen
desatur
airway
bleed
cough
role
bronchoscopi
bal
pediatr
oncolog
well
establish
literatur
look
data
larg
tertiari
center
unit
kingdom
method
retrospect
look
flexibl
bronchoscopi
conduct
cancer
patient
persist
fever
pediatr
tertiari
care
facil
period
look
result
bal
determin
modif
clinic
manag
attribut
bronchoscopi
result
total
patient
identifi
correspond
flexibl
bronchoscopi
bal
diagnosi
children
follow
acut
lymphoblast
leukemia
acut
myeloid
leukemia
aml
chronic
myeloid
leukemia
lymphoblast
lymphoma
lymphoblast
burkitt
like
lymphoma
ewe
sarcoma
neuroblastoma
pontin
brainstem
tumor
ewe
sarcoma
seven
patient
stem
cell
transplant
bronchoscopi
repeat
bronchoscopi
treatment
modifi
bronchoscopi
none
repeat
bronchoscopi
patient
treatment
modifi
either
diagnos
aml
two
patient
bone
marrow
stem
cell
transplant
organ
identifi
bal
follow
pneumocysti
jirovecii
case
mycoplasma
pneumonia
case
adenoviru
case
influenza
case
neg
bal
rule
fungal
infect
patient
enabl
high
dose
system
steroid
therapi
conclus
studi
show
bronchoscopi
oncolog
pediatr
patient
use
yield
chang
clinic
manag
signific
portion
popul
children
common
cancer
aml
end
receiv
intervent
procedur
persist
fever
clear
associ
treatment
modif
bone
marrow
stem
cell
transplant
patient
bone
marrow
stem
cell
transplant
treatment
modifi
research
larger
sampl
size
warrant
fulli
evalu
role
bronchoscopi
futur
manag
refer
terkawi
rs
altirkawi
ka
terkawi
mukhtar
g
flexibl
bronchoscopi
children
util
complic
intern
journal
pediatr
adolesc
medicin
issn
http
clinic
valu
function
paramet
determin
genesi
prolong
chronic
children
cough
udaltsova
evudaltsova
melnikova
mizernitski
hospit
pediatr
yaroslavl
state
medic
univers
yaroslavl
russia
clinic
institut
pediatr
name
acad
yue
veltishchev
russian
univers
medicin
name
n
pirogov
moscow
russia
aim
investig
clinic
signific
function
paramet
microcircul
veget
nervou
vn
respiratori
system
differenti
diagnosi
children
prolong
chronic
cough
patient
method
children
age
year
cough
week
examin
patient
divid
six
group
gr
accord
diseas
patient
postnas
drip
syndrom
pnd
infecti
genesi
patient
allerg
rhiniti
ar
patient
lower
respiratori
tract
infect
without
wheez
patient
acut
wheez
patient
postinfecti
cough
pic
patient
mild
persist
bronchial
asthma
ba
exacerb
incomplet
remiss
catamnesi
last
month
control
gr
c
includ
healthi
children
studi
exclud
patient
diagnosi
chronic
bronchiti
n
whoop
cough
n
psychogen
neurogen
cough
n
gastroesophag
reflux
diseas
n
foreign
bodi
airway
obstruct
n
epilepsi
n
patient
underw
histori
examin
comput
capillaroscopi
nail
bed
evalu
heart
rate
variabl
hrv
mc
russia
computer
bronchophonographi
mei
russia
result
morpholog
chang
capillari
similar
direction
children
cough
week
patient
cough
due
allerg
diseas
respiratori
tract
character
signific
deform
arteri
part
capillari
increas
length
perivascular
area
l
compar
children
infecti
genesi
cough
chang
often
observ
paramet
venou
part
capillari
p
may
indic
persist
chronic
allerg
inflamm
patient
ar
ba
pronounc
increas
l
observ
children
ba
year
old
compar
patient
older
year
p
character
preval
parasympathicu
activ
hrv
analysi
increas
rmssd
sdnn
compar
c
pronounc
imbal
autonom
regul
found
patient
ba
increas
vlf
reduct
hf
lf
compar
hrv
paramet
similar
orient
predomin
tone
sympathicu
sn
reduct
rmssd
hf
increas
vlf
lf
compar
c
p
character
pronounc
activ
sn
p
may
indic
high
degre
tension
adapt
mechan
vn
children
pic
patient
acut
wheez
ba
show
higher
level
coeffici
acoust
compon
work
breath
high
frequenc
zone
khz
compar
c
p
test
standard
dose
salbutamol
posit
gr
although
pronounc
decreas
typic
ba
p
base
data
obtain
clinic
function
paramet
microcircul
vn
differenti
diagnosi
allerg
infecti
genesi
cough
week
patient
pnd
determin
rise
bodi
temperatur
increas
cough
exercis
level
total
ige
blood
serum
l
coeffici
tortuos
arteri
part
capillari
sdnn
addit
criteria
diagnos
ba
children
cough
week
follow
clinic
function
paramet
propos
degre
allergen
condit
patient
l
uneven
calib
capillari
hf
lf
conclus
result
show
function
paramet
microcircul
vn
respiratori
system
use
addit
criteria
differenti
diagnosi
allerg
infecti
genesi
prolong
chronic
cough
children
import
relat
earli
diagnost
ba
children
noninvas
hemoglobin
sphb
measur
new
monitor
devic
pulmonari
hemodynam
condit
neonat
infant
three
kg
umehara
numehara
n
kusakawa
pediatr
st
luke
intern
hospit
akashi
cho
chuuo
ward
tokyo
japan
introduct
new
technolog
puls
provid
continu
noninvas
estim
hemoglobin
concentr
sensor
place
extrem
word
may
possibl
measur
pulmonari
hemodynam
condit
without
collect
blood
time
noninvas
method
usual
neonat
often
undergo
signific
decreas
hemoglobin
hb
due
immatur
hematopoiet
function
frequent
undergo
blood
test
medic
intervent
requir
neonat
infant
kg
rel
small
circul
blood
volum
easi
develop
iatrogen
anemia
result
collect
blood
therefor
noninvas
method
detect
blood
hb
level
may
help
reduc
iatrogen
anemia
pain
caus
take
blood
current
avail
noninvas
hemoglobin
sphb
devic
aim
children
kg
howev
feasibl
neonat
infant
kg
known
purpos
studi
clarifi
whether
use
sphb
devic
appear
feasibl
neonat
infant
kg
method
subject
newborn
infant
schedul
blood
test
includ
hb
measur
blood
sampl
nicu
st
luke
intern
hospit
equip
prototyp
sphb
devic
finger
sensor
routin
function
monitor
masimo
ver
sensor
rev
k
use
sensor
attach
lower
extrem
manner
puls
oximet
sensor
appropri
light
shield
measur
sphb
measur
record
start
minut
prior
schedul
usual
blood
sampl
heel
cut
observ
least
minut
infant
stabil
confirm
stabil
sphb
valu
minut
venou
blood
sampl
ml
depend
concomit
blood
test
perform
neonatologist
routin
monitor
continu
routin
throughout
procedur
specimen
immedi
taken
accur
measur
hospit
laboratori
analysi
differ
sampl
hb
sphb
evalu
linear
regress
analysi
result
infant
age
day
day
median
day
bodi
weight
rang
gram
median
gram
studi
sampl
analyz
eleven
infant
underw
second
sampl
interv
week
due
medic
necess
case
advers
event
due
measur
sphb
blood
sampl
studi
differ
sampl
hb
sphb
level
fell
mostli
within
rang
fair
correl
r
bland
altman
plot
indic
prototyp
system
tend
show
rel
high
sphb
valu
sampl
hb
level
almost
gdl
limit
agreement
discuss
correl
sphb
sampl
hb
level
good
sphb
devic
appear
feasibl
even
devic
use
neonat
infant
kg
wide
rang
hb
level
attach
sphb
devic
neonat
infant
kg
possibl
detect
anemia
faster
reduc
unnecessari
blood
test
furthermor
pulmonari
edema
circul
failur
caus
excess
blood
transfus
may
prevent
erythropoietin
therapi
given
anemia
prematur
hb
infant
weigh
less
kg
sphb
tend
exhibit
higher
valu
sampl
hb
latter
level
almost
gdl
therefor
sphb
could
underestim
anemia
sphb
measur
lower
extrem
sampl
blood
hb
taken
upper
extrem
almost
differ
valu
fact
consid
measur
locat
anywher
like
bioengin
factor
measur
play
signific
role
data
skew
although
current
access
inform
need
conclus
applic
prototyp
sphb
devic
appear
feasibl
neonat
infant
kg
wide
rang
hb
level
may
possibl
measur
pulmonari
hemodynam
condit
without
collect
blood
time
noninvas
method
howev
time
sphb
devic
still
room
improv
accuraci
level
almost
gdl
data
obtain
studi
use
refer
futur
improv
radiat
dose
pediatr
chest
comput
tomographi
scan
perform
tertiari
care
hospit
dowich
soar
torr
ane
lima
nietto
bacelar
cauduro
cauduro
hospit
de
clinica
de
porto
alegr
porto
alegr
brazil
physic
hospit
de
clinica
de
porto
alegr
porto
alegr
brazil
school
universidad
feder
rio
grand
sul
porto
alegr
brazil
hospit
de
clinica
de
porto
alegr
porto
alegr
brazil
purpos
studi
evalu
radiat
dose
children
year
age
undergo
chest
comput
tomographi
ct
examin
radiolog
depart
tertiari
care
hospit
expos
perform
retrospect
studi
consecut
pediatr
patient
age
year
underw
ct
chest
octob
octob
inspiratori
chest
ct
singl
acquisit
singl
phase
without
inject
includ
data
radiat
exposur
tube
current
tube
voltag
ct
dose
volum
ctdi
dose
length
product
dlp
dose
estim
ssde
well
demograph
clinic
data
record
chest
ct
median
age
year
iqr
male
dose
estim
calcul
use
cm
phantom
dose
estim
ssde
gener
patient
result
compar
ctdi
patient
group
categori
base
mean
effect
diamet
chest
anteroposterior
time
chest
diamet
follow
group
cm
group
cm
group
cm
group
cm
group
cm
factor
associ
higher
radiat
dose
assess
use
multipl
linear
regress
analysi
statist
analys
perform
use
statist
packag
social
scienc
version
studi
approv
local
research
ethic
committe
median
interquartil
rang
percentil
group
ssde
mgi
p
group
group
group
group
group
ctdi
group
group
group
group
group
dlp
group
group
group
group
group
cdti
systemat
underestim
radiat
dose
relat
ssde
median
interquartil
rang
patient
group
percentil
percentag
much
ctdi
underestim
ssde
group
group
group
group
group
ct
dose
paramet
tube
current
tube
voltag
age
weight
mean
effect
diamet
variabl
associ
higher
radiat
dose
demonstr
feasibl
perform
evalu
pediatr
ct
radiat
dose
tertiari
care
hospit
result
demonstr
need
continu
monitor
pediatr
radiat
dose
ct
evidenc
high
dose
detect
addit
ctdi
systemat
underestim
radiat
dose
comparison
ssde
pediatr
patient
use
primari
paramet
monitor
ct
protocol
manag
empyema
thoracoscop
surgeri
vat
vs
chest
drain
fibrinolysi
cdf
systemat
review
nataraja
r
pacilli
paediatr
surgeri
monash
children
hospit
melbourn
australia
purpos
studi
ideal
surgic
approach
empyema
children
year
remain
controversi
vat
cdf
accept
method
aim
studi
clarifi
techniqu
provid
best
outcom
materi
method
systemat
review
conduct
accord
prisma
guidelin
select
studi
includ
random
control
trial
rct
retrospect
prospect
compar
studi
cs
studi
contain
children
adult
clear
distinct
exclud
conduct
comprehens
use
model
produc
risk
ratio
rr
categor
variabl
standard
differ
mean
sdm
continu
variabl
along
confid
interv
ci
valu
use
assess
heterogen
consid
substanti
heterogen
studi
egger
regress
test
use
assess
public
bias
p
valu
consid
signific
result
identifi
studi
duplic
remov
meet
inclus
criteria
studi
rct
cs
includ
result
report
figur
incid
total
complic
differ
two
group
rr
ci
p
figur
length
hospit
stay
significantli
shorter
vat
group
sdm
ci
p
figur
need
significantli
lower
vat
group
rr
ci
p
figur
egger
regress
test
identifi
signific
bias
studi
p
outcom
conclus
current
evid
suggest
vat
cdf
empyema
similar
incid
complic
howev
vat
associ
shorter
hospit
stay
reduc
need
center
minim
invas
surgeri
expertis
vat
consid
treatment
choic
surgic
manag
empyema
use
biphas
cuirass
ventil
batteri
movabl
treatment
emerg
depart
shimada
nishihara
okada
pediatr
yodogawa
chiristian
hospit
osaka
citi
japan
pediatr
okada
kodomo
mori
clinic
kasukab
citi
japan
children
brought
emerg
depart
respiratori
issu
often
caus
ueda
et
al
report
biphas
cuirass
ventil
bcv
comfort
fit
easili
express
effect
earli
therefor
use
bcv
first
patient
respiratori
distress
much
possibl
recent
patient
respiratori
distress
util
bcv
use
batteri
order
continu
medic
treatment
without
interrupt
transport
sick
children
emerg
depart
pediatr
ward
earli
intervent
bcv
respiratori
distress
children
possibl
start
treatment
immedi
continu
treatment
without
interrupt
transport
ward
institut
case
continu
neg
mode
bcv
start
emerg
depart
symptom
improv
shortli
case
respiratori
rate
heart
rate
improv
minut
start
continu
neg
mode
bcv
hypercapnia
improv
less
hour
case
bcv
work
smoothli
respiratori
condit
improv
children
respiratori
distress
breath
spontan
need
artifici
respir
difficult
maintain
airway
pressur
use
ventil
case
ventil
unstabl
treatment
hand
bcv
requir
sedat
greater
mobil
due
batteri
power
continu
treatment
hospit
suggest
start
treatment
bcv
emerg
depart
continu
treatment
without
interrupt
transport
patient
ward
feasibl
safe
furthermor
treatment
conduct
load
batteri
bcv
requir
ga
pipe
oxygen
air
word
treatment
avail
situat
difficulti
ga
suppli
time
disast
countri
experienc
certain
disast
util
includ
electr
ga
suppli
thu
cut
bcv
run
batteri
power
suppli
also
work
situat
without
ga
pipe
consid
effect
mean
even
acut
respiratori
manag
method
time
disast
use
bcv
batteri
earli
intervent
emerg
depart
also
effect
mean
transport
disast
use
inhal
antibiot
iab
chronic
lower
respiratori
infect
daeleman
de
wachter
cool
vandenpla
malfroot
pediatr
universitair
ziekenhui
brussel
vrije
universiteit
brussel
vub
brussel
belgium
pediatr
pulmonolog
infectiolog
universitair
ziekenhui
brussel
vrije
universiteit
brussel
vub
brussel
belgium
neonatolog
universitair
ziekenhui
brussel
vrije
universiteit
brussel
vub
brussel
belgium
introduct
base
experi
cf
grow
interest
use
iab
lower
respiratori
tract
infect
studi
perform
mostli
adult
bronchiectasi
pneumonia
copd
mycobacteri
diseas
infect
appli
ab
formul
inhal
well
use
inject
ab
inhal
also
use
iab
erad
organ
p
aeruginosa
bronchiectasi
investig
aim
investig
toler
efficaci
iab
treat
infant
children
method
retrospect
review
data
iab
treatment
cours
young
subject
pediatr
depart
result
eight
subject
boy
age
year
median
month
chronic
colon
pseudomona
resist
speci
includ
underli
medic
condit
extrem
prematur
ga
week
depend
bpd
includ
pulmonari
hypertens
tracheocanula
cpap
bipap
syndrom
ga
week
sever
pulmonari
hypertens
depend
tracheocanula
congenit
esophag
atresia
tracheal
fistula
recurr
aspir
pneumonia
bronchiectasi
polymalform
syndrom
mental
retard
intract
respiratori
infect
adolesc
bronchiectasi
pcp
pneumonia
lymphoma
adolesc
reason
start
iab
absenc
respons
repetit
iv
antibiot
cours
practic
issu
iv
access
increas
ventilatori
condit
recurr
acut
exacerb
percent
treatment
start
hospit
adolesc
start
iab
outpati
consult
age
start
iab
vari
month
year
age
durat
treatment
day
sever
month
iab
util
colomycin
amikacin
gentamycin
ceftazidim
mono
bitherapi
base
sensit
test
dose
prepar
extrapol
cf
guidelin
includ
use
salbutamol
iab
avoid
bronchial
hyperreact
inhal
well
toler
safe
erad
success
result
clinic
improv
decreas
ventil
condit
less
acut
exacerb
sever
month
conclus
data
use
iab
prematur
young
children
scarc
pilot
data
show
treatment
iab
select
subject
sever
respiratori
condit
safe
effect
feasibl
children
avoid
need
parenter
administr
iab
current
formal
indic
scientif
evid
ongo
clinic
trial
await
open
lung
biopsi
chronic
pulmonari
diseas
children
esref
sesref
hizal
emiralioglu
dogru
yalcin
ozcelik
kiper
dogan
dikmen
pulmonolog
hacettep
univers
faculti
medicin
ankara
turkey
pulmonolog
cengiz
gokcek
children
hospit
gaziantep
turkey
surgeri
hacettep
univers
faculti
medicin
ankara
turkey
introduct
studi
aim
evalu
efficaci
open
lung
biopsi
children
chronic
lung
diseas
method
patient
underw
open
lung
biopsi
hacettep
univers
depart
pediatr
pulmonolog
examin
retrospect
result
twelv
patient
boy
girl
underw
open
lung
biopsi
diagnost
purpos
mean
age
patient
year
year
four
patient
immun
defici
diagnos
patient
chronic
granulomat
diseas
n
cvid
n
hypogammaglobulinemia
n
none
patient
malign
mean
time
onset
respiratori
symptom
open
lung
biopsi
month
rang
month
none
patient
develop
acut
respiratori
failur
nine
patient
requir
mechan
ventil
first
hour
postop
mean
chest
tube
withdraw
time
patient
day
day
day
three
patient
diagnos
hypersensit
pneumon
patient
spc
defici
patient
interstiti
pneumonia
patient
granulomat
lymphocyt
interstiti
lung
diseas
patient
cryptogen
organ
pneumonia
patient
follicular
bronchiol
patient
pulmonari
hemosiderosi
patient
giant
air
cyst
patient
granulomatosi
inflamm
ten
patient
underw
treatment
chang
biopsi
result
accord
biopsi
result
steroid
treatment
start
patient
patient
given
mycophenol
mofetil
patient
given
hydroxychloroquin
treatment
conclus
result
suggest
open
lung
biopsi
safe
guid
diagnosi
children
chronic
lung
diseas
regul
type
interferon
product
antivir
innat
immun
zhang
yyzhang
chen
wang
children
hospit
zhejiang
univers
school
medicin
hangzhou
china
zhejiang
univers
hangzhou
china
object
acut
respiratori
tract
infect
arti
common
type
infecti
diseas
children
viru
infect
account
mani
atri
major
virus
rna
virus
addit
influenza
viru
effect
treatment
rna
viru
infect
thu
attempt
explor
regul
mechan
rna
viru
infect
might
help
find
new
approach
treatment
rna
viru
infect
futur
tumor
necrosi
protein
member
tumor
necrosi
famili
neg
regul
immun
respons
could
prevent
hyperrespons
maintain
immun
homeostasi
howev
regulatori
role
rna
viru
infect
effect
signal
pathway
rna
viru
infect
poorli
clarifi
studi
aim
investig
effect
underli
mechan
rna
viru
infect
method
collect
peripher
blood
mononuclear
cell
children
infect
respiratori
syncyti
viru
rsv
common
viru
children
control
healthi
children
detect
express
also
detect
level
macrophag
vitro
vsv
common
viru
use
research
infect
meanwhil
aim
explor
effect
underli
mechan
regul
rna
viru
respons
gain
loss
function
result
studi
detect
signific
decreas
mrna
peripher
blood
mononuclear
cell
pbmc
case
children
infect
rsv
compar
pbmc
control
healthi
children
vitro
also
found
express
vsv
infect
impli
might
play
critic
role
viral
immun
furthermor
observ
macrophag
suscept
vesicular
stomat
viru
vsv
infect
show
increas
level
mrna
vsv
infect
vitro
addit
defici
found
enhanc
ifn
inflammatori
cytokin
product
macrophag
moreov
overexpress
dampen
capac
macrophag
produc
ifn
inflammatori
cytokin
furthermor
could
restrain
activ
signal
pathway
thu
inhibit
product
type
interferon
inflammatori
cytokin
conclus
taken
togeth
result
suggest
could
suppress
interferon
inflammatori
cytokin
product
induc
rna
viru
inhibit
activ
signal
pathway
research
uncov
import
neg
role
regul
innat
antivir
immun
may
help
provid
new
strategi
treatment
viral
infect
clinic
vascular
ring
abnorm
retrospect
studi
case
abdelaziz
belaloui
belhim
khoualdi
amal
raiski
ly
metton
rue
emir
abdelkad
annaba
algeria
rue
bestandji
constantin
algeria
cliniqu
el
houceini
constantin
algeria
cardiolog
cliniqu
alazhar
algier
algeria
cardiac
surgeri
cliniqu
alazhar
algier
algeria
introduct
vascular
ring
abnorm
vra
rare
condit
clinic
present
essenti
relat
degre
compress
trachea
esophagu
vra
often
mistaken
bronchial
asthma
know
evok
simpl
element
avoid
delay
diagnosi
materi
method
retrospect
studi
period
year
cover
case
vra
collect
pediatr
pulmonolog
clinic
analyz
clinic
data
radiolog
biolog
investig
well
surgic
report
evolut
result
total
children
includ
studi
explor
outpati
male
predomin
note
f
sex
ratio
age
vari
day
year
onset
clinic
sign
first
month
life
patient
children
present
stridor
often
start
first
month
life
import
earlier
doubl
aortic
arch
cough
present
case
earli
life
relat
tracheal
malacia
congest
hoars
worsen
effort
wheez
present
patient
digest
sign
mainli
vomit
patient
dysphagia
patient
complic
esophag
food
bolu
obstruct
requir
extract
patient
patient
hospit
least
case
treat
bronchial
asthma
often
consid
difficult
control
chronic
obstruct
bronchopathi
chronic
cough
chest
show
right
tracheal
imprint
right
deviat
case
right
aorta
case
barium
swallow
perform
patient
show
esophagu
impress
type
vra
confirm
patient
ct
scan
distribut
follow
arteria
lusoria
case
neuhaus
anomali
case
doubl
aortic
arch
daa
case
innomin
arteri
case
circumflex
arteri
case
retrotrach
left
pulmonari
arteri
case
right
aortic
arch
branch
case
pulmonari
function
test
pft
guid
diagnosi
case
bronchoscopi
perform
patient
confirm
tracheal
malacia
congenit
heart
diseas
rare
seri
surgeri
perform
patient
case
daa
case
neuhaus
anomali
case
retrotrach
left
pulmonari
arteri
case
arteria
lusoria
eight
patient
wait
surgeri
parent
refus
surgeri
case
surgic
indic
patient
postop
complic
infecti
case
high
blood
pressur
case
laryng
paralysi
case
persist
mild
tracheomalacia
case
conclus
vra
rare
condit
although
deserv
known
pediatrician
gynecologist
prenat
diagnosi
seri
radiologist
diagnos
time
explor
must
take
account
level
irradi
barium
swallow
must
abandon
mri
must
take
place
radiolog
explor
pft
import
place
diagnosi
surgic
indic
must
studi
case
case
basi
total
improv
alway
observ
remain
depend
degre
tracheomalacia
congenit
cystic
adenomatoid
malform
report
two
case
abdelaziz
rue
emir
abdelkad
annaba
algeria
rue
bestandji
constantin
algeria
congenit
cystic
adenomatoid
malform
ccam
common
malform
lower
respiratori
tract
repres
pulmonari
malform
diagnosi
increasingli
made
antenat
ultrasonographi
chest
infect
compromis
vital
prognosi
pulmonari
function
report
two
case
children
ccam
case
girl
histori
recurr
bacteri
pneumonia
right
lower
lobe
sinc
age
year
radiolog
investig
particular
ct
angiographi
show
presenc
larg
cyst
pulmonari
condens
locat
apic
segment
lower
lobe
without
sign
pulmonari
sequestr
bronchoscopi
find
foreign
bodi
granuloma
hydatid
cyst
membran
retent
hydatid
serolog
neg
immunolog
profil
show
primari
acquir
immun
defici
explor
pulmonari
scintigraphi
show
hypoperfus
right
lower
lobe
pulmonari
function
test
normal
associ
cardiac
renal
malform
regard
element
diagnosi
ccam
retain
child
oper
underw
lower
right
lobectomi
good
postop
evolut
patholog
confirm
ccam
type
larg
cyst
accord
stoker
classif
case
girl
histori
recurr
chest
infect
right
lower
lobe
sinc
age
month
respiratori
distress
requir
five
hospit
ct
scan
confirm
presenc
cystic
lesion
right
lower
lobe
two
small
cystic
lesion
apic
segment
left
lower
lobe
system
vessel
elimin
sequestr
bronchoscopi
normal
well
hydatid
cyst
serolog
associ
renal
cardiac
malform
diagnosi
ccam
retain
patient
refer
surgeon
right
inferior
lobectomi
surgeri
decid
limit
ablat
right
ventral
paracardi
segment
immedi
surgic
evolut
good
patholog
confirm
diagnosi
ccam
type
four
month
later
child
present
chest
infect
right
inflam
lobe
ct
confirm
presenc
cystic
lesion
inferior
lobe
howev
left
lesion
disappear
second
surgeri
perform
inferior
lobectomi
carri
good
conclus
none
two
patient
diagnos
antenat
period
despit
ultrasound
monitor
pregnanc
notic
import
delay
diagnosi
despit
clinic
radiolog
evid
select
surgeri
second
patient
fail
recurr
chest
infect
must
evok
ccam
surgeri
situat
rule
possibl
treatment
unusu
repetit
hepatotox
indonesian
children
nataprawira
hm
rahmani
ermawati
child
health
faculti
medicin
universita
sadikin
hospit
bandung
indonesia
background
drug
induc
hepatotox
adih
one
seriou
advers
effect
ascrib
tb
drug
caus
increas
serum
aspart
aminotransferas
ast
andor
alanin
aminotransferas
alt
total
bilirubin
adih
uncommonli
report
children
particularli
recurr
repeat
adih
requir
stop
potenti
hepatotox
drug
systemat
regular
monitor
liver
enzym
even
though
avail
british
thorac
societi
bt
american
thorac
societi
at
guidelin
reintroduct
regimen
treat
adih
adult
guidelin
adopt
offici
indonesia
aim
report
unusu
repetit
adih
indonesian
children
case
report
six
case
tb
mening
miliari
tb
pulmonari
tb
age
rang
month
experienc
repeat
adih
report
four
sever
tb
case
receiv
daili
therapi
compris
isoniazid
inh
rifampicin
rif
pyrazinamid
pza
ethambutol
plan
continu
period
month
follow
inh
rif
period
month
wherea
two
pulmonari
tb
case
receiv
drug
inh
rif
pza
period
month
continu
period
month
inh
rif
patient
increas
serum
ast
alt
total
bilirubin
hepat
marker
show
neg
result
abnorm
identifi
hepatobiliar
ultrasonographi
adih
occur
drug
stop
immedi
without
consid
sever
adih
adih
occur
intens
phase
tb
regimen
although
one
continu
phase
howev
case
experienc
repeat
adih
inh
reintroduct
two
case
experienc
repeat
adih
three
time
other
experienc
adih
two
time
manag
adih
case
modifi
at
guidelin
treat
individu
one
tb
mening
case
receiv
levofloxacin
rif
treat
third
instanc
adih
present
patient
continu
phase
manag
full
dose
inh
rif
good
clinic
respons
note
acetyl
statu
adih
case
studi
conclus
diagnosi
adih
still
conduct
clinic
laboratori
examin
reintroduct
drug
adih
taken
care
treat
individu
offici
guidelin
treat
adih
indonesian
children
challeng
made
us
creat
propos
guidelin
adih
base
at
guidelin
keyword
hepatotox
children
retrospect
studi
diagnost
accuraci
tb
pcr
vs
cultur
diagnos
children
age
month
year
tertiari
care
center
ancheta
j
garcia
r
pediatr
makati
medic
center
makati
philippin
introduct
tuberculosi
tb
prevent
treatabl
ill
children
infrequ
confirm
bacteriolog
due
lack
effect
diagnost
tool
earli
identif
tb
import
help
initi
adequ
treatment
patient
prevent
spread
resist
strain
object
studi
aim
establish
diagnost
accuraci
tb
pcr
versu
tb
cultur
rifampicin
resist
pcr
versu
convent
suscept
test
bodi
fluid
inpati
outpati
filipino
children
age
month
year
suspect
tubercul
diseas
seen
tertiari
care
center
method
retrospect
analyt
studi
seen
tertiari
care
center
januari
may
studi
period
patient
clinic
featur
radiograph
tomograph
imag
hematolog
find
suggest
tuberculosi
diagnost
tb
sampl
bodi
fluid
recruit
studi
result
among
patient
suspect
tb
found
posit
pcr
one
forti
tb
four
overal
rifampicin
resist
sensit
specif
posit
predict
valu
neg
predict
valu
tb
pcr
use
tb
cultur
gold
standard
respect
sensit
specif
posit
predict
valu
neg
predict
valu
tb
pcr
rifampicin
resist
detect
use
tb
cultur
suscept
gold
standard
respect
overal
accuraci
tb
pcr
detect
tb
diseas
accuraci
tb
pcr
detect
rifampicin
resist
conclus
find
studi
suggest
tb
pcr
play
import
role
tb
diseas
diagnosi
clinic
radiolog
assess
continu
essenti
diagnosi
childhood
tuberculosi
high
accuraci
tb
pcr
detect
rifampicin
resist
allow
rapid
presumpt
diagnosi
tb
diseas
allow
prompt
institut
therapi
howev
convent
cultur
still
need
detect
resist
drug
rifampicin
keyword
tb
pcr
tuberculosi
filipino
pediatr
accuraci
hyperton
salin
nebul
prior
chest
physiotherapi
effect
children
bronchiectasi
gunathilaka
g
kodippilikand
wickramasingh
depart
respiratori
medicin
ladi
ridgeway
hospit
colombo
sri
lanka
faculti
medicin
univers
colombo
colombo
sri
lanka
introduct
though
cystic
fibrosi
cf
commonest
caus
bronchiectasi
western
world
bronchiectasi
major
contributor
burden
chronic
respiratori
morbid
develop
countri
failur
expector
collect
mucu
result
plug
airway
thu
creat
viciou
cycl
progress
airway
damag
therefor
airway
clearanc
techniqu
play
import
role
manag
bronchiectasi
although
multipl
airway
clearanc
techniqu
introduc
none
latter
valid
usag
method
would
depend
effect
conveni
complianc
cost
hyperton
salin
nebul
prior
airway
clearanc
method
manag
cf
bronchiectat
adult
henc
plan
assess
effect
hyperton
salin
nebul
convent
physiotherapi
children
bronchiectasi
aim
evalu
effect
hyperton
salin
nebul
prior
physiotherapi
improv
lung
function
children
bronchiectasi
object
primari
object
assess
chang
phase
phase
secondari
object
assess
improv
spirometr
paramet
fvc
ratio
pefr
rate
exacerb
materi
method
year
old
children
bronchiectasi
attend
tertiari
care
hospit
colombo
sri
lanka
august
decemb
includ
studi
inabl
compli
regular
follow
use
regular
hyperton
salin
nebul
preced
one
year
chronic
colon
pseudomona
respiratori
tract
frequent
exacerb
presenc
typic
extra
pulmonari
featur
cf
children
unabl
perform
spirometri
test
due
poor
effort
exclud
baselin
spirometri
perform
select
patient
treat
accord
airway
clearanc
techniqu
prescrib
treat
physician
one
group
children
receiv
hyperton
salin
nebul
follow
inhal
bronchodil
prior
chest
physiotherapi
group
receiv
inhal
bronchodil
prior
chest
physiotherapi
techniqu
use
deliv
bronchodil
meter
dose
inhal
spacer
devic
group
use
home
nebul
taught
parent
order
deliv
salin
adequ
train
chest
physiotherapi
given
parent
two
session
physiotherapist
physiotherapi
session
min
recommend
session
perform
day
number
exacerb
period
document
spirometr
assess
done
complet
two
month
therapi
data
process
microsoft
excel
independ
test
u
test
use
examin
statist
signific
statist
signific
establish
p
valu
less
descript
statist
present
mean
sd
result
total
children
evalu
studi
fifteen
children
receiv
hyperton
salin
nebul
prior
use
bronchodil
chest
physiotherapi
given
bronchodil
chest
physiotherapi
demograph
baselin
measur
compar
two
group
common
etiolog
suggest
post
infect
bronchiectasi
children
mean
improv
percentag
predict
significantli
higher
p
hyperton
salin
nebul
group
non
salin
group
hyperton
salin
group
show
statist
significantli
higher
mean
improv
predict
fvc
salin
group
compar
non
salin
group
p
signific
improv
pefr
demonstr
hyperton
salin
convent
group
p
mean
improv
percentag
predict
mef
significantli
higher
p
hyperton
salin
group
convent
group
howev
ratio
compar
number
exacerb
significantli
lower
salin
nebul
group
compar
non
salin
group
p
conclus
hyperton
salin
nebul
prior
use
bronchodil
chest
physiotherapi
effect
strategi
improv
qualiti
airway
clearanc
techniqu
hyperton
salin
nebul
improv
dynam
lung
volum
includ
fvc
signific
improv
pefr
seen
use
hyperton
salin
premed
chest
physiotherapi
hyperton
salin
nebul
also
reduc
rate
exacerb
recommend
random
control
trial
larger
number
need
test
effect
use
hyperton
salin
nebul
chest
physiotherapi
key
word
bronchiectasi
hyperton
salin
fvc
ratio
pefr
mef
molecular
epidemiolog
characterist
subtyp
respiratori
syncyti
viru
eastern
china
dong
l
li
hy
dong
yw
dai
lh
fan
jm
chen
xf
disciplin
pediatr
respiratori
diseas
second
affili
hospit
yuy
children
hospit
wenzhou
medic
univers
wenzhou
china
object
investig
epidemiolog
characterist
respiratori
syncyti
viru
rsv
subtyp
genotyp
eastern
china
explor
genet
variabl
attach
g
protein
gene
among
subtyp
rsv
strain
method
nasopharyng
secret
np
children
year
age
hospit
lower
respiratori
tract
infect
lrti
three
tertiari
hospit
consecut
season
juli
june
collect
rsv
antigen
determin
use
direct
immunofluoresc
sampl
rsv
antigen
posit
randomli
select
epidem
season
rna
extract
identifi
subtyp
b
use
chain
reaction
randomli
select
subtyp
strain
nearli
attach
g
protein
amplifi
pcr
sequenc
result
total
specimen
collect
patient
consecut
epidem
period
posit
rsv
among
randomli
select
sampl
sampl
identifi
rsv
subtyp
b
respect
subgroup
type
predomin
two
epidem
season
strain
complet
sequenc
g
gene
obtain
includ
four
group
genotyp
genotyp
common
one
predomin
form
first
four
popular
season
follow
genotyp
first
verifi
decemb
total
strain
genotyp
genotyp
subtyp
season
differ
variat
second
hypervari
region
g
gene
rate
homolog
prototyp
strain
strain
subtyp
rsv
nucleotid
level
amino
acid
level
comparison
strain
among
sequenc
subtyp
rsv
rate
homolog
nucleotid
level
amino
acid
level
g
protein
variant
includ
substitut
insert
repeat
glycosyl
site
mutat
obviou
sever
variat
acid
sequenc
insert
genotyp
conclus
predomin
genotyp
subtyp
rsv
consecut
epidem
season
eastern
china
variat
nucleotid
amino
acid
sequenc
g
protein
obviou
variou
transmiss
chain
rsv
caus
differ
genotyp
consecut
season
ruptur
massiv
pulmonari
hydatid
cyst
girl
case
report
babaei
hbabaei
kavandi
ward
mousavi
teach
hospit
zanjan
univers
medic
scienc
zanjan
iran
human
univers
zanjan
zanjan
iran
morbid
hydatid
cyst
children
uncommon
portion
world
still
countri
report
lancet
echinococcosi
locat
hyper
endem
area
alveolar
hydatidosi
surgic
remov
unsuccess
mortal
rate
year
case
present
girl
refer
hospit
product
cough
intermitt
decreas
conscious
level
septemb
mild
tachypnea
posit
find
first
physic
examin
chest
order
show
surprisingli
right
side
massiv
pleural
effus
concurr
pneumothorax
shift
mediastina
opposit
side
consult
surgeri
depart
perform
patient
addit
clinic
imag
show
bronchiectasi
upper
lobe
right
lung
water
sign
ct
made
preliminari
initi
diagnosi
echinococcu
lung
ultim
start
albendazol
mgkg
treatment
surgeri
perform
equip
hospit
right
posterolater
thoracotomi
lung
empyema
ruptur
hydatid
cyst
pleural
adhes
fibrin
report
final
wide
decort
perform
patient
discharg
day
hospit
good
condit
administr
albendazol
continu
parent
advis
referr
pediatr
infecti
diseas
clinic
serial
observ
good
perform
school
well
novemb
last
recal
date
ruptur
may
occur
therapi
percutan
aspir
trauma
lead
sever
complic
massiv
hemoptysi
tension
pneumothorax
lung
abscess
asphyxia
preval
allerg
rhiniti
atop
eczema
among
schoolchildren
jordan
f
pediatr
jordan
univers
scienc
technolog
irbid
jordan
background
preval
rate
allerg
diseas
asthma
allerg
rhiniti
atop
eczema
increas
worldwid
among
children
object
part
intern
studi
asthma
allergi
childhood
isaac
phase
iii
determin
preval
asthma
allerg
rhiniti
atop
eczema
among
schoolchildren
age
year
year
method
intern
studi
asthma
allergi
childhood
isaac
phase
iii
questionnair
administ
children
age
group
questionnair
collect
complet
parent
result
total
number
student
includ
studi
group
respons
rate
schoolchildren
asthma
found
primari
school
children
age
year
signific
wheez
ever
compar
older
children
p
asthma
common
male
preval
allerg
rhiniti
ever
primari
schoolchildren
older
children
respect
p
current
symptom
ar
primari
schoolchildren
older
children
respect
p
hay
fever
primari
school
children
compar
older
children
age
year
old
p
preval
eczema
ever
primari
older
schoolchildren
respect
p
eczema
primari
schoolchildren
older
children
respect
p
conclus
first
studi
preval
allerg
diseas
jordan
asthma
increas
allerg
diseas
uncommon
problem
area
allerg
rhiniti
common
older
children
femal
commonli
allerg
rhiniti
eczema
contribut
oxygen
therapi
high
flow
manag
sever
bronchiol
gener
pediatr
ward
belhadj
khalsi
fkhalsi
f
louati
ben
romdhan
tinsa
f
hamouda
boussetta
k
pediatr
depart
b
children
hospit
tuni
tuni
tunisia
purpos
aim
studi
describ
contribut
hfnc
manag
evolut
sever
bronchiol
method
retrospect
studi
case
sever
bronchiol
three
month
novemb
januari
compar
two
group
first
group
includ
case
sever
bronchiol
hfnc
use
second
group
includ
patient
place
hfnc
due
lack
avail
result
eighti
case
sever
bronchiol
collect
place
hfnc
averag
age
day
day
histori
prematur
found
case
hypotrophi
case
neonat
mechan
ventil
case
congenit
heart
diseas
case
viral
contagion
found
case
case
hfnc
use
first
hour
hospit
first
hour
case
averag
durat
hfnc
day
day
mean
total
hospit
stay
day
hfnc
group
versu
day
group
statist
signific
differ
p
transfer
intens
care
unit
indic
case
group
use
hfnc
versu
case
second
group
conclus
hfnc
appear
realli
effect
sever
bronchiol
decreas
use
invas
ventil
especi
children
month
age
hfnc
avail
gener
pediatr
ward
easi
use
improv
prognosi
patient
reduc
pressur
pediatr
intens
care
unit
vitamin
supplement
tuberculin
skin
test
convers
among
healthi
children
tuberculosi
contact
yani
ffyani
lipoeto
supriyatno
darwin
child
health
faculti
medicin
univers
mdjamil
hospit
padang
west
sumatera
indonesia
nutrit
faculti
medicin
univers
andala
padang
west
sumatera
indonesia
child
health
faculti
medicin
univers
indonesia
cipto
mangunkusumo
hospit
jakarta
indonesia
histolog
faculti
medicin
univers
andala
padang
west
sumatera
indonesia
background
tuberculosi
tb
contact
increas
risk
tb
infect
among
children
whose
immun
system
fulli
develop
vitamin
known
affect
innat
adapt
immun
inhibit
bacteri
invas
therefor
protect
develop
tb
infect
indic
tst
convers
object
evalu
effect
vitamin
supplement
among
healthi
children
tuberculosi
contact
develop
tst
convers
method
conduct
random
control
trial
children
tuberculosi
contact
whose
tuberculin
skin
test
tst
neg
healthi
administ
high
singl
dose
vitamin
supplement
twice
interv
week
week
perform
tst
posit
tst
diamet
mm
indic
tst
convers
ethic
approv
obtain
ethic
committe
faculti
medicin
universita
andala
result
differ
tst
convers
intervent
placebo
group
p
valu
baselin
characterist
show
mean
level
vitamin
ng
ml
vitamin
supplement
significantli
increas
vitamin
level
intervent
group
vs
p
compar
placebo
group
vs
p
conclus
differ
tst
convers
intervent
placebo
group
vitamin
supplement
twice
week
among
healthi
children
tb
contact
although
increas
vitamin
serum
level
studi
bacteri
agent
pneumonia
children
detect
antibiogram
pattern
hamadan
west
iran
yousefimashouf
mryousefimashouf
mr
medic
microbiolog
hamadan
univers
medic
scienc
faculti
medicin
hamadan
iran
background
aim
bacteri
pneumonia
still
one
danger
infecti
diseas
caus
seriou
complic
mortal
children
aim
present
studi
identifi
common
bacteri
agent
caus
pneumonia
children
less
year
old
detect
resist
current
antibiot
hamadan
method
overal
children
suspect
pneumonia
investig
result
pleural
fluid
cultur
antibiogram
pattern
frequenc
age
sex
season
patient
also
studi
data
gather
questionnair
analyz
use
system
speci
identifi
biochem
serolog
method
antibiogram
test
also
perform
use
method
result
children
suspect
pneumonia
case
posit
bacteri
cultur
also
bacteria
common
speci
staphylococcu
aureu
streptococcu
pneumonia
klebsiella
ozaena
pseudomona
aeruginosa
haemophilu
influenza
bacteroid
speci
streptococcu
e
coli
neisseria
meningitidi
acinetobact
speci
bacteria
posit
cultur
observ
children
year
age
group
male
winter
result
antibiogram
show
effect
antibiot
cefixim
ceftriaxon
gentamycin
ciprofloxacin
gram
bacteria
show
high
resist
tetracyclin
amoxicillin
ampicillin
conclus
present
studi
show
bacteria
particular
staphylococcu
aureu
streptococcu
pneumonia
predomin
caus
bacteri
pneumonia
children
less
year
old
region
speci
show
high
resist
routin
antibiot
tetracyclin
amoxicillin
ampicillin
correspond
client
statist
refer
clinic
rate
airborn
particl
pollut
babaei
lbabaei
nabatchian
babaei
chemistri
faculti
scienc
islam
azad
zanjan
branch
zanjan
iran
inspector
farahtab
spin
textil
compani
zanjan
iran
depart
mousavi
teach
hospit
zanjan
univers
medic
scienc
zanjan
iran
citi
locat
countri
iran
middl
east
contin
region
dm
latitud
longitud
coordin
n
e
zanjan
longitud
latitud
figur
recent
year
countri
climat
threaten
four
main
dust
particl
focus
western
neighbor
signific
case
forti
airborn
particl
flow
last
year
iraq
east
syria
countri
record
document
environment
organ
show
known
hotspot
activ
around
march
septemb
annual
past
year
school
closur
work
shut
down
day
know
airborn
particl
play
import
role
dysfunct
pulmonari
system
also
trigger
attack
known
case
asthmat
children
present
studi
tri
show
relationship
number
patient
refer
zanjan
solitari
pediatr
asthma
allergi
clinic
rate
airborn
particl
record
depart
environ
zanjan
branch
airborn
particl
divid
two
classif
coars
particl
larger
micron
diamet
fine
particl
micron
less
diamet
air
monitor
zanjan
conduct
local
environment
organ
provid
air
pollut
data
regard
ozon
particul
matter
recommend
air
qualiti
system
aq
contain
data
approxim
monitor
station
citi
center
around
area
mainli
urban
area
collect
data
citi
center
station
client
statist
clinic
correspond
rate
airborn
particl
pollut
record
citi
center
station
neg
effect
air
pollut
pulmonari
function
place
children
greater
risk
air
exacerb
asthma
durat
live
studi
review
indic
outdoor
air
pollut
affect
appear
exacerb
asthma
children
j
asthma
jun
doi
epub
apr
outdoor
air
pollut
asthma
children
tzivian
l
accord
aqi
air
pollut
even
moder
rang
children
asthma
limit
time
outdoor
especi
pm
exercis
outdoor
condit
recommend
morbid
despit
school
open
student
histori
asthma
exempt
school
aqi
zanjan
citi
center
station
daymonth
perform
interferon
gamma
releas
assay
tuberculin
skin
test
tb
diagnosi
hiv
infect
children
kaswandani
nkaswandani
n
nurul
pediatr
univers
indonesia
jakarta
indonesia
background
tuberculosi
tb
import
opportunist
infect
children
human
immunodefici
viru
hiv
high
burden
tb
countri
diagnosi
tb
immunocompromis
children
difficult
tuberculin
test
tst
interferon
gamma
releas
assay
igra
gold
expect
accur
diagnosi
tb
infect
hiv
infect
children
report
accuraci
children
hiv
infect
still
vari
object
evalu
accuraci
tst
diagnos
tb
hiv
infect
children
method
studi
conduct
hiv
infect
children
suspect
tb
age
month
year
old
data
includ
histori
take
physic
examin
thorax
radiolog
tst
bacteriolog
examin
xpert
mtbrif
mgit
cultur
collect
result
preval
tb
children
confirm
tb
clinic
tb
clinic
symptom
children
tb
chronic
cough
bodi
weight
decrement
reduct
activ
lymph
node
enlarg
prolong
fever
sensit
toward
clinic
tb
children
ci
specif
ci
ppv
ci
npv
ci
sensit
tuberculin
test
toward
clinic
tb
ci
specif
ci
ppv
ci
npv
ci
sensit
toward
bacteriolog
examin
ci
specif
ci
ppv
ci
npv
ci
accur
toward
bacteriolog
examin
tuberculin
test
could
evalu
conclus
qft
tst
show
high
specif
low
sensit
diagnos
tb
accuraci
detect
tb
hiv
infect
children
slightli
superior
tst
therefor
two
method
could
choic
depend
avail
patient
comfort
fibrosi
bronchiectasi
children
etiolog
clinic
profil
outcom
set
singl
unit
experi
wda
anuradha
k
kg
gunathilaka
p
wickramasingh
ladi
ridgeway
hospit
children
colombo
sri
lanka
faculti
medicin
univers
colombo
colombo
sri
lanka
introduct
fibrosi
cf
bronchiectasi
common
cf
bronchiectasi
develop
develop
countri
signific
contribut
chronic
respiratori
morbid
howev
limit
scientif
data
avail
clinic
profil
manag
bronchiectasi
children
without
cf
said
end
result
repeat
episod
insult
respiratori
system
due
sever
etiolog
lead
perman
bronchial
tree
injuri
dilat
clinic
case
definit
bronchiectasi
imprecis
sever
extent
highli
variabl
rang
minimum
respiratori
morbid
death
symptom
nonspecif
chest
radiograph
rel
insensit
diagnosi
therefor
high
degre
suspicion
need
evalu
children
recurr
respiratori
tract
infect
sign
suggest
chronic
respiratori
insuffici
children
suspect
bronchiectasi
undergo
comput
tomograph
hrct
scan
without
delay
confirm
diagnosi
defin
distribut
sever
airway
involv
lung
function
test
older
children
provid
measur
function
impair
involv
manag
approach
bronchiectasi
follow
similar
approach
manag
cf
bronchiectasi
specif
guidelin
review
children
bronchiectasi
done
aim
contribut
fill
gap
understand
clinic
profil
outcom
object
describ
clinic
profil
etiolog
specif
manag
outcom
children
fibrosi
bronchiectasi
attend
tertiari
care
hospit
colombo
sri
lanka
method
children
hrct
diagnosi
bronchiectasi
present
professori
pediatr
unit
ladi
ridgeway
hospit
colombo
period
septemb
decemb
select
review
absenc
typic
clinic
featur
two
neg
sweat
test
perform
minimum
month
apart
taken
exclud
cystic
fibrosi
detail
chart
review
children
diagnos
fibrosi
bronchiectasi
done
result
major
patient
bronchiectasi
femal
mean
age
studi
sampl
year
sd
mean
age
diagnosi
bronchiectasi
year
sd
indic
perform
hrct
major
children
combin
recurr
respiratori
tract
infect
persist
crepit
examin
mean
durat
symptom
medic
concern
prior
diagnosishrct
year
sd
bilater
involv
seen
patient
patient
refer
center
pediatrician
gener
practition
suspicion
bronchiectasi
rest
diagnos
admit
exacerb
background
recurr
respiratori
tract
infect
twelv
children
show
weight
height
bmi
centil
age
less
mean
number
episod
exacerb
per
year
spirometri
done
patient
analysi
clinic
profil
best
forc
expiratori
volum
secondforc
vital
capac
ratio
fvc
reduc
predict
valu
major
patient
fvc
patient
patient
home
oxygen
therapi
predict
less
children
analysi
etiolog
reveal
one
patient
common
variabl
immun
defici
year
past
histori
tuberculosi
year
intralobar
sequestr
year
late
diagnosi
sever
gastroesophag
reflux
diseas
year
commonest
etiolog
post
infecti
one
episod
sever
pneumonia
need
respiratori
support
infanc
common
etiolog
exclud
nine
children
identifi
etiolog
diagnost
facil
primari
cilliari
dyskinesia
pcd
avail
patient
typic
clinic
profil
pcd
satisfactori
postur
drainag
follow
rest
defici
techniqu
pneumococc
vaccin
given
patient
outsid
expand
program
immun
patient
compli
regular
three
patient
undergon
lobectomi
sampl
children
home
oxygen
therapi
depend
parent
activ
daili
live
conclus
commonest
caus
bronchiectasi
group
post
infect
signific
delay
diagnosi
despit
children
symptomat
high
degre
suspicion
need
earli
diagnosi
especi
children
histori
sever
respiratori
infect
earli
childhood
need
creat
awar
import
earli
diagnosi
bronchiectasi
import
correct
postur
drainag
techniqu
would
lead
less
complic
better
prognosi
pleuropulmonari
blastoma
congenit
pulmonari
airway
malform
challeng
diagnosi
asymptomat
child
stachewski
verron
k
souza
nascimento
pereira
de
oliveira
junior
pulmonolog
gpaci
hospit
sorocaba
brazil
patholog
univers
campina
odontolog
piracicaba
brazil
surgeri
gpaci
hospit
sorocaba
brazil
introduct
congenit
pulmonari
airway
malform
cpam
abnorm
lung
develop
distinguish
radiolog
clinic
rare
primari
tumor
pleuropulmonari
blastoma
ppb
report
rare
case
cpam
ppb
overlap
absolut
asymptomat
girl
huge
cystic
lesion
case
present
girl
refer
hospit
giant
cystic
pulmonari
lesion
larg
solid
mass
lesion
undergon
huge
increas
month
sinc
first
discov
pediatrician
random
chest
perform
flu
initi
clinic
examin
reveal
good
condit
pulmonari
auscult
absolut
normal
despit
dramat
appear
radiolog
find
report
anomali
antenat
ultrasound
neonat
complic
good
birth
weight
w
h
cm
develop
episod
respiratori
distress
pneumonia
whatsoev
first
chest
perform
month
old
show
cystic
lesion
right
hemithorax
white
shadow
bottom
lesion
ct
scan
show
cystic
lesion
contain
thin
intern
septat
consolid
area
last
imag
perform
month
later
ct
scan
demonstr
import
increas
cystic
lesion
opac
imag
child
underw
right
thoracotomi
fifth
intercost
space
multilocul
giant
cystic
lesion
found
occupi
entir
hemithorax
compress
right
lower
lobe
solid
round
mass
mechan
ventil
lobe
got
insuffl
recov
function
normal
anatomi
affect
lobe
appear
normal
remov
cystic
mass
perform
simultan
posterior
apic
segment
lower
lobe
lesion
fix
grossli
diamet
cystic
mass
cm
histopatholog
cystic
epitheli
layer
compos
predominantli
flatten
cell
subepitheli
layer
foci
spindl
cell
atyp
appear
moreov
parenchyma
show
normal
microscop
characterist
immunohistochem
analysi
detect
posit
desmin
intracellular
intermedi
filament
found
muscl
tissu
demonstr
atyp
stromal
cell
indic
sarcomat
differenti
characterist
pleuropulmonari
blastoma
imag
patient
receiv
chemotherapi
first
postop
year
follow
close
present
good
condit
imag
chest
show
cystic
lesion
shadow
red
arrow
imag
ct
scan
show
defin
multilocul
cystic
lesion
red
arrow
round
mass
imag
eighteen
month
chest
show
huge
increas
cyst
lesion
round
mass
arrow
togeth
correspond
ct
scan
b
imag
cystic
mass
compress
lower
right
lobe
black
arrow
round
mass
previou
imag
imag
primit
mesenchym
cell
locat
epithelium
circl
b
primit
mesenchym
cell
show
posit
desmin
red
arrow
discuss
congenit
pulmonari
airway
malform
cpam
formerli
known
congenit
cystic
adenomatoid
malform
ccam
consist
multicyst
mass
segment
lung
tissu
abnorm
bronchial
prolifer
account
approxim
congenit
cystic
lung
diseas
pediatr
lung
cancer
histori
cpam
five
subtyp
classifi
mainli
accord
cystic
size
type
larg
cyst
type
ii
cyst
less
cm
diamet
type
iii
microcyst
involv
entir
lobe
type
iv
unlin
cyst
typic
affect
singl
lobe
indistinguish
type
imag
type
rare
lethal
postnat
ppb
rare
intrathorac
malign
neoplasm
origin
lung
develop
aris
lung
pleura
describ
manivel
et
al
later
subdivid
three
type
basi
morpholog
pattern
type
multilocular
cyst
contain
primit
small
mesenchym
cell
within
cyst
wall
type
ii
cystic
solid
compon
mix
type
iii
exclus
solid
tumor
order
increas
malign
priest
et
al
report
type
observ
patient
first
year
life
compar
type
ii
iii
found
older
patient
year
age
type
differ
rest
subtl
malign
chang
good
prognosi
clinic
present
may
asymptomat
secondari
symptom
due
expans
infect
cyst
infect
sometim
recurr
frequent
find
chest
cystic
lesion
hyperinfl
mediastin
shift
pneumothorax
usual
adjac
rib
eros
calcif
ct
scan
remain
sensit
techniqu
includ
largest
cyst
size
natur
cyst
septat
contain
solid
compon
presenc
system
vascular
suppli
incid
ppb
among
appar
benign
lesion
sever
studi
suggest
two
entiti
indistinguish
precis
relationship
cpam
malign
especi
pleuropulmonari
blastoma
ppb
remain
unknown
studi
indic
ppb
etiolog
may
origin
previous
exist
cpam
lung
noth
proven
date
case
correl
two
patholog
present
similar
histolog
type
gener
diagnosi
made
microscop
analysi
hematoxylin
eosin
sometim
necessari
perform
immunohistochemistri
conflict
case
biomark
desmin
myogenin
may
observ
borderlin
case
accord
hill
et
al
order
distinguish
ppb
patholog
necessari
observ
presenc
multilocular
cystic
area
well
circumscrib
tumor
normal
parenchyma
presenc
small
foci
primit
cell
epitheli
layer
flat
cell
notic
case
conclus
congenit
pulmonari
airway
malform
cpam
type
pleuropulmonari
blastoma
ppb
indistinguish
clinic
radiolog
present
therefor
children
asymptomat
cystic
lesion
assess
thoroughli
lesion
resect
earli
avoid
later
complic
malign
care
histolog
examin
resect
specimen
mandatori
identifi
occult
malign
therebi
manag
treatment
properli
reach
best
prognosi
valid
spirometri
refer
valu
italian
preschool
children
del
greco
p
caparrelli
c
calogero
c
fenu
g
lombardi
e
bronchopneumolog
meyer
children
hospit
florenc
itali
rational
global
lung
initi
spirometri
refer
valu
potenti
valuabl
tool
interpret
spirometri
worldwid
although
valid
proven
mani
countri
doubt
remain
popul
aim
studi
assess
valid
refer
valu
preschool
italian
children
method
healthi
children
recruit
randomli
select
kindergarten
around
florenc
itali
subject
histori
respiratori
symptom
assess
use
standard
questionnair
isaac
modifi
translat
italian
children
born
less
week
gestat
age
receiv
oxygen
birth
day
exclud
children
episod
wheez
ever
episod
wheez
previou
month
includ
children
respiratori
symptom
sign
time
test
spirometri
perform
spiro
cosm
spiromet
cosm
rome
itali
accord
atser
spirometri
recommend
preschool
forc
vital
capac
fvc
forc
expiratori
volum
forc
expiratori
flow
fvc
calcul
use
absolut
valu
larger
consid
clinic
signific
analysi
result
questionnair
spirometri
transform
numer
valu
report
excel
tabl
subsequ
analyz
use
statas
window
analysi
perform
use
pair
type
parametr
statist
test
allow
verifi
averag
valu
distribut
differ
significantli
certain
refer
valu
mean
valu
spirometr
paramet
fvc
forc
expiratori
flow
fvc
obtain
examin
sampl
compar
predict
valu
spirometr
paramet
deriv
gli
refer
equat
valu
p
consid
statist
clinic
signific
result
total
healthi
children
femal
male
age
rang
yr
mean
age
sd
yr
mean
height
cm
mean
weight
kg
perform
accept
reproduc
spirometri
maneuv
feasibl
total
children
reproduc
maneuv
reproduc
maneuv
mean
sd
measur
spirometri
indic
predict
valu
use
report
pair
show
measur
valu
significantli
differ
predict
valu
mean
measur
valu
smaller
show
differ
clinic
signific
potenti
studi
limit
number
subject
enrol
studi
confirm
valid
refer
equat
less
local
healthi
control
male
femal
would
need
valid
publish
refer
equat
degre
certainti
sinc
smaller
sampl
size
differ
may
occur
pure
chanc
furthermor
rel
inclus
flexibl
use
select
sampl
closer
realiti
popul
avoid
select
abnorm
normal
children
would
distort
studi
result
overestim
result
still
topic
mani
discuss
regard
would
normal
paramet
necessari
consid
conclus
first
studi
aim
assess
valid
refer
valu
preschool
italian
children
data
far
suggest
differ
measur
predict
valu
use
neither
statist
clinic
signific
healthi
italian
preschool
refer
quanjer
ph
stanojev
cole
tj
et
al
refer
valu
spirometri
age
rang
global
lung
function
equat
eurrespir
j
asher
mi
keil
u
anderson
hr
beasley
r
et
al
intern
studi
asthma
allergi
childhood
isaac
rational
method
eurrespir
j
beydon
n
davi
sd
lombardi
e
et
al
offici
american
thorac
societyeuropean
respiratori
societi
statement
pulmonari
function
test
preschool
children
j
respircrit
care
med
quanjer
j
stock
tj
cole
gl
et
al
influenc
secular
trend
sampl
size
refer
equat
lung
function
test
eurrespj
lum
bountziouk
v
sonnappa
et
al
healthi
children
select
refer
sampl
spirometri
eurrespij
sleep
habit
lower
primari
school
children
singapor
lim
mt
agustin
cai
wong
muhammad
ramamurthi
goh
teck
univers
children
medic
institut
nation
univers
hospit
singapor
kim
wee
school
commun
inform
nanyang
technolog
univers
singapor
singapor
backgroundobject
sleep
essenti
optim
bodi
function
nation
sleep
foundat
recommend
primari
school
children
get
hour
sleep
per
day
previou
studi
singapor
show
sleep
durat
significantli
lower
preschool
children
compar
western
popul
littl
publish
data
sleep
habit
primari
school
children
singapor
studi
aim
investig
sleep
practic
amongst
lower
primari
school
age
children
singapor
method
questionnair
survey
parent
children
age
year
old
attend
primari
school
singapor
result
total
questionnair
given
complet
respons
rate
children
felt
sleepi
day
least
day
per
week
children
fall
asleep
watch
televis
least
day
per
week
children
slept
less
recommend
hour
school
day
day
children
got
less
hour
sleep
children
children
regular
bedtim
routin
least
night
week
popular
activ
hour
bedtim
watch
televis
children
regularli
engag
watch
televis
night
children
use
smartphon
game
hour
bedtim
children
use
comput
watch
video
hour
bedtim
despit
parent
survey
felt
child
sleep
problem
amongst
parent
popular
activ
hour
bedtim
watch
televis
parent
parent
use
smartphon
social
media
hour
bedtim
conclus
daytim
sleepi
present
third
children
children
survey
get
recommend
durat
sleep
lack
regular
bedtim
routin
use
televis
smartphon
bedtim
known
neg
affect
sleep
qualiti
howev
parent
think
child
sleep
problem
parent
challeng
due
parent
suboptim
sleep
habit
includ
high
rate
digit
devic
use
amongst
parent
educ
need
ensur
children
get
right
qualiti
quantiti
sleep
breath
behavior
symptom
children
nigerian
citi
ayuk
acayuk
uwaezuok
ndu
iloh
ndukwu
ekwochi
asinobi
nduagubam
osuorah
colleg
medicin
univers
nigeria
nsukka
enugu
nigeria
colleg
medicin
enugu
state
univers
teach
hospit
enugu
nigeria
colleg
health
scienc
nnamdi
azikiw
univers
awka
nigeria
medic
research
council
uk
gambia
unit
fajara
gambia
gabon
background
breath
sdb
compris
breath
difficulti
lead
signific
morbid
children
assess
valid
questionnair
screen
tool
polysomnographi
psg
avail
data
scarc
disord
black
children
aim
studi
aim
determin
preval
sdb
behavior
manifest
associ
risk
factor
poor
score
children
nigerian
citi
method
descript
studi
conduct
use
child
sleep
questionnair
srbd
children
age
month
year
consent
household
recruit
result
three
hundr
nineti
nine
analyz
mean
age
month
male
femal
ratio
children
belong
famili
middl
statu
sdb
problem
present
sleep
habit
significantli
preval
symptom
includ
difficulti
wake
sleep
among
children
age
year
p
easi
distract
p
disrupt
p
among
children
age
year
old
sdb
highli
correl
assess
compon
except
restless
r
p
easi
distract
r
p
stoppag
breath
sleep
r
p
conclus
sdb
preval
rate
set
similar
previous
document
rate
develop
countri
high
preval
rate
compon
sdb
inattent
disrupt
significantli
associ
sdb
notabl
children
age
year
children
signific
sdb
note
studi
refer
complet
psg
test
pulmonari
lymphoid
tissu
malt
lymphoma
viru
mani
year
cardiac
transplant
bedoya
mbedoya
barredo
roja
colin
pulmonolog
miller
school
medicin
univers
miamijackson
memori
hospit
miami
usa
hematolog
oncolog
miller
school
medicin
univers
miamijackson
memori
hospit
miami
usa
patholog
miller
school
medicin
univers
miamijackson
memori
hospit
miami
usa
introduct
primari
lung
lymphoma
rare
lung
disord
mostli
present
lymphoid
tissu
malt
lymphoma
type
extranod
lymphoma
rare
patholog
children
median
age
diagnosi
year
lung
locat
repres
case
gastrointestin
gi
tract
involv
predomin
primari
locat
malt
lymphoma
unlik
case
gi
malt
lymphoma
lung
establish
associ
microbi
infect
present
case
girl
underw
orthotop
cardiac
transplant
infanc
present
sign
symptom
concern
lymphoprolif
disord
ptld
follow
recurr
pneumothorac
underw
lung
biopsi
reveal
malt
lymphoma
viru
ebv
case
report
femal
histori
idiopath
dilat
cardiomyopathi
statu
post
orthotop
cardiac
transplant
year
age
patient
rel
uncompl
cours
age
persist
cough
declin
spirometri
trigger
comput
tomographi
ct
chest
abdomen
reveal
diffus
lymphadenopathi
concern
ptld
laparoscop
mesenter
lymph
node
biopsi
result
posit
ebv
infecti
lesion
follow
mediastin
lymph
node
biopsi
due
uncertainti
regard
ptld
result
inconclus
well
cough
weight
loss
signific
decreas
pulmonari
function
test
eventu
culmin
recurr
pneumothorac
lead
lung
biopsi
establish
malt
lymphoma
lung
well
infect
ebv
discuss
primari
lung
lymphoma
rare
disord
repres
primari
pulmonari
malign
malt
lymphoma
frequent
subset
primari
pulmonari
lymphoma
may
present
pulmonari
symptom
dyspnea
cough
chest
pain
constitut
symptom
patient
develop
cough
weight
loss
recurr
pneumothorac
latter
unusu
present
point
us
seriou
morbid
requir
lung
biopsi
diagnosi
ptld
rel
common
complic
prolong
immunosuppress
recipi
solid
organ
bone
marrow
transplant
often
associ
ebv
malt
lymphoma
classifi
entiti
within
spectrum
ptld
infrequ
associ
ebv
report
rais
question
link
patient
pulmonari
malt
lymphoma
orthotop
cardiac
transplant
associ
ebv
studi
bacteri
contamin
neonat
intens
care
unit
nicu
pediatr
hospit
hamadan
west
iran
yousefimashouf
mr
medic
microbiolog
hamadan
univers
medic
scienc
faculti
medicin
hamadan
iran
background
aim
bacteri
contamin
hospit
one
major
problem
hospit
caus
seriou
damag
human
societi
one
major
caus
increas
bacteri
contamin
misus
disinfect
increas
antibiot
resist
hospit
aim
studi
evalu
bacteri
contamin
intens
care
unit
nicu
determin
antibiot
resist
pattern
isol
bacteria
fatemih
hospit
west
iran
materi
method
studi
sampl
randomli
collect
environ
apparatu
neonat
intens
care
unit
includ
wash
sink
ward
floor
patient
bed
phototherapi
oxygen
mask
incub
infant
scale
suction
staff
finger
sampl
inocul
emb
blood
agar
steril
wet
swab
transfer
medic
laboratori
identif
strain
test
antibiogram
nccl
protocol
antibiot
disk
consist
ampicillin
imipenem
ceftriaxon
ceftizoxim
erythromycin
vancomycin
gentamicin
cephalexin
cefepim
ciprofloxacin
data
gather
questionnair
analyz
use
spss
softwar
result
averag
rate
bacteri
contamin
nicu
contamin
area
wash
sink
suction
lowest
phototherapi
oxygen
mask
respect
frequent
bacteria
isol
follow
staphylococcu
epidermidi
bacillu
subtili
acinetobact
baumannii
e
coli
isol
sensit
imipenem
ceftriaxon
vancomycin
cefepim
ciprofloxacin
wherea
resist
ampicillin
gentamicin
erythromycin
cephalexin
conclus
result
show
consider
bacteri
contamin
nicu
particular
acinetobact
baumannii
high
drug
resist
strain
isol
hospit
seem
steril
disinfect
method
hospit
perform
correctli
thu
recommend
health
worker
train
regularli
control
incid
nosocomi
bacteria
key
word
nosocomi
infect
antibiot
resist
bacteria
neonat
cautionari
tale
tachypn
infant
bronchiol
season
chilukuri
l
abdel
aziz
maddipati
tmaddipati
children
young
peopl
depart
st
helen
knowsley
teach
hospit
nh
trust
whiston
unit
kingdom
abstract
although
diagnosi
bronchiol
usual
straightforward
cardiac
metabol
musculoskelet
hematolog
condit
may
present
similar
way
therefor
overlook
method
describ
four
case
present
increas
work
breath
treat
initi
bronchiol
howev
progress
clinic
cours
case
investig
reveal
altern
diagnosi
result
first
case
babi
boy
present
symptom
bronchiol
treat
accordingli
slow
respons
treatment
subsequ
ct
scan
reveal
diagnosi
congenit
lobar
emphysema
need
resect
anoth
old
child
similar
clinic
present
found
white
cell
count
hemoglobin
platelet
blood
film
confirm
diagnosi
acut
lymphocyt
leukemia
third
case
babi
girl
show
persist
tachypnea
intermitt
grunt
proport
chest
sign
blood
ga
reveal
metabol
acidosi
urin
persist
alkalin
renal
ultrasound
show
nephrocalcinosi
lead
diagnosi
distal
renal
tubular
acidosi
final
old
boy
present
symptom
suggest
bronchiol
subsequ
confirm
pulmonari
vein
stenosi
conclus
case
seri
demonstr
rare
respiratori
condit
mimic
present
common
condit
bronchiol
highlight
import
detail
histori
examin
infant
present
increas
work
breath
atyp
find
present
delay
respons
standard
treatment
seek
senior
specialist
review
think
box
vital
correl
doppler
echocardiographi
main
pulmonari
arteri
ventilationperfus
scintigraphi
case
syndrom
vilaplana
moral
toral
martin
infantil
hospit
gener
universitario
de
elda
virgen
de
la
salud
alicant
spain
infantil
hospit
gener
universitario
de
alicant
alicant
spain
infantil
hospit
gener
universitario
de
alicant
alicant
spain
medicina
nuclear
hospit
universitario
san
juan
de
alicant
alicant
spain
introduct
syndrom
sj
infrequ
entiti
sometim
diagnos
casual
find
chest
radiograph
hyperluc
lung
lung
lobe
clinic
patient
may
product
cough
short
breath
dyspnea
exert
sometim
hemoptysi
patient
littl
associ
sequela
diagnos
adult
appropri
clinic
set
radiographi
ct
usual
suffici
diagnos
condit
scintigraphi
scan
may
contribut
diagnosi
show
display
characterist
pattern
match
ventil
perfus
defect
recent
observ
patient
complic
pneumonia
doppler
echocardiographi
pulmonari
main
arteri
pulmonari
arteri
blood
suppli
markedli
decreas
affect
lung
scintigraphi
compar
doppler
echocardiographi
pulmonari
main
arteri
patient
recent
diagnos
syndrom
case
report
boy
underw
chest
radiographi
context
acut
bronchiti
complet
atelectasi
left
lower
lobe
lll
lingula
bronchiectasi
hyperinfl
left
upper
lobe
lul
ipsilater
deviat
mediastinum
observ
healthi
child
wheez
episod
trigger
upper
respiratori
tract
infect
histori
cough
expector
choke
pneumonia
signific
bacteri
infect
boy
without
respiratori
distress
lung
auscult
show
hypoventil
crackl
left
hemithorax
chang
chest
observ
oral
cours
pulmonari
ct
scan
show
atelectasi
entir
lll
bronchiectasi
hypoattenu
rest
lung
segment
due
air
trap
thicken
bronchial
tree
bronchiectasi
lul
retent
secret
addit
decreas
size
left
pulmonari
arteri
decreas
vasculatur
left
lung
observ
child
underw
fiberopt
bronchoscopi
discard
presenc
foreign
bodi
intrabronchi
lesion
abnorm
segment
sampl
respiratori
secret
collect
grow
haemophilu
influenza
studi
tuberculin
test
sweat
test
immun
system
evalu
render
normal
result
doppler
echocardiographi
show
clear
flow
asymmetri
main
pulmonari
arteri
markedli
decreas
blood
flow
left
pulmonari
arteri
ratio
right
left
pulmonari
arteri
flow
estim
scintigraphi
show
match
sever
deterior
ventil
perfus
left
lung
perfus
ratio
right
left
lung
diagnosi
sj
establish
recommend
made
receiv
respiratori
physiotherapi
pneumococc
vaccin
earli
antibiotherapi
case
respiratori
exacerb
discuss
sj
consid
rel
uncommon
complex
diseas
character
unilater
hyperluc
part
entir
lung
decreas
vascular
air
trap
current
consid
form
bronchiol
obliteran
syndrom
may
emerg
episod
viral
pneumonia
progress
fibrou
obliter
bronchial
lumen
lead
emphysema
compon
vascul
obliteran
consequ
alter
pulmonari
perfus
diagnosi
exclus
discard
caus
pulmonari
hyperluc
pneumothorax
emphysema
endobronchi
obstruct
hypoplast
lung
pulmonari
embol
agenesi
pectorali
major
muscl
pulmonari
ct
test
choic
diagnosi
show
destruct
affect
lung
parenchyma
without
bronchiectasi
addit
ipsilater
pulmonari
arteri
diminish
calib
scintigraphi
scan
may
contribut
diagnosi
patient
access
test
doppler
echocardiographi
reveal
decreas
pulmonari
arteri
flow
affect
side
correl
degre
pulmonari
hypoperfus
observ
scintigraphi
find
suggest
doppler
echocardiographi
main
pulmonari
arteri
could
simpl
method
verifi
degre
pulmonari
hypoperfus
sj
unilater
asymmetr
pulmonari
disord
respiratori
health
children
syndrom
ireland
diskin
cdiskin
clark
flanagan
mcveigh
cox
respiratori
medicin
ladi
children
hospit
dublin
ireland
syndrom
ireland
sandyford
dublin
ireland
paediatr
nation
univers
ireland
galway
ireland
medicin
nation
univers
ireland
galway
ireland
purpos
signific
proport
children
syndrom
ds
frequent
suffer
respiratori
condit
obstruct
sleep
apnea
osa
intern
guidelin
recommend
screen
osa
children
ds
preval
respiratori
condit
irish
children
ds
unknown
preval
syndrom
estim
syndrom
ireland
live
birth
significantli
greater
compar
worldwid
incid
report
world
health
organ
live
birth
worldwid
method
respiratori
health
questionnair
distribut
parent
children
ds
ireland
regist
syndrom
ireland
dsi
result
three
hundr
nineti
three
survey
return
parent
survey
report
diagnosi
osa
child
diagnosi
rate
low
compar
high
rate
report
osa
symptom
report
snore
apnea
restless
night
children
receiv
diagnosi
osa
median
number
symptom
report
older
children
higher
burden
symptom
high
frequenc
symptom
known
impact
neg
qualiti
life
includ
daytim
somnol
new
enuresi
children
diagnosi
osa
poor
complianc
prescrib
therapi
describ
never
use
cpap
complianc
percept
benefit
directli
relat
immedi
long
term
impact
howev
wear
cpap
report
clear
benefit
describ
treatment
moder
extrem
success
one
quarter
parent
report
recurr
chest
infect
one
third
report
concern
regard
swallow
implic
largest
survey
kind
conduct
intern
parent
children
syndrom
report
signific
respiratori
morbid
high
preval
osa
variabl
perceiv
benefit
treatment
complianc
cpap
signific
proport
children
recurr
infect
prolong
durat
survey
highlight
need
increas
awar
servic
children
ds
higher
risk
develop
respiratori
disord
signific
clinic
servic
provis
econom
implic
need
address
find
author
consid
context
matter
patient
sleep
studi
pediatr
popul
castilla
la
mancha
good
tool
present
time
raynero
rcraynero
villarino
fuent
hospit
virgen
de
la
salud
toledo
spain
centro
de
salud
de
sonseca
sonseca
toledo
spain
object
object
project
analyz
sleep
pediatr
popul
castilla
la
mancha
produc
repres
percentil
graph
popul
aim
compar
use
present
time
method
observ
retrospect
studi
children
attend
healthi
child
review
clinic
month
number
hour
sleep
record
includ
differ
day
night
hour
patient
associ
percentil
accord
graph
current
use
refer
iglowstein
data
analyz
bear
mind
differ
age
rang
elabor
repres
percentil
chart
popul
result
total
children
analyz
period
children
month
children
month
children
year
children
year
children
year
children
year
result
show
clear
differ
percentil
sampl
current
use
refer
two
clear
exampl
would
follow
graph
vs
refer
graph
infant
month
sleep
hour
day
percentil
vs
percentil
infant
month
sleep
hour
day
percentil
vs
percentil
infant
month
sleep
hour
day
percentil
vs
percentil
boy
sleep
hour
day
percentil
vs
percentil
boy
sleep
hour
day
percentil
vs
percentil
conclus
graph
current
use
refer
sleep
repres
popul
cultur
geograph
differ
sleep
percentil
obtain
analysi
popul
clearli
differ
current
use
refer
percentil
rang
obtain
analysi
popul
clearli
lower
current
use
refer
reflect
sleep
disord
preval
frequent
reason
consult
evid
invers
proport
associ
sleep
durat
variou
patholog
mainli
overweight
obes
percentil
sleep
durat
fundament
tool
detect
children
risk
develop
sleep
problem
current
graph
emerg
sampl
subject
zurich
repres
popul
use
graph
origin
studi
popul
would
allow
us
identifi
effect
patient
sleep
depriv
therefor
risk
develop
secondari
problem
sleep
depriv
rare
case
hemoptysi
mucoepidermoid
carcinoma
lung
boy
miranda
hoepker
gutierrez
pediatr
hospit
nacion
de
san
jose
costa
rica
patholog
hospit
nacion
de
san
jose
costa
rica
respiratori
medicin
hospit
nacion
de
san
jose
costa
rica
introduct
present
case
boy
histori
chronic
cough
hemoptysi
case
report
boy
poorli
control
asthma
treat
inhal
steroid
exacerb
present
histori
predomin
nocturn
product
cough
associ
two
episod
hemoptysi
relev
respiratori
symptom
chest
perform
reveal
right
upper
lobe
collaps
consolid
lead
referr
institut
thorough
diagnost
workup
histori
foreign
bodi
aspir
fever
night
sweat
weight
loss
underw
initi
flexibl
bronchoscopi
show
endobronchi
exophyt
nodular
lesion
right
upper
lobe
see
figur
given
longstand
histori
respiratori
symptom
area
refer
initi
diagnosi
presumpt
endobronchi
tuberculosi
nevertheless
tuberculin
skin
test
mm
ziehl
nielsen
stain
polymeras
chain
reaction
pcr
bronchoalveolar
lavag
bal
sampl
bronchial
brush
neg
mycobacterium
tuberculosi
sampl
posit
streptococcu
pneumonia
therefor
commenc
iv
antibiot
persist
hemoptysi
high
resolut
computer
tomographi
scan
hrct
scan
chest
perform
look
malign
vascular
abnorm
studi
reveal
nearli
complet
atelectasi
right
upper
lobe
plu
endobronchi
lesion
obliter
right
upper
lobe
bronchi
also
show
cylindr
bronchiectasi
intraparenchym
caviti
second
bronchoscopi
perform
show
similar
find
therefor
endobronchi
biopsi
exophyt
lesion
perform
bronchial
biopsi
character
cell
abund
fluffi
cytoplasm
larg
mucin
vacuol
compat
mucoepidermoid
carcinoma
mec
child
underw
lobectomi
right
upper
lobe
guid
flexibl
bronchoscopi
given
worldwid
report
suggest
surgeri
rather
chemotherapi
radiotherapi
patient
receiv
therapi
underw
surgic
remov
tumor
complet
resect
histopatholog
analysi
consist
well
differenti
mec
cm
stage
metastasi
lymph
node
without
extracapsular
extens
current
patient
continu
routin
surveil
thrive
well
asymptomat
lung
function
remain
stabl
conclus
among
rare
caus
hemoptysi
pediatr
pulmonologist
expect
encount
tumor
pulmonari
adenoma
carcinoma
may
present
particularli
older
children
therefor
malign
must
alway
consid
part
differenti
diagnosi
persist
hemoptysi
children
underli
chronic
lung
diseas
mucoepidermoid
carcinoma
rare
diseas
account
less
primari
malign
lung
tumor
deriv
epitheli
mucou
secretori
cell
common
origin
salivari
gland
tumor
characterist
trait
differenti
benign
malign
lesion
mec
gener
occur
central
bronchial
region
patient
tumor
aris
right
upper
bronchu
common
clinic
symptom
sign
includ
cough
hemoptysi
bronchiti
wheez
sometim
fever
therefor
clinic
pictur
mec
similar
common
entiti
asthma
lower
respiratori
tract
infect
pneumonia
tumor
usual
small
rang
cm
usual
soft
polypoid
color
diagnosi
base
sole
histopatholog
report
standard
treatment
prognosi
depend
histolog
grade
tumor
mec
rare
entiti
pediatr
pulmonologist
encount
keep
mind
figur
figur
exophyt
endobronchi
lesion
hemoptysi
right
upper
lobe
macroscop
microscop
pictur
lesion
